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1 Summary 
 
Proteins are composed of 20 canonical amino acids whose unique arrangements predefine 
a protein’s structure and function. Importantly, most proteins are not static conformations 
but rather very dynamic entities that undergo various structural modifications under 
different “stimuli”. The comprehension of these dynamic processes is necessary to 
understand how proteins work. 
Förster/Fluorescence resonance energy transfer (FRET) became a powerful tool to 
investigate conformational changes of proteins, and recent advances in technology haven 
given the capability for studies even on a single-molecule (sm) level. Therefore precise 
labeling of the proteins with suitable fluorophores is essential, however, remains a 
challenging task at present. Although chemical bioconjugation of fluorophores and proteins 
work, more or less reliably, specificity is a drawback for longer polypeptides and full-length 
proteins. 
To overcome the issue of specificity, synthetic biologists have opened new avenues by 
developing an expansion of the genetic code. This technique requires the introduction of 
exogenous nonsense suppressor tRNAs and their cognate aminoacyl-tRNA synthetases 
(aaRS) into the host cell, that have to work completely orthogonal to the endogenous 
components. This allows the incorporation of additional “unnatural” amino acids (UAAs) 
into proteins at the genetic level. These UAAs can bear many different functional groups 
with unique chemical or biophysical properties. 
Since we were interested in introducing two fluorophores, site-specifically into a protein, 
we had to use two tRNA/aaRS pairs, along with the plasmid harboring the gene of interest. 
This general approach necessitated multiple plasmids with different antibiotic resistances 
leading to heightened stress in the host cells. Additionally, using two non-cognate 
tRNA/aaRS pairs displayed toxic side-effects and required balanced levels within cells. 
Moreover, the two different UAAs drastically decreased the suppression efficiency and, in 
turn, the expression levels of protein. Therefore, an overall optimization of the system was 
essential. 
Herein, we describe the optimization process. We set out to reduce the number of plasmids 
used in this system, resulting in a highly modular genetic tool. We designed this system to 
allow for easy exchange with other tRNA/aaRS pairs to introduce new UAAs. We explored 
1: Summary  2 
promoter libraries to fine-tune the expression levels of tRNA/aaRS pairs, which had 
profound effects on the UAA incorporation efficiency. 
Using the above system we achieved higher levels of protein expression with two different 
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2 Introduction 
2.1 Proteins Encoded By The Genetic Code 
The three domains of (cellular) life proposed by Woese[1] imply millions of discovered 
species, as well as those yet undiscovered[2,3]. Despite this huge diversity, all living 
organisms, whether they are single or multi-celled, have common similarities. They are all 
built upon simple organic compounds, such as nucleotides and amino acids, the biological 
“bricks of life”. These monomeric subunits form larger polymeric macromolecules, including 
DNA/RNA and proteins respectively, assembled in intricate networks of biological 
processes. 
Proteins play a leading part in these highly complex biological systems since they 
participate in virtually all processes, making them one of the most studied objects in life 
science. Their variety in structure and function is determined by unique arrangements of 
the 20 canonical amino acids. Minor mutations, even a single amino acid, can lead to 
altered conformations that perturb the native function of the protein. The individual amino 
acid arrangement is dictated by the nucleotide sequence of a protein’s gene, encoded by 
non-overlapping triplet codons, composed of a combination of the four bases adenine (A), 
cytosine (C), guanine (G) and thymine (T). This genetic code consists of 64 possible codons 
from which 61 are assigned to the 20 amino acids and the remaining three to the 
termination of protein synthesis[4–11]. 
The assembly of proteins is performed by ribosomes, huge macromolecular complexes 
composed of ribosomal (r) RNAs and proteins divided into small and large subunits. The 
process of decoding the mRNA into proteins is called translation and can be separated into 
the four steps. These are termed initiation, elongation, termination, and recycling[12,13]. 
Protein synthesis in prokaryotes and eukaryotes is different but primarily they differ only in 
the initiating steps [14]. 
Translational events in the prokaryote Escherichia coli (E. coli) starts with the complex 
formation between initiation factors IF1 and IF3, as well as the small (30S) ribosomal 
subunit[15,16]. This complex is able to bind cellular mRNAs by the interaction of the anti-
Shine-Dalgarno sequence on the 16S rRNA and the Shine-Dalgarno sequence 
(5’-AGGAGG-3’) on the mRNA, located upstream of an AUG start codon[17,18]. The mRNA is 
guided by this sequence and is thereby positioned in the P site of the ribosome. The 
recruitment of the GTP-binding protein IF2 and the initiator tRNA, aminoacylated with 
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formylated methionine (fMet-tRNA), prepares the 30S initiation complex for the association 
with the large (50S) subunit of the ribosome upon GTP hydrolysis. The newly formed 70S 
initiation complex is poised for the translational elongation phase[13–15]. 
During elongation, adding amino acids in recurring steps extends the nascent polypeptide 
chain. Therefore, ternary complexes composed of elongation factor Tu (EF-Tu), GTP and 
tRNA, which has been previously aminoacylated with the correct amino acid by a cognate 
aminoacyl-tRNA synthetase (aaRS)[19,20], are delivered into the decoding center within the 
A site of the ribosome[21]. The ribosome actively monitors the selection of the proper 
aminoacyl-tRNA, which is dictated by the mRNA codon, and thus maintains the fidelity of 
the genetic code[22–24]. Whereas the first two codon-anticodon base pairs have to form strict 
Watson-Crick pairs (A-U and G-C), excluding non-cognate and wobble pairs, wobble pairing 
at the third position of the codon is tolerated[23,25]. This means, the 5’-base of the tRNA 
anticodon can form non-Watson-Crick base pairs with the 3’-base of the mRNA codon, 
permitting some tRNAs to decode more than one codon. The delivery of the appropriate 
ternary complex into the ribosome’s A site facilitates GTP hydrolysis by EF-TU, followed by 
its dissociation from the ribosome and the accommodation of the aminoacylated tRNA 
acceptor stem in the peptidyl transferase center (PTC) within the large subunit for peptide 
bond formation[13,24]. This causes the transfer of the nascent peptide chain from the P site 
to the A site tRNA. To remove the deacylated tRNA in the P site and to position a new 
codon in the A site for the arrival of another aminoacyl-tRNA in the next round, the 
elongation cycle ends with the translocation of the tRNAs and the mRNA by precisely one 
codon. This process is catalyzed by the elongation factor EF-G at the cost of GTP 
hydrolysis[13,26]. 
The elongation phase terminates when one of the three stop codons (UAA, UAG or UGA) 
moves into the A site. These codons are recognized by the release factors RF1 (UAA, UAG) 
and RF2 (UAA, UGA)[27,28] that mediate the cleavage of the nascent polypeptide chain from 
the tRNA bound in the ribosome’s P site, leading to the release of the newly synthesized 
protein from the ribosome. Afterwards, the GTP-binding protein RF3 accelerates the 
dissociation of RF1/RF2 from the ribosome, which is subsequently recycled for the 
translation of further proteins[13]. 
 
2: Introduction  5 
2.2 Expansion And Modification of The Genetic Code 
The genetic code of all living organisms is near-universally conserved and was long 
concidered to be restricted to the 20 naturally occurring amino acids. In 1986 two 
workgroups independently discovered that the nonstandard amino acid selenocysteine 
(Sec) is directly incorporated into proteins in response to in-frame opal stop codons (UGA), 
instead of being created by posttranslational modification[29,30]. Afterward, this system was 
regarded as an expansion of the genetic code and selenocysteine was titled the 21st amino 
acid[31,32]. Sixteen years later pyrrolysine (Pyl) was found to be the 22nd genetically encoded 
amino acid, this time in response to the amber stop codon (UAG)[33–35]. Whereas Sec is 
present in prokaryotes and eukaryotes[36], the distribution of Pyl appears limited to the 
Methanosarcinacea and Gram-positive Desulfitobacterium hafniense[37]. Furthermore, both 
amino acids differ in their aminoacylation mechanism. Sec is made via an enzymatically 
modified serine that was charged to a special selenocysteinyl-tRNA. In contrast, Pyl is 
directly paired to pyrrolysyl-tRNA (PylT) by the cognate aminoacyl-tRNA synthetase PylS[37–
39]. 
In addition to Sec and Pyl, even more deviations have been found to the standard genetic 
code. Genome analyses revealed ten codon reassignments in prokaryotic and eukaryotic 
nuclear codes which all are a subset of 16 changes occurring in mitochondrial codes[40]. 
Moreover, some methanogenic archaea compensate the lack of a canonical cysteinyl-tRNA 
synthetase by a particular pathway using O-phosphoserine that is enzymatically converted 
to cysteine prior to incorporation into a nascent protein[40]. All these modifications show a 
certain flexibility of the genetic code towards evolutionary novelties, giving the potential 
for additional genetically encoded nonstandard amino acids that might exist in still-
uncharacterized genomes[40]. However, the search for the 23rd amino acid has not yet been 
successful, making the appearance of further widely spread amino acids improbable[41]. 
At the end of the last century, scientists began to exploit the degeneracy of the genetic 
code, in order to artificially expand it for the genetically encoded incorporation of amino 
acids with new functionalities into proteins. These “unnatural” amino acids (UAAs) bear 
many different functional groups, such as posttranslational modifications, UV-inducible 
crosslinkers, spectroscopic probes and chemical handles that can be modified chemically, 
even in living cells[42]. This required the introduction of exogenous tRNAs and their cognate 
aaRSs into the host cell, which have to work completely orthogonal to the endogenous 
components. That means, the introduced tRNAs should not be charged with any canonical 
amino acid by the host’s aaRSs and, in turn, the orthogonal aaRS should not aminoacylate 
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any endogenous tRNA with UAAs. The anticodon of the orthogonal tRNA is typically 
complementary to blank (nonsense, frameshift, or otherwise unused) codons, especially 
the rarely used amber stop codon, allowing the reassignment of the appropriate codon to 
the amino acid used as a substrate by the orthogonal aaRS. The feasibility of this method 
was proven in 1998 by Furter who was able to site-specifically incorporate p-fluoro-
phenylalanine (p-F-Phe) into dihydrofolate reductase (DHFR) in E. coli expressing a yeast 
amber suppressor tRNA/phenylalanyl-tRNA synthetase (PheRS) pair[43]. 
 
Figure 2.1: Schematic view for genetic code expansion. 
Desired unnatural amino acids (UAAs) are taken up by the cell using endogenous transporters. These UAAs are 
used by evolved aminoacyl-tRNA synthetases (aaRSs) to charge corresponding evolved tRNAs. The tRNAs are 
then used by the ribosomes to decode (mostly) amber codons introduced in the mRNA, to incorporate the UAAs 
at predetermined sites on the protein of interest. 
 
Whereas the yeast PheRS accepted the substrate analogue p-F-Phe without further 
modifications, advances in this system necessitated the adaption of aaRS’ specificities 
towards specific UAAs[44]. Furthermore, the original standard amino acid phenylalanine was 
still a substrate for the PheRS, resulting in non-homogenously labeled protein. This 
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disadvantage was overcome by a large excess (up to 30-fold) of p-F-Phe supplementation in 
the growth medium[43]. The first tRNA/aaRS pair that was truly orthogonal and only 
recognizing the desired UAA was derived from the tyrosyl pair from Methanococcus 
jannaschii (M. jannaschii) in the workgroup of Peter Schultz. This pair was evolved to 
incorporate O-methyl-L-tyrosine into DHFR in response to an amber codon[45] (Figure 2.1). 
To achieve this, they developed a systematic approach to alter the specificity of a 
synthetase for a certain UAA. First, all active-site residues interacting with the actual 
tyrosine substrate were randomly mutated, yielding a large library of synthetase variants 
which were passed through multiple rounds of stringent positive and negative selection. 
The positive selection was based on a reporter plasmid containing an antibiotic resistance 
gene with amber mutations at permissive sites, in this case a chloramphenicol 
acetyltransferase (CAT). E. coli cells simultaneously transformed with this reporter and the 
aaRS library plasmids were only able to survive in media containing chloramphenicol and 
the UAA, if they harbored a functional synthetase variant recognizing either the UAA or a 
natural amino acid (also see Ch. 3.2.4.1). The subsequent negative selection eliminated 
undesired aaRSs suppressing amber codons with endogenous amino acids in the absence of 
the UAA. Therefore, active synthetase clones from the first round were combined with a 
reporter plasmid comprising an amber mutant of the toxic barnase gene. Clones that 
produce full-length barnase protein using canonical amino acids will die because of its 
ribonuclease activity, which is toxic to cells without its specific inhibitor barstar[46] (also see 
Ch. 3.2.4.3). Multiple rounds of these two selections were performed, leading to an 
orthogonal, highly specific and amber suppressing aaRS variant[44] (Figure 2.2). 
 
Figure 2.2: General selection scheme for the evolution of aminoacyl-tRNA synthetase (aaRS) substrate 
specificities for unnatural amino acids (UAAs)
[44]
. 
First, non-functional aaRS library variants are removed in a positive selection in the presence of the UAA and 
chloramphenicol (Cm). Functional variants suppress the amber codon within the chloramphenicol 
acetyltransferase (CAT) gene with both natural and unnatural amino acids. Synthetases specific for the UAA are 
isolated in a negative selection in the absence of the UAA, while suppression of the amber codons in the 
barnase gene leads to cell death. 
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The success in E. coli led to the development of a very similar selection approach in yeast, 
driven by amber suppression in the transcriptional activator GAL4. The production of full-
length GAL4 in the presence of the UAA activates the expression of GAL4-responsive HIS3, 
URA3, and lacZ reporter genes, allowing for survival on media lacking histidine or uracil. 
Negative selections to remove unspecific synthetases are based on the conversion of the 
protoxin 5-fluoroorotic acid (5-FOA) to its toxic product by the URA3 gene product on 
media without the UAA[44,47]. 
The evolution of tRNA synthetases in cells of higher eukaryotes, like mammalians, is more 
difficult due to technical issues concerning transformation efficiency, slow doubling times, 
and growth conditions. In this direction, a shuttle approach was applied with tRNA/aaRS 
pairs, which are orthogonal both in E. coli or Saccharomyces cerevisiae (S. cerevisiae) and in 
mammalian cells. Pairs evolved for UAAs in the easier to handle bacterium or yeast can 
then be transferred into mammalian cells while keeping orthogonality[48]. 
Using the aforementioned techniques a variety of orthogonal tRNA/aaRS pairs from various 
organisms have been used to add up to 100 unique unnatural amino acids to the genetic 
code of prokaryotes, including E. coli and some mycobacteria, and eukaryotes, like the 
yeasts S. cerevisiae and Pichia pastoris and even the multicellular organisms Caenorhabditis 
elegans and Mus musculus[42,48]. However, the majority of all genetic code expansion 
approaches were performed with only four different tRNA/aaRS pairs, each suitable for a 
particular model organism. First, the already mentioned M. jannaschii tyrosyl pair 
(MjYRS/MjYT) is orthogonal only in E. coli and other bacteria. The second and third are two 
synthetases from E. coli decoding for tyrosine (EcTyrRS) and leucine (EcLeuRS) in 
combination with their cognate tRNAs and can be utilized only in yeast, mammalian and 
other eukaryotic cells. Lastly, the aforesaid PylS/PylT pair from Methanosarcina species 
provides the advantage of being orthogonal in both bacteria and eukaryotic cells, showing 
no cross-reactions with endogenous synthetases or tRNAs. Additionally, the natural aaRS 
substrate specificity must not be destroyed before the evolution for a new UAA, since it 
decodes pyrrolysine and none of the 20 canonical amino acids[49]. 
 
2.3 Limitations And Optimizations of The Expanded Genetic Code 
Although the genetically encoded incorporation of UAAs into proteins works, in principle, 
this system has to cope with a large range of limitations. These restrictions reduce the 
efficiency or even the feasibility of the system. Not all the desired UAAs exhibit the cell 
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permeability required to cross the cell membrane, impeding the uptake by the cell and 
thereby the integration into the translational apparatus. Even if the UAA can be imported, 
the structural nature of the aaRS’ active site must allow the evolution of its specificity to 
the particular amino acid. Furthermore, the incorporation efficiency of UAAs at certain sites 
in the protein can also be negatively influenced by effects of the mRNA context[50] and the 
local protein structure[51], as well as further factors like protein folding and stability[48]. 
One of the main reasons for decreased yields of proteins with UAAs is the competition of 
reassigned codon suppression with other cell activities, such as binding of a release factor 
to a stop codon or the erroneous recognition of a frameshift codon by three-base 
anticodon tRNAs. In E. coli suppression of the most commonly used blank codon, the amber 
codon, is impaired by the interaction with its release factor RF1, leading to truncated 
proteins. The incorporation of several UAAs into the same protein intensifies this effect. A 
simple deletion of the RF1-encoding gene, prfA, seemed to be unfeasible since this factor 
has been reported to be essential[52,53]. 
However, a couple of workgroups successfully reduced the competing effect of RF1 or even 
managed to perform a prfA knockout. For instance, enhanced amber suppression efficiency 
by overexpressing the C-terminus of the ribosomal protein L11, which has been suggested 
to play an important role in RF1-mediated translation termination, facilitated the 
incorporation of up to three acetyllysines into the same green fluorescent protein (GFP)[54]. 
Rydén and Isaksson found a temperature sensitive RF1 mutant that showed an increased 
efficiency to several amber tRNA suppressors[55]. This could be utilized to favor UAA 
incorporation in response to amber codons, but ongoing growth at high temperature would 
be fatal for the cell and could affect the production of many recombinant proteins 
adversely. 
The Nakamura group was able to compensate for this temperature dependent RF1 growth 
deficit by engineering RF2 with a single amino acid substitution to an omnipotent release 
factor (RF2*), capable to terminate translation at all three stop codons[56]. The use of RF2* 
even permitted a chromosomal RF1/RF2 double knockout, indicating that RF1 is 
nonessential in E. coli. This hypothesis was emphasized by the work of Wang and co-
workers who showed the feasibility of a prfA deletion strain by “fixing” the RF2-encoding 
prfB gene. The engineering of their RF2 variant (prfBf) included the removal of an in-frame 
UAG autoregulation element and the reversion of a peculiar mutation (A246T) that only 
occurs in E. coli strains derived from K-12, impairing RF2’s release activity for the ochre 
(UAA) codon by a factor of five[57]. The reduced activity of mutated RF2 was supposed to be 
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the reason for the apparent RF1 essentiality. Indeed, later experiments confirmed that 
previously reported attempts to knock out RF1 failed because they used E. coli K-12 strains 
containing the peculiar A246T mutation. Deletion trials using three common E. coli B strains 
(REL606, BL21, and BL21(DE3)), derived from the second progenitor of most E. coli strains 
and encoding wild type RF2, allowed successful prfA knockout. Thus, RF1 was proposed to 
be nonessential for wild type E. coli with nonmutated RF2[58]. The employment of RF1 
knockout strains with either wild type background (B strains) or the “fixed” RF2 facilitated 
the genetically encoded incorporation of up to ten identical UAAs into the same protein. 
The workgroups of Yokoyama and Sakamoto accomplished the deletion of prfA while 
leaving RF2 untouched. They used a combination of a bacterial artificial chromosome, 
harboring the seven essential open reading frames (ORFs) of E. coli naturally ending with an 
UAG codon but replaced by UAA, and an amber suppressor tRNA. This kept the cells viable 
and permitted the UAG-dependent incorporation of up to ten natural or six unnatural 
amino acids into the same polypeptide[59]. The role of the amber suppressor tRNA was 
supposed to alleviate the significantly impaired fitness observed for all mentioned RF1 
knockout strains. Its UAG-decoding activity was thought to prevent ribosome stalling at 
UAG codons and to allow the expression of the nonessential ORFs ending with an amber 
codon which are then terminated by naturally occurring in-frame “backup” stop codons, 
opal or ochre, downstream of the suppressed one. Stalled ribosomes have at least three 
disadvantages that reduce a cell’s fitness. First, they cannot finish required protein 
synthesis. Second, if stalled they are “trapped” to the particular mRNA and cannot be 
recycled to translate further mRNAs. Third, the tmRNA surveillance system[60,61] is activated, 
a rescue mechanism responsible for cleavage of the appropriate mRNA and tagging of the 
premature protein for degradation. Degradation of an overwhelming number of proteins 
can induce cell death[57,59]. Indeed, Yokoyama and Sakamoto could show in following 
experiments that an efficient decoding of the amber codon, using a tRNA variant with 
enhanced suppression activity, instead of reducing the number of UAGs in the genome 
improved the growth of a prfA-deficient strain of E. coli[62]. 
By contrast, the laboratories of Church and Isaacs used multiplex automated genome 
engineering (MAGE)[63] to create an E. coli strain that had all known UAG stop codons 
replaced with synonymous UAA codons[64]. Afterwards, they deleted RF1 in this strain, 
reassigning UAG as a sense codon, and compared their approach with those reported by 
Wang as well as Yokoyama and Sakamoto. They found that their strain was the only one 
without deleterious effects causing impaired fitness. Furthermore, they proposed that RF1 
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is essential only for UAG translational termination and not for UAA termination or other 
essential cellular functions, since RF2 was kept unmodified[65]. 
Chin and co-workers pursued an alternative strategy, which did not focus on deletion or 
mutation of the release factors. They utilized orthogonal ribosomes (O-ribosomes) to 
reduce the competing effect of RF1. Developed by Chin and Rackham, O-ribosomes form 
the basis of a parallel and independent translational machinery since their anti-Shine-
Dalgarno sequence was mutated to exclusively bind to the likewise modified Shine-
Dalgarno sequences of orthogonal mRNAs (O-mRNAs). These O-mRNAs, containing an 
orthogonal ribosomal binding site (ORBS), are in turn, not a substrate for endogenous 
ribosomes[66]. As part of a parallel and independent system O-ribosomes are unburdened 
from the maintenance of housekeeping gene expression and therefore evolvable to handle 
new challenges, whereas mutations of the natural ribosome are potentially lethal to the 
cell. By mutating merely two positions (U531G and U534A) in a loop of the 16S rRNA in the 
A site, that was found to be in close proximity to both the anticodon of tRNAs bound to 
mRNA and the RF1, Chin and co-workers created an evolved O-ribosome (termed ribo-X) 
which showed greatly enhanced suppression of amber codons placed in O-mRNAs. They 
hypothesized that this improvement resulted from a decreased functional interaction of 
ribo-X with RF1[67]. 
Even in systems optimized for release factor competition an adequate delivery of tRNAs 
charged with the correct UAA is required. Therefore, the expression of the appropriate 
tRNAs and their cognate aaRSs have to be carefully balanced, to guarantee an efficient 
translation but also avoid the overconsumption of biological resources and the generation 
of toxic side effects by an excessive production of these components. Furthermore, 
unnecessary metabolic burden for the cell, provoked by, for example, plasmids and 
corresponding antibiotics, should be prevented. With regard to these issues, several 
strategies to improve full-length protein yields have been investigated. The simplest 
solution involved combining the genes encoding the orthogonal tRNA and synthetase on a 
single plasmid compatible with most expression vectors and strains[68,69]. The Schultz 
laboratory developed a single-plasmid system (pSup) that was consecutively optimized. By 
merging derivatives of the M. jannaschii tyrosyl pair under the control of enhanced 
promoters (proK instead of lpp promoter for the tRNACUA and a strong mutant glnS 
promoter instead of the wild type variant for the aaRS) on a single vector and raising the 
tRNA copy number from one to three or six, they observed a 20-fold[48] increase in the yield 
of an UAA-containing myoglobin protein in E. coli[69]. An improved version of pSup, called 
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pSUPAR, comprised an additional copy of the synthetase under the control of an arabinose-
inducible ara promoter[70]. The replacement of the polycistronic tRNA cluster in pSUPAR 
with only one copy of an optimized M. jannaschii amber suppressor tyrosyl-tRNA, which 
has been reported to be generally less toxic to E. coli and to show increased UAA 
incorporation efficiency with several aaRS[71], resulted in pEVOL. Compared to the first 
described pSup, pEVOL led to roughly 250% greater yields of UAA-containing proteins[51]. 
Based on these insights, they finally designed the suppressor plasmid pUltra which 
harbored a single copy each of the tRNA cassette from pEVOL and the synthetase MjYRS 
under the control of a tacI promoter. They found pUltra to be better than pEVOL, 
particularly when tested with weakly expressing mutants or inherently weak suppressor 
tRNA/aaRS pairs, and achieved the efficient incorporation of up to three UAAs in response 
to amber stop codons within the same GFP protein. 
Since pUltra and pEVOL both have a unique origin of replication and antibiotic resistance 
marker they are mutually compatible. This was exploited to simultaneously insert two 
different UAAs into the same protein using amber and ochre codons with pEVOL encoding 
the M. jannaschii amber suppressor pair and pUltra a pyrrolysyl-tRNA/aaRS pair optimized 
for enhanced ochre suppression. Furthermore, the simple configuration of pUltra enabled 
the generation of pUltraII, a single plasmid containing both suppression systems for amber 
and ochre codons. The dual suppressor pUltraII showed similar full-length protein 
expression levels relative to pUltra and pEVOL in combination, but reduced the metabolic 
burden for the cell by one plasmid and thereby one antibiotic[72]. 
Further efforts to find and optimize factors that affect the incorporation efficiency of 
unnatural amino acids were made. For instance, in one approach MjYRS was mutated to 
mediate a better recognition of the cognate tRNA’s CUA anticodon[73]. Another study 
described the development of EF-TU mutants that better accept UAAs, particularly those 
with large side chains or altered backbones[74]. But the simultaneous incorporation of two 
or more distinct UAAs into the same polypeptide poses a difficult challenge. 
Each individual UAA necessitates its own orthogonal tRNA/aaRS pair decoding a unique 
codon. The use of stop codons to generate proteins with multiple UAAs, as reported by 
Wan et al.[75] or Chatterjee et al.[72] (employing pUltra and pEVOL as described above), 
quickly reaches its limit. Reassigning some of the 61 other triplet codons encoding natural 
amino acids would be an option but not easy to handle because this requires genome wide 
replacements with yet unknown consequences. In addition, even if feasible, this would 
provide a relatively small set of new blank codons, whereas the usage of codons extended 
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to four bases theoretically affords 256 novel blank codons. The combination of a 
quadruplet and an amber codon has already been successfully utilized to incorporate two 
unremarkable UAAs into the same model protein[76]. However, the capability of natural 
ribosomes to decode four-base codons with extended anticodon tRNAs is moderate, 
probably due to poor tRNA accommodation in the ribosome’s decoding center[77]. This 
inefficiency cannot be circumvented by evolving the endogenous ribosome because this 
potentially leads to cell death. For this reason, the Chin laboratory further evolved their 
orthogonal ribo-X to create an O-ribosome, called ribo-Q1, which exhibits enhanced 
quadruplet and amber decoding on O-mRNAs. Although they randomly mutated 127 
nucleotides of the A site’s 16S rRNA, ribo-Q1 contains just two mutations (A1196G and 
A1197G) with respect to ribo-X, allowing an efficient decoding of four-base codons 
approaching the level of triplet decoding on the natural ribosome[78]. 
Finally, the number of currently existing mutually orthogonal tRNA/aaRS pairs in bacteria, 
namely the MjYT/MjYRS pair from M. jannaschii and the PylT/PylS pair from 
Methanosarcina species, confines the incorporation of different UAAs into the same 
polypeptide to two. Since it is not clear if a sufficient number of pairs can be discovered 
that have been formed by natural evolutionary divergence and which fulfill the absolute 
required criterion to be orthogonal to both endogenous and already existing exogenous 
pairs to encode additional unnatural amino acids, alternative strategies need to be 
invented. One approach was reported by Neumann et al. who designed an orthogonal 
tRNA/aaRS pair de novo from an existing one by duplicating the MjYT/MjYRS pair in a logical 
series of mutagenesis and selection steps[79]. 
 
2.4 Applications of The Expanded Genetic Code 
The principles of genetic code expansion haven been applied in numerous studies in order 
to investigate the nature of a protein itself or to give a protein new properties which are 
not provided by the common 20 amino acids. Site-specifically incorporated unnatural 
amino acids offer a myriad of new functionalities, such as posttranslational modifications, 
UV-inducible crosslinkers, spectroscopic probes and chemical handles that can be 
subsequently altered, in vitro and in some cases even in vivo[42,48,49]. In the following, a small 
selection of UAAs and their application is presented, exemplifying the enormous potential 
of an expanded genetic code for basic and applied scientific research. 
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To understand how biological processes form life, one has to investigate the participating 
proteins and their interaction partners. This is sometimes problematic when these 
interactions are only transient, weak or at particular subcellular locations. Genetically 
encoded crosslinkers that react with nearby molecules in response to (UV)-light facilitate 
the covalent trapping of interaction partners for subsequent identification. Several 
crosslinking systems exist for bacteria, yeast and mammalian cells, including azido 
derivatives of phenylalanine[47,80], diazirines[81,82] and benzophenones, such as the by far 
most frequently used p-benzoyl-L-phenylalanine (BPA)[47,83]. BPA helped to address 
questions concerning the mechanism of polypeptide translocation across the cytoplasmic 
membrane in E. coli mediated by the bacterial SecY-SecE-SecG (SecYEG) translocon, a 
channel-like transmembrane complex, and the SecA ATPase[84,85]. Wilkins et al. used BPA to 
study how histone modifications in yeast influence the complicated but important 
biological process of chromosome condensation in mitosis[86] and Tagami et al. to define 
conformational changes in the bacterial RNA polymerase of Thermus thermophilus[87]. 
A cells’ proteome is dynamically controlled by posttranslational modifications (PTMs) that 
can change a protein’s molecular function, affinity for binding partners, localization and 
stability. However, for the majority of these PTMs the modifying enzymes are still unknown, 
making the production of homogeneously and site-specifically modified proteins 
challenging. This can be achieved by using genetic code expansion, which permits the 
genetically encoded installation of PTMs into proteins, in order to assess the role of a 
protein’s PTMs. So far, a variety of methods have been reported for incorporating 
nitrated[88] and sulfated[89] tyrosine, analogues of phosphorylated tyrosine[90], 
phosphorylated serine[91], mono-[92,93] and dimethylated[94], acetylated[95] and 
ubiquitinated[96] lysine into recombinant proteins. Employing these methods, the effect of 
H3 K56 acetylation on nucleosome and chromatin structure and function has been 
examined, revealing that this modification mediated an increased DNA breathing on the 
nucleosome[97]. In another case the role of an acetylated lysine in a protein involved in HIV 
infection, cyclophilin A (CypA), has been identified to regulate key functions of CypA that, 
among other things, lead to diminished effects of the widely-used immunosuppressive drug 
cyclosporine[98]. 
Furthermore, UAAs with spectroscopic properties have been installed into proteins. For 
example, the phenylalanine derivative p-azido-L-phenylalanine (AzF), which can also be 
used as a crosslinker[47,80] (see above), is suitable for infrared (IR) spectroscopy since its 
vibration of the azido group absorbs in a clear spectral window at ∼2100 cm−1, well 
2: Introduction  15 
separated from intrinsic protein vibrations. This has been exploited to examine fast 
conformational changes, that the G protein-coupled receptor rhodopsin undergoes after 
light activation and binding a cytoplasmic G protein, by Fourier transform infrared (FTIR) 
difference spectroscopy[99,100]. Another IR-labeled phenylalanine, bearing a cyano group in 
place of the azido moiety (p-cyano-L-phenylalanine), absorbing at ∼2200 cm−1, was 
incorporated into myoglobin to probe metal ion and ligand binding[101]. Unnatural amino 
acids holding 19F, 13C or 15N isotopes[70,102–104], that can be detected by nuclear magnetic 
resonance (NMR), enable single site structural investigations of proteins, in contrast to 
global labeling by growth medium supplementation with 13C-glucose and 15N-ammonium. Li 
et al. could perform NMR supported analysis of protein dynamics inside of cells, “in-cell 
NMR” (also see Ch. 5.4), since they were able to detect several site-specifically 19F-labeled 
proteins in living E. coli[104]. 
Genetically encoded UAAs were not only used to determine functionalities of proteins and 
their related biological processes. Liu and colleagues introduced, among others, 
p-acetyl-L-phenylalanine (pAcF) into different cis-regulatory leader-peptide elements. These 
small molecules served as ON or OFF switches and thereby regulated the transcription of 
downstream genes[105]. The same amino acid was also employeed to make the therapeutic 
agent, human growth hormone (hGH), more viable without perturbing its biological activity. 
To this end, the reactive functional group of pAcF was posttranslationally modified by 
PEGylation (covalent attachment of polyethylene glycol (PEG)) in a bioorthogonal “click 
reaction” (for “click reaction” also see next chapter and Ch. 5.1 to 5.3)[48,106]. 
 
2.5 The Genetically Encoded Incorporation of FRET Pairs 
Highly sensitive fluorophores belong to a class of spectroscopic probes not mentioned in 
the previous chapter. They can be used to determine protein expression, activity, 
localization, and function[107]. GFP is one of the most widely studied and exploited 
fluorophores in biochemistry and cell biology[108]. However, as a fluorescent protein it 
needs to be correctly folded to be functional. Thus, GFP cannot be site-specifically placed at 
any position in a protein of interest and is therefore fused to the protein’s termini. In 
addition, its size would perturb the structure and function of the investigated protein. 
Genetically encoded (small) fluorescent UAAs, in theory, would cause minimal structural 
perturbation and are unlikely to impair a protein’s function and localization. Unfortunately, 
many fluorophores are not cell-permeable or are simply too large to be a substrate for the 
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aaRSs. Hence, only a small number of fluorescent UAAs have been directly incorporated 
into proteins [109–112]. Nevertheless, Charbon et al. were indeed able to localize the 
chaperonin protein GroEL under normal and stress conditions in living cells by labeling with 
a coumarin fluorophore containing UAA, whereas GFP fusions proved to interfere with 
GroEL function[113]. Summerer et al. incorporated a dansyl-UAA into the protein human 
superoxide dismutase to follow its denaturation in the presence of guanidinium 
chloride[110]. 
In order to facilitate the labeling of proteins with a broader range of fluorophores, since 
hundreds of small organic dyes are commercially available[107], one had to find an 
alternative strategy. The genetically encoded installation of an UAA containing a 
bioorthogonal reactive moiety provides one avenue because they allow the subsequent 
site-specific modification of a protein with almost any probe by bioorthogonal “click 
chemistry”[114] and hence also any fluorophore that is compatible with the installed UAA. 
“Click reactions” between an azide and a terminal alkyne necessitate the use of cytotoxic 
Cu(I) to catalyze the cycloaddition[115], impeding in vivo applications. More recently, Cu(I)-
free approaches with cyclooctyne derivatives were developed, which activate the alkyne via 
ring strain[116,117]. The Ebright laboratory coupled fluorescent probes by Staudinger ligation 
to genetically encoded AzF to investigate the opening and closing of the bacterial RNA 
polymerase clamp[118]. Intracellular reduction is one disadvantage of genetically encoded 
azides. Alternative strategies employ inverse electron-demand Diels-Alder cycloaddition 
reactions between genetically encoded strained alkenes and alkynes and labeling reagents 
conjugated to tetrazines and/or azides[119]. The lysine derivatives Nε-5-norbornene-2-
yloxycarbonyl-L-lysine (NorK) and bicyclo[6.1.0]non-4-yn-9-ylmethanol-L-lysine (BCNK) have 
been successfully incorporated into proteins by the Chin laboratory, followed by labeling 
with fluorophores conjugated to tetrazines[120,121]. 
The simultaneous installation of two or more fluorophores in a single polypeptide permits 
the investigation of conformational changes, even on a single-molecule (sm) level, using the 
powerful technique Förster/Fluorescence resonance energy transfer (FRET). FRET relies on 
the energy transfer from a donor to an acceptor fluorophore in a distance-dependent 
manner and is capable of detecting distances and their changes in a nanometer scale, both 
in vitro and in vivo[122,123]. However, the precise and site-specific labeling of the proteins 
with suitable fluorophores is essential for FRET experiments but a challenging task and is 
often the limiting factor. Brustad et al. studied T4 lysozyme folding using FRET with site-
specific dual-labeling. One label was generated by a genetically encoded pAcF with a 
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hydroxylamine-containing fluorophore and the other from a single cysteine with a 
maleimide conjugated fluorophore[124]. Nevertheless, this technique is restricted in its 
applicability to single-cysteine proteins. The incorporation of two distinct and suitable UAAs 
into the same protein and the subsequent bioorthogonal labeling of these provides an 
elegant method for the genetically encoded incorporation of FRET pairs into proteins[72,78]. 
 
2.6 Specific Aims 
This work is intended to apply the principles of genetic code expansion to achieve the 
efficient incorporation of two different unnatural amino acids into the same polypeptide, 
allowing us the generation of proteins with a variety of functionalities, including FRET pairs, 
multiple different NMR and IR probes, combinations of posttranslational modifications and 
bioorthogonal reactive groups for subsequent chemical modifications. 
The eye of a needle for this aim is the efficiency of (multiple) UAA incorporation. Although 
several trials to optimize this efficiency have been performed by others in the past, none of 
these approaches provided a systematic study on the correlation of aaRS and tRNA 
expression levels including the aminoacylation status of the tRNA. Thus, only little insight is 
given into which of these components is the actual limiting factor. It is therefore necessary 
to establish assays for the detection of the abundance and activity of each component, in 
order to identify and optimize the constraints of the genetic code expansion system. 
Once the system is optimized, we will start to focus on the production of proteins with FRET 
pairs to investigate their conformational states and the transitions between them. This can 
be studied in single-molecule FRET experiments for which the precise labeling of proteins 
with suitable fluorophores is a limiting factor. 
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3 Materials And Methods 
3.1 Materials 
3.1.1 Devices And Instruments 
AbiPrism 3100 DNA Sequencer Applied Biosystems, Darmstadt 
Accumax Pipet Help Accumax, INDIA 
Agarose Gel Electrophoresis Chamber GP-Kuststofftechnik, Kassel 
Autoclave HST 4-5-8 Zirbus, Bad Grund 
BioPhotometer Eppendorf, Hamburg 
Biovortex V1 Peqlab, Erlangen 
Bunsen Burner Fuego Basis WLD-Tec, Göttingen 
Cell Sorter iCyt Synergy Sony Biotechnology, USA 
Centrifuge 5415R Eppendorf, Hamburg  
Centrifuge Allegra 2IR Beckman Coulter, Krefeld  
Centrifuge Avanti J-20 XPIJA-20 Beckman Coulter, Krefeld  
Centrifuge HERAEUS Pico 17 Thermo Scientific, Schwerte 
Concentrator 5301 Eppendorf, Hamburg  
Electroblotter (Semidry) PeqLab, Erlangen 
Electroblotter (Semidry; 20 × 20 cm) VWR International, Darmstadt  
Electroporator Easyject Prima EquiBio, Willstätt 
FLUOstar Omega BMG Labtech, Ortenberg 
Gel Doc 2000 BioRad, München  
Gel Shaker Duomax 1030 Heidolph, Schwabach 
Gel Shaker Rotamax 120 Heidolph, Schwabach 
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Hamilton Syringe 50 µL Hamilton, USA 
Hybridizer Oven HB-1000 UVP, USA 
Hypercassette 18 × 24 cm GE Healthcare, München 
Incubator Mytron WB 60 k Mytron, Heiligenstadt 
Labcycler SensoQuest, Göttingen  
Magnetic Stirrer MR Hei-Standard Heidolph, Schwabach 
Magnetic Stirrer MR3000 Heidolph, Schwabach 
Microfluidizer 110 S Microfluidics, USA  
Optimax X-Ray Film Processor Protec, Oberstenfeld 
pH Meter PT-15 Sartorius, Göttingen 
Photometer Biometra, Göttingen  
Pipets Research Plus (10, 100, 1000 µL) Eppendorf, Hamburg 
Power Supply 300V VWR International, Darmstadt 
Power Supply EV231 Consort, BELGIUM  
Power Supply MP-250V Major Science, USA 
Rotating Mixer RM5 Assistant 348 Karl Hecht KG, Sondheim/Rhön 
Rotor JA-20 Beckman Coulter, Krefeld  
Rotor JLA-8.1000 Beckman Coulter, Krefeld  
Scale 770 Kern, Balingen-Frommern 
Scanner CanoScan 5600F Canon Deutschland, Krefeld 
Sonifier 250 Branson, USA  
Special Accuracy Scale BP410S Sartorius, Göttingen 
Tankblotter Criterion (1.3 L) BioRad, München 
Tankblotter Mini Trans-Blot (0.45 L) BioRad, München 
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Thermomixer comfort 1.5 mL Eppendorf, Hamburg  
Typhoon 9400 Variable Mode Imager Amersham (GE Healthcare), München 
Unitron Incubators Infors HT, Einsbach 
UV table TFX-20.LC Vilber Lourmat, Eberhardzell 
Vertical Double Gel Systems PeqLab, Erlangen  
Vertical Gel Electrophoresis Chamber H10 Mini GP-Kunststofftechnik, Kassel 
Vortex generator VV3 VWR International, Darmstadt 
X-Ray Cassette 18 × 24 Rego X-Ray GmbH, Augsburg 
 
3.1.2 Chemicals 
All chemicals were purchased from those companies listed below, unless stated otherwise, 






VWR International, Darmstadt 
 
3.1.3 Consumables And Other Materials 
96-Well Black Microplates VWR International, Darmstadt 
Amersham ECL Plus WB Detection Reagent GE Healthcare, München 
Amersham ECL Prime WB Detection Reagent GE Healthcare, München 
Amersham ECL Select WB Detection Reagent GE Healthcare, München 
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Amersham Hyperfilm ECL GE Healthcare, München 
Amicon Ultra-15 Centrifugal Filter Units Merck, Darmstadt 
(NMWL 3 kDa, 10 kDa, 30 kDa, 50 kDa) 
CDP-Star ECL Substrate Roche, Mannheim 
Centrifugal Ultrafiltration Devices Sartorius, Göttingen 
(MWCO 3k, 10k) 
Coli Rollers Plating Beads Novagen, USA 
Deep Well Plates, 2 mL - Sterile Axygen Scientific, USA 
Electroporation Cuvettes, 2 mm gap Peqlab, Erlangen 
Eppendorf Tubes (1.5 mL, 2.0 mL) Eppendorf, Hamburg 
Falcon Tubes (15 mL, 50 mL) Sarstedt, Nümbrecht 
Gas Permeable Adhesive Seals Thermo Scientific, Schwerte 
GSH Sepharose Beads GE Healthcare, München 
HisLink Protein Purification Resin Promega, USA 
Hybond-N+ Transfer Membrane, Nylon GE Healthcare, München 
Immobilon-P Transfer Membrane, PVDF Merck, Darmstadt 
Instant Blue Biozol, Eching 
PCR Soft Tubes (0.2 mL) Biozym, Austria 
peqGOLD Universal Agarose Peqlab, Erlangen 
Petri Dishes 145 × 20 mm  Greiner Bio One, Solingen 
Petri Dishes 92 × 16 mm Sarstedt, Nümbrecht 
Pipet Tips Sarstedt, Nümbrecht 
Plate 96 DW Square U VWR International, Darmstadt 
Protran Nitrocellulose Transfer Membrane Whatman, Dassel 
Slide-A-Lyzer® Mini Dialysis Units Thermo Scientific, Schwerte 
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Spectra/Por Closures, 55 mm Spectrum Laboratories, Netherlands 
Spectra/Por Dialysis Membrane, 50 mm Spectrum Laboratories, Netherlands 
Syringe Filters (0.2 and 0.45 µm) Sartorius, Göttingen 
UV Cuvettes (UVette) Eppendorf, Hamburg 
Whatman filter paper Whatman, Dassel 
 
3.1.4 DNA, Protein And RNA Size Standards 
GeneRuler™ 1 kb DNA Ladder Thermo Scientific, Schwerte 
PageRuler Prestained Protein Ladder Thermo Scientific, Schwerte 
Unstained Protein Molecular Weight Marker Thermo Scientific, Schwerte 
Low Molecular Weight Marker 10-100 nt USB® Products/Affymetrix, USA 
Low Range ssRNA Ladder NEB, Frankfurt 
Oligonucleotide Ladder (20, 35, 45, 58, 70 nt) Self-made from Sigma-Aldrich primers 
 
3.1.5 Antibiotics 
Table 3.1: Overview of antibiotics used in growth media/agar plates 
Antibiotic Work Concentration 
[µg/mL] 
Company 
Ampicillin (Amp) 100 AppliChem, Darmstadt 
Chloramphenicol (Cm) 50 AppliChem, Darmstadt 
Kanamycin (Kan) 50 AppliChem, Darmstadt 
Spectinomycin (Sm) 75 Sigma-Aldrich, Steinheim 
Tetracycline (Tet) 25 AppliChem, Darmstadt 
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3.1.6 Culture Media And Agar Plates 
For agar plates the corresponding medium was supplemented with 1.5% (w/v) agar-agar. 
M9 salts, LB and 2YT medium were sterilized by autoclaving at 121 °C for 20 min. Antibiotics 
and other supplements were added after cooling to at least 55 °C. 
Table 3.2: Overview of growth media used for culturing of E. coli 
LB Medium 2YT Medium M9 Minimal Medium 
10 g tryptone 
5 g yeast extract 
5 g NaCl 
Adjust to 1 L ddH2O  
16 g tryptone 
10 g yeast extract 
5 g NaCl 
Adjust to 1 L ddH2O 
200 mL M9 salts (5x) 
2 mL MgSO4 (1 M) 
20 mL glucose (20%; w/v) 
0.1 mL CaCl2 (1 M) 
Adjust to 1 L ddH2O 
M9 salts (5x) 
250 mM Na2HPO4 
100 mM KH2PO4 
50 mM NaCl 
100 mM NH4Cl 
 
3.1.7 Unnatural Amino Acids 
Unnatural amino acids (UAAs) were dissolved with NaOH in ddH2O (see Table 3.3) just 
before the addition to the medium. 
Table 3.3: Overview of unnatural amino acids used for genetic code expansion 








(in 1 M NaOH) 




(in 0.5 M NaOH) 




(in 0.2 M NaOH) 




(in 0.2 M NaOH) 
2 SynAffix, Nijmegen (NL) 
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3.1.8 Enzymes 
Enzymes were used as recommended by the company’s protocol. The following table gives 
an overview about the enzymes used in this study. 
Table 3.4: Overview of enzymes used 
Enyzme Company 
T4 DNA ligase 
Shrimp Alkaline Phosphatase (SAP) 
Taq DNA Polymerase 
Phusion DNA Polymerase 
Restriction enzymes: BamHI, DpnI, HindIII, KpnI, 
MfeI, NcoI, NdeI, NotI, PstI, SacI, SalI, StuI, XhoI 
Proteinase K 
Thermo Scientific, Schwerte 
Alkaline Phosphatase, Calf Intestinal (CIP) 
Restriction enzymes: AgeI, BamHI, BsaI, DpnI, 
NdeI, NheI, SalI, StuI 
NEB, Frankfurt 
Expand High Fidelity Polymerase Mix Roche, Mannheim 
Pfu Turbo DNA Polymerase Agilent, Böblingen 
 
3.1.9 Cell Lines 
Table 3.5: Overview of cell lines used 
Cell line Genotype Company 
E. coli DH10B F-mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15ΔlacX74 recA1 endA1 araD139Δ 
(ara,leu)7697 galU galK λ-rpsL nupG 
Invitrogen, 
Darmstadt 
E. coli BL21 (DE3) fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
NEB, Frankfurt 
E. coli SHuffle  
T7 Express 
fhuA2 lacZ::T7 gene1 [lon] ompT ahpC 
gal λatt::pNEB3-r1-cDsbC (SpecR, lacIq) ΔtrxB 
sulA11 R(mcr-73::miniTn10--TetS)2 [dcm] 





3: Materials And Methods  25 
3.1.10 Buffers And Solutions 
All buffers were prepared with ddH2O. 
Table 3.6: Overview of commonly used buffers & solutions 
Buffer/Solution Ingredients  
PIC (1×) 75 µM pefabloc SC 
150 nM leupeptin 
37.5 µM O-phenanthroline 
500 nM pepstatin A 
Sterilize using syringe filters (0.2 µm) 
PBS (1×) 137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
pH 7.4 
TBS (1×) 50 mM TRIS-HCl, pH 7.5 
150 mM NaCl 
CaCl2 Solution  
for competent cells 
60 mM CaCl2 
10 mM Pipes-KOH, pH 7.0 
15% glycerol (v/v) 
Autoclave 
Store at 4 °C 
TBE (1×) 89 mM TRIS base 
89 mM boric acid 
2 mM EDTA-Na2 
DNA Loading Buffer (1×) 3% glycerol (v/v) 
1 mM TRIS base, pH 7.5 
1 mM EDTA-Na2 
Bromphenol blue 
Xylene cyanol 
SDS Running Buffer (1×) 25 mM TRIS base 
192 mM glycine 
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SDS Sample Buffer (1×) 2.5% glycerol (v/v) 
12.5 mM TRIS-HCl, pH 6.8 
25 mM DTT 
0.5% SDS (w/v) 
0.025% bromphenol blue (w/v) 
WB Transfer Buffer (1×) 1× SDS running buffer 
15-20% MeOH (v/v) 
PonceauS Solution (0.5%) 0.5% PonceauS (w/v) 
5% TCA (w/v) 
TE buffer (1×) 10 mM TRIS, pH 8.0 
1 mM EDTA-Na2 
Acid Urea Sample Buffer 0.1 M sodium acetate, pH 5.0 
8 M urea 
0.05% bromphenol blue (w/v) 
0.05% xylene cyanol (w/v) 
Acid Urea Running Buffer (1×) 0.1 M sodium acetate, pH 5.0 
NB Transfer Buffer (1×) 40 mM TRIS-HCl, pH 8.0 
2 mM EDTA-Na2 
SSC Buffer (1×) 150 mM NaCl 
15 mM trisodium citrate 
pH 7.0 
Prehybridization Solution (1×) 6× SSC 
10× Denhardt’s solution (Invitrogen) 
0.5% SDS (w/v) 
Hybridization Solution (1×) 6× SSC 
0.1% SDS (w/v) 
tRNA probe 1:3000 (v/v) 
Sterilize using syringe filters (0.2 µm) 
Buffer 1 (1×) 100 mM maleic acid 
150 mM NaCl 
pH 7.5 (with NaOH pellets) 
Blocking Reagent (10%) 10% blocking reagent ((w/v); Roche) 
1× buffer 1 
Autoclave and store at 4 °C 
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Buffer 2 (1×) 10% blocking reagent, 10% (v/v) 
1× buffer 1 
Buffer 3 (1×) 100 mM TRIS base, pH 9.5 
100 mM NaCl 
 
3.1.11 DNA Kit Systems 
Kits were used according to manufacturer’s protocol, except for XP2 binding buffer from 
peqGOLD Gel Extraction Kit and CP binding buffer from Cycle Pure Kit. XP2 was used in a 
w(gel)/v(buffer) ratio of 1:3 instead of 1:1 and CP buffer was used in a v(PCR)/v(buffer) ratio 
of 1:5 instead of 1:1. 
 
peqGOLD Cycle-Pure Kit (S-Line) Peqlab, Erlangen 
peqGOLD Gel Extraction Kit (S-Line) Peqlab, Erlangen 
peqGOLD Plasmid Miniprep Kit I& II Peqlab, Erlangen 
QIAGEN Plasmid Mini Kit QIAGEN, Hilden 
QIAquick Gel Extraction Kit QIAGEN, Hilden 
QIAquick PCR Purification Kit QIAGEN, Hilden 
 
3.1.12 Fluorescent Dyes 
Table 3.7: Overview of fluorescent dyes used for protein labeling. 
All dyes were prepared as stock solutions with 10 mg/mL in DMSO. Abs. Max. = Absorption Maximum; Em. 
Max = Emission Maxium; Abb. = Abberior 





Atto565 563 592 Maleimide ATTO-TEC, Siegen 
Abb. Star635 634 654 Tetrazine AG Hell, Göttingen[125] 
Abb. Star635P 635 655 Tetrazine AG Hell, Göttingen[125] 
KK9046 632 654 Tetrazine AG Hell, Göttingen[125] 
KK114 637 660 Tetrazine AG Hell, Göttingen[125] 
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3.1.13 Antibodies 
Table 3.8: Overview of antibodies used for immuno blotting (western & northern blots). 
His = histidine; GFP = green fluorescent protein; GST = glutathione S-transferase; DIG = digoxigenin; 
Myc = myelocytomatosis; MBP = maltose binding protein; AP = alkaline phosphatase; HRP = horseradish 
peroxidase 






















His mouse - 3% BSA-PBS 27-4710-01 GE Healthcare, 
München 
GFP mouse - 3% BSA-PBS sc-9996 Santa Cruz, 
Heidelberg 
GST goat - 3% BSA-PBS 27-4577-01 GE Healthcare, 
München 
DIG sheep AP 1:10.000 in  
1× Buffer 2 
11093274910 Roche, 
Mannheim 
Myc mouse - 5% Milk-TBS sc-40 Santa Cruz, 
Heidelberg 





















 mouse goat HRP 5% Milk-PBS 
(TBS for Myc) 
ab6789 / 
A8924 
Abcam, UK / 
Sigma-Aldrich, 
Steinheim 
rabbit goat HRP 5% Milk-PBS ab6721 / 
R5506 
Abcam, UK / 
Sigma-Aldrich, 
Steinheim 
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3.2 Methods 
3.2.1 Microbiological Methods 
3.2.1.1 Chemical Competent Cells 
Chemical competent cells were prepared from overnight starting cultures by expanding the 
cells to an OD600 of 0.1, in the desired volume needed. After incubation at 37 °C cells were 
harvested at an OD600 of 0.6-0.8 by splitting them into 50 mL aliquots followed by 
centrifugation (4 °C, 15 min, 4,147 × g). All following steps were performed on ice. Each 
pellet was washed with 10 mL CaCl2 solution (Table 3.6) and centrifuged as before. 
Afterwards, cells were washed again with 10 mL CaCl2 solution but incubated at 4 °C for 1 h 
before subsequent final centrifugation. Pellets were resuspended in 2 mL CaCl2 solution and 
frozen in liquid nitrogen as 200 µL aliquots or used directly for transformations. 
 
3.2.1.2 Electro Competent Cells 
For the production of electro competent cells a main culture was grown, split and 
centrifuged as described in chapter 3.2.1.1. Remaining salts were removed by washing 
twice with 10 mL 15% glycerol/H2O (v/v) at 4 °C. After the final centrifugation pellets were 
resuspended in reflow (remaining supernatant), pooled and directly used for 
transformations[126]. 
 
3.2.1.3 Transformation of Chemical Competent Cells 
Chemically competent E. coli cells were transformed with plasmids using the heat shock 
method. 50 µL of chemical competent cells (Ch. 3.2.1.1) were mixed with 150-500 ng DNA 
and incubated on ice for 10 min. After heat shocking for 2 min at 42 °C, the cells were put 
back on ice for 3 min. For the recovery, 1 mL LB medium (Table 3.2) was added, followed by 
incubation (37 °C, 750 rpm) for 1 h. Transformants were plated on agar media containing 
the appropriate antibiotics (Table 3.1) or used for the inoculation of an overnight culture. 
The heat shock method was suitable for the transformation with up to two plasmids at 
once. If cells needed to be transformed with more plasmids, a two-step variant via the 
preparation of electro competent cells (Ch. 3.2.1.2) was used. 
3: Materials And Methods  30 
3.2.1.4 Transformation of Electro Competent Cells 
Electro competent cells were transformed with up to 1 µg of plasmid DNA, typically 
prepared by ethanol precipitation (Ch. 3.2.3.7). A maximum of 10 µL of DNA was added to 
100 µL electro competent cells (Ch. 3.2.1.2) and then transferred into precooled 
electroporation cuvettes. Electro shock was performed at 2.5 kV. For the recovery, 1 mL 
2YT medium (Table 3.2) was added and the suspension transferred to an Eppendorf tube, 
followed by incubation (37 °C, 600 rpm) for 1.5 h. Transformants were plated on agar plates 
containing appropriate antibiotics (Table 3.1) or used for the inoculation of an overnight 
culture. In some cases a dilution series was plated to analyze the diversity/efficiency of the 
transformation[126]. 
 
3.2.2 Protein Biochemical Methods 
3.2.2.1 Recombinant Protein Expression 
Recombinant protein expressions were prepared from cells transformed with the 
appropriate plasmids. Depending on the type of induction of the protein expression, E. coli 
DH10B or BL21 (DE3) (for T7 driven promoters, Table 3.5) were used.  
Overnight precultures were used to inoculate main cultures (20 mL to several liters LB or 
2YT medium containing the required antibiotics, Table 3.1) to an OD600 of 0.1. Cells were 
incubated at 37 °C, 200 rpm, to an OD600 of 0.8-1.0. Protein expression was induced by 
supplementing the media with either, 0.2% arabinose (w/v) or 1 mM IPTG (final 
concentrations). In some cases no addition of an inducer was necessary since the promoter 
was constitutively active. For the incorporation of UAAs into proteins of interest, the media 
was supplemented with the appropriate probe by first dissolving (see Table 3.3) and then 
added to the main culture. This was performed at inoculation when constitutive promoters 
were being used or in combination with the inducers for inducible promoters. 
Cells were typically harvested at 4-6 h after induction by centrifugation, washed with PBS 
and stored at -20 °C or directly used for cell lysis (Ch. 3.2.2.2). 
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3.2.2.2 Cell Lysis 
Several methods to lyse bacterial cell pellets were used. For whole cell lysate analysis, small 
pellets from up to 2 mL medium were boiled in 1× SDS sample buffer (Table 3.6) for 10 min 
at 95 °C. Samples were subsequently centrifuged (16,100 × g, RT, 5 min) and directly used 
for SDS PAGE (Ch. 3.2.2.3). For protein isolation, larger cell pellets (from 50 mL to 500 mL 
medium) were resuspended in 20-50 mL lysis buffer, which was generally supplemented 
with protease inhibitors (1× PIC and 1mM PMSF in DMSO; Table 3.6), 1 mg/mL lysozyme, 
0.5 mg/mL DNase I and 1 mM DTT (see Ch. 3.2.2.6 to 3.2.2.9 for details). Cells were then 
incubated on ice for 20-30 min. Disruption of the cells was carried out on ice by either 
ultrasonic sound, using a sonifier, or by pressure (80 psi) using a pneumatic cell 
disintegrator (fluidizer). The lysate was clarified by centrifugation (20,000 × g, 4 °C, 30 min). 
Afterwards, the supernatant could be employed for protein purification. 
 
3.2.2.3 Discontinuous Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
Table 3.9: Composition of polyacrylamide gels for SDS PAGE 
Resolving Gel Stacking Gel 
12% 15% 4% 
375 mM TRIS-HCl, pH 8.8 375 mM TRIS-HCl, pH 8.8 125 mM TRIS-HCl, pH 6.8 







0.1% APS (w/v) 0.1% APS (w/v) 0.05% APS (w/v) 
0.04% TEMED (v/v) 0.04% TEMED (v/v) 0.1% TEMED (v/v) 
 
Discontinuous sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) as 
described by Laemmli[127] was performed to analyze the size and purity of proteins. 
Thereby, the strong anionic detergent SDS causes the denaturation of proteins and confers 
a negative charge to them, simultaneously. The discontinuity between stacking and 
resolving gel relies on different pore sizes and pH values, as well. The pH gradient is 
responsible for the stacking of the proteins at the border to the resolving gel. Whereas the 
stacking gels always have the same concentration of acrylamide, those of the resolving gels 
were varied depending on the expected protein size. During this study 12 and 15% gels 
were used. Protein ladders (Ch. 3.1.4) helped to estimate the molecular weights of the 
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separated proteins. Before loading a gel, protein solutions were mixed with 4× sample 
buffer heated to 95 °C for 10 min followed by a short centrifugation. Small cell pellets were 
prepared as described in Ch. 3.2.2.2. Electrophoresis was performed at 200 V for 60-
120 min in 1× SDS running buffer until the bromphenol blue dye traveled the length of the 
gel. 
After electrophoresis was performed, separated proteins were either visualized by 
Coomassie Brilliant Blue staining (with Instant Blue, according to manufacturer’s manual) or 
transferred to nitrocellulose, or PVDF, membrane by western blotting (Ch. 3.2.2.4). 
 
3.2.2.4 Western Blot 
Immunoblotting was performed to verify the expression of proteins by the direct transfer of 
proteins from SDS-PAGE (Ch. 3.2.2.3) onto membrane, followed by incubation with specific 
antibodies against the protein itself, or a protein tag, e.g., His6-tag. 
Semidry blots of SDS gels were performed with nitrocellulose membranes, sandwiched 
between three layers of Whatman filter papers on each side, which were soaked in 
1× WB transfer buffer. This stack was fixed in a semidry blotter and the transfer was carried 
out with an electric currency of 250 mA constant for 45 min, RT. 
Wet blots were performed with PVDF membrane that was first activated with MeOH and 
then washed with water followed by soaking in 1× WB transfer buffer. The membrane, SDS 
gel and Whatman filter papers were assembled according to the instruction manual of the 
blotter. The transfer was applied at 100 V constant for 30-90 min, at 4 °C. 
The success of the transfer was determined by Coomassie staining of the gel and PonceauS 
staining of the membrane. PVDF membrane was first washed with water and MeOH before 
staining with PonceauS. PonceauS stain was removed from the membranes by washing in 
water, followed by incubation in TBS or PBS (determined by primary antibody buffer 
composition). Blocking of the membrane was performed for at least 10 min in buffer 
conditions similar to the primary antibody of interest (minus the antibody). 
Primary antibodies (Table 3.8) were incubated on the membrane for 2 h with shaking, at RT 
or overnight at 4 °C. The membranes were then washed three times, for 10 min, in the 
appropriate buffer (TBS or PBS) plus 0.1% Tween20 (v/v). Secondary antibody was applied 
and allowed to incubate with shaking, for 1 h, at RT. The membrane was then washed as 
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previously described. Remaining detergent was removed by additional washing with water, 
followed by PBS or TBS. 
Chemiluminescence detection of protein was performed dependent upon the enzyme 
conjugated to the secondary antibody (Table 3.8). The ECL substrates used were, CDP-Star 
for AP-conjugates and Amersham ECL WB reagents for HRP-conjugates. The substrates 
were incubated on the membranes for 5 min prior to detection. In an X-ray cassette, 
emitted light was captured on ECL films for several seconds, to minutes, until the desired 
band intensities were achieved. The films were developed in an automatic X-ray film 
processor. 
 
3.2.2.5 Measuring Protein Concentration 
Protein concentrations were measured using the Bradford assay developed by Marion 
Bradford[128]. The reactive reagent is based on Coomassie Brilliant Blue G-250, which turns 
from its unbound red form to blue upon protein binding. This causes a shift of the 
absorption spectrum maximum of the dye to 595 nm in a proportional manner. The linear 
range of the assay depends on the protein and fluctuates between 0 and 2 mg/mL. 
Therefore, protein samples often needed to be diluted. 
In general, 10 µL of protein sample was mixed with 500 µL Bradford reagent, incubated at 
RT for 5 min and then the absorbance was measured at 595 nm. Water or buffer without 
protein served as a reference. The amount of protein was estimated by means of a 
standard curve made with dissolved BSA. 
 
3.2.2.6 Small Scale GST-MBP Expression And Purification 
Overnight cultures of E. coli DH10B containing the appropriate plasmid combinations (see 
Figure 4.37) were used to inoculate 50 mL main cultures to OD600 of 0.1. The UAA BocK was 
supplemented to the main cultures at OD600 of 0.6 to 0.8 to a final concentration of 1 mM 
and the lac promoter dependent expression of PylS was induced by a final concentration of 
1 mM IPTG. Cells with three plasmids were pelleted (4 °C, 15 min, 4,147 × g) 280 min after 
UAA addition and with four plasmids after 330 min. Pellets were washed with 1× PBS and 
cell counts were normalized by OD600, followed by centrifugation as before. GST-MBP fusion 
proteins were purified as described by Neumann[78]. Cells were resuspended and lysed in 
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1 mL lysis buffer (1× PBS supplemented with 1× BugBuster (Novagen), 1× PIC, 1 mM PMSF, 
lysozyme, 0.5 mg/mL DNaseI) for 2 h on ice. Undigested DNA was sheared by ultrasonic 
sound using a sonifier and the lysate was subsequently clarified by centrifugation (4 °C, 
30 min, 16,100 × g). Batch affinity purification of GST containing proteins was performed 
using 50 µL of glutathione sepharose beads with shaking (1 h, 4 °C). Beads were washed 3 
times with 1 mL 1× PBS, before elution by heating for 10 min at 80 °C in 60 µL 1× SDS 
sample buffer (named Elution). For the investigation of the solubility of GST-MBP fusion 
proteins, cell debris from clarifying the lysate (named Pellet) were resuspended in 60 µL 1× 
SDS sample buffer. 15 µL of the unbound proteins in the lysate (named Flowthrough) were 
mixed with 5 µL 4× SDS sample buffer. All samples were analyzed on a 15% SDS gel 
(Ch. 3.2.2.3). 
 
3.2.2.7 Small Scale Histone H3 Expression And Purification 
Overnight cultures of E. coli BL21 containing the appropriate plasmid combinations were 
used to inoculate 500 mL main cultures to OD600 of 0.1. The UAAs BocK, BCNK and NorK 
were supplemented to the main cultures at OD600 of 0.6 to 0.8 to a final concentration of 
1 mM and histone H3 expression was induced by a final concentration of 1 mM IPTG 30 min 
after UAA-addition. Cells were pelleted (4 °C, 30 min, 4,000 × g) 4 to 4:30 h after induction 
and pellets were washed with 1× PBS prior to storage at -20 °C. Frozen pellets were 
resuspended in 30 mL lysis buffer (1× PBS supplemented with 1× PIC, 1 mM PMSF, 1 mM 
DTT, lysozyme) and incubated at 37 °C for 30 min with shaking. DNA was sheared by 
ultrasonic sound using a sonifier (2 min, output: 6, cycle constant, 4 °C) and the lysate was 
subsequently centrifuged (4 °C, 30 min, 18,000 × g). The supernatant was discarded and the 
inclusion bodies containing pellet was resuspended in 1× PBS supplemented with 1% 
Triton X-100 and 1 mM DTT. After centrifugation (4 °C, 30 min, 18,000 × g), the pellet was 
washed (1× PBS with 1 mM DTT) and stored at -20 °C after centrifugation as before. Frozen 
pellets were resuspended and macerated in 1 mL DMSO for 30 min at 37 °C with shaking. 
Afterwards, proteins were extracted from inclusion bodies with the aid of 25 mL 
guanidinium solution (6 M guanidinium chloride, 20 mM TRIS (pH 8.0), 2 mM DTT) for 1 h at 
37 °C with shaking. After centrifugation as above, the supernatant was transferred into a 
fresh Falcon tube and His6-tagged H3 histones were bound in batch to 500 µL of Ni
2+-beads 
with shaking (1 h, 4 °C). Beads were washed with 100 mL wash-buffer (8 M urea, 100 mM 
NaH2PO4, 1 mM DTT, pH 6.2) before proteins were eluted with elution-buffer (7 M urea, 
20 mM NaOAc, 200 mM NaCl, 1 mM DTT, pH 4.5). All fractions from elution were analyzed 
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on 15% SDS gels (Ch. 3.2.2.3). Fractions containing the desired histones were pooled and 
dialyzed overnight against water with 5 mM β-mercaptoethanol (BME; 2 L) followed by two 
dialyses for 1 to 2 h each. Dialyzed samples were frozen in liquid nitrogen as 500 µL aliquots 
and stored at -80 °C. 
 
3.2.2.8 Large Scale Nanobody NbSyn2 Expression And Purification 
Overnight cultures of E. coli BL21 transformed with either pCLA166 + pCLA177 or pCLA174 + 
pCLA177 were used to inoculate a 500 mL main culture to OD600 of 0.1 each. Cultures were 
incubated at 37 °C for 3 h and subsequently supplemented with the UAA NorK (2 mM final 
concentration). Nanobody expression was induced by a final concentration of 1 mM IPTG 
and temperature was shifted to 28 °C for overnight expression (∼16 h). Samples for 
western blot were taken before and after induction, normalized to OD600 of 1.5. Cells were 
pelleted (4 °C, 30 min, 4,000 × g) and stored at -20 °C. The remaining medium of both 
cultures was pooled and filtered using a vacuum filter system with 0.45 µm pore size filter 
papers. The filtered medium was supplemented with 5 mM imidazole, 1.5 mM PMSF, 
1× PIC and adjusted to pH 7.5. Ni2+-beads (2 mL) were rinsed with washing buffer (50 mM 
NaH2PO4, 300 mM NaCl, 5 mM imidazole, pH 7.5) two times and added to the medium. 
Binding of His6-tagged nanobodies was allowed to occur overnight at 4 °C with stirring. 
Beads were pelleted and two times washed with 50 mL washing buffer at 4 °C for 15 min 
with shaking. Proteins were eluted six times with 1.5 mL elution buffer (50 mM NaH2PO4, 
300 mM NaCl, 500 mM imidazole, pH 7.5) at 4 °C for 10 min with shaking. All fractions from 
elution were analyzed on a 15% SDS gel (Ch. 3.2.2.3). Fractions containing the desired 
nanobodies were pooled and concentrated to 500 µL using centrifugal filter units. 
 
3.2.2.9 Expression And Purification of Isotopically Labeled sfGFP 
An overnight culture of E. coli BL21 transformed with pCLA96 and pCLA105, grown in LB 
medium, was used to inoculate a main culture of 250 mL M9 minimal medium 
supplemented with 15N labeled 15NH4Cl to OD600 of 0.2. Cells were incubated at 37 °C for 
7.5 h and pelleted (4 °C, 30 min, 4,000 × g) at OD600 of ∼1.0. Samples for western blot were 
taken from overnight and main culture, normalized to OD600 of 1.5. Pelleted cells were 
washed with 1× PBS prior to storage at -20 °C. Frozen cells were resuspended and lysed in 
15 mL lysis buffer (Ni2+-wash buffer (20 mM TRIS-HCl, 250 mM NaCl, 10 mM imidazole, 
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pH 8.0) supplemented with 1× PIC, 1 mM PMSF, lysozyme, 0.5 mg/mL DNaseI) for 1 h on 
ice. Undigested DNA was sheared by ultrasonic sound using a sonifier and the lysate was 
subsequently clarified by centrifugation (4 °C, 30 min, 16,100 × g). His6-tagged proteins 
from the lysate were bound in batch to 500 µL of Ni2+-beads with agitation (1 h, 4 °C). Beads 
were washed with 50 mL cold Ni2+-wash buffer, before elution with four times 1 mL 
Ni2+-elution buffer (20 mM TRIS-HCl, 250 mM NaCl, 200 mM imidazole, pH 8.0). All fractions 
from elution were analyzed on a 15% SDS gel (Ch. 3.2.2.3). Fractions containing the desired 
sfGFP were pooled, concentrated to 400 µL using centrifugal filter units and simultaneously 
dialyzed against M9 minimal medium without glucose. 
 
3.2.2.10 Protein Expression For In-Cell NMR Measurements 
Overnight cultures of E. coli BL21 containing the appropriate plasmid combinations, grown 
in LB medium, were used to inoculate a main culture of 250 mL M9 minimal medium with 
unlabeled NH4Cl to OD600 of 0.2. Cells were incubated at 37 °C until they reached OD600 of 
0.6 to 0.8, pelleted (RT, 20 min, 4,000 × g) and resuspended in M9 medium supplemented 
with 15N labeled 15NH4Cl and 150 µg/mL spectinomycin. After additional 4 h of incubation at 
37 °C cells were pelleted again (RT, 20 min, 4,000 × g) and resuspended in 1 mL unlabeled 
M9 medium for NMR analysis (performed by AG Zweckstetter). 
 
3.2.2.11 Labeling of Proteins With Fluorophores 
In general, the ratio of protein to dye should be 1:10 (w/w) that means 100 µg of protein 
would be labeled with 10 µg dye. All dyes (Table 3.7) were prepared as stock solutions with 
10 mg/mL in DMSO. Here they were used in a ratio of 1:100 (v/v). Labeling reactions were 
performed at RT for 1.5-2 h or at 4 °C overnight. 
For the consecutive double labeling of histone H3, 100 µL of purified histones with BocK, 
BCNK or NorK incorporated (Ch. 3.2.2.7) were first labeled with 1 µL Abb. Star635 at RT for 
1.5 h. An aliquot of 20 µL was kept as “tetrazine only” samples and the rest was dialyzed 
two times for 30 min against 200 mL water supplemented with 1 mM TCEP using Slide-A-
Lyzer® Mini Dialysis Units. Additionally, 100 µL unlabeled histones were dialyzed for 
“maleimide only” samples. Next, dialyzed unlabeled and single labeled samples were mixed 
with 1 µL Atto565 at 4 °C overnight. Unbound dyes were removed from all samples by SDS-
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PAGE and the gel was scanned with a Typhoon imager to detect labeled proteins prior to 
Coomassie staining. 
The maleimide conjugated dye, Atto565, was excited by the green laser (532 nm) and 
emitted light passed through a 580 nm band-pass 30 nm (580 BP 30) filter. For all tetrazine 
conjugated fluorophores the red laser (633 nm) was used in combination with a 670 nm 
band-pass 30 nm (670 BP 30) filter. Sensitivity was set to normal and the voltage for the 
photomultiplier tube (PMT) had to be adapted for each blot individually. The resolution for 
the most scans was 200 µm per pixel, in some cases it was increased to 100 µm per pixel. 
 
3.2.2.12 Fluorescence Measurement With A Plate Reader 
A FLUOstar Omega (BMG Labtech) plate reader was used to measure fluorescence from 
sfGFP in intact cells. Samples from E. coli DH10B containing the appropriate plasmid 
combinations to express sfGFP, from genes with WT sequence or harboring an amber 
and/or a frameshift codon, were taken with intent to being normalized to OD600 of 0.5 by 
pelleting (3 min, 16,100 × g) and resuspending in 1 mL 1× PBS. 200 µL of this cell suspension 
was transferred into one well of a 96-well black microplate. 200 µL 1× PBS was used as a 
reference. The fluorescent signals from GFP were measured using the self-written program 
“GFP_ORBS-REPORTER” (Plate mode settings: No. of flashes per well: 10; Scan mode: 
Orbital averaging; Scan diameter [mm]: 3; Optic Settings: Excitation 485 nm; 
Emission: 520 nm; Gain: variable; General settings: Top optic used; Positioning 
delay [s]: 0.2). Kinetic non-endpoint measurments over time were performed using the 
program “GFP-NMR” that only differs in the number of measuring points. 
 
3.2.2.13 Fluorescence-Activated Cell Sorting 
Fluorescence-activated cell sorting (FACS), established by the workgroup of Herzenberg[129], 
was done at the MRC Laboratory of Molecular Biology, Cambridge, using the cell sorter 
iCyt Synergy (Sony Biotechnology). It was used for sorting living E. coli based on the 
fluorescence intensity of sfGFP within the cells. Therefore, 10 mL aliquots normalized to 
OD600 of 1.0 were prepared from 100 mL overnight cultures of E. coli DH10B containing the 
appropriate plasmid combinations to express sfGFP, from genes with WT sequence or 
harboring an amber and a frameshift codon (see Figure 4.34). Cells were pelleted (4 °C, 
15 min, 4,147 × g) and three times washed with two-fold filtered (syringe filters (0.2 µm)) 
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1× PBS. Cell suspensions were diluted to 105 cells prior to use in the FACS machine, which 
was finally calibrated to test 30,000 cells per second. Sorted positive clones were 
temporarily stored in 200 µL SOC medium. For recovery an additional 1 mL SOC medium 
was added and cells were incubated at 37 °C for 1 h. Recovered cells were transferred into 
500 mL LB medium containing the appropriate antibiotics, in order to prepare glycerol 
stocks (500 µL cell culture with 500 µL glycerol (50%)) and to isolate DNA (Ch. 3.2.3.1). 
 
3.2.3 Nucleic Acid Biochemical Methods 
3.2.3.1 Preparation of Plasmid DNA  
Plasmid DNA was isolated and purified with the help of kit systems (Ch. 3.1.11) according to 
manufacturer’s manual. In general, bacteria were transformed with the desired plasmid 
(Ch. 3.2.1.3) and used to inoculate an overnight culture (5 mL LB, 37 °C) containing a 
selective antibiotic. Up to 4 mL of this culture were harvested by centrifugation (16,100 × g, 
RT, 3 min) and disrupted by alkaline lysis using the kit buffers. The purification of the DNA 
was performed over silica columns. 
 
3.2.3.2 Restriction Enzyme Digestion 
Digestion of DNA was performed by restriction enzymes (Table 3.4) following 
manufacturer’s protocols. These enzymes are endonucleases which operate by recognizing 
a specific sequence of nucleotides, varying between four and eight base pairs in length, and 
often palindromic, followed by producing double strand breaks in the DNA[130]. Thereby, 
some enzymes create overhanging ends (sticky) and some create ends without overhangs 
(blunt). Categorized into four groups (TypeI-IV) based on different traits they differ amongst 
others in the position of the cleavage site relative to the recognition sequence.  
TypeII endonucleases, which were used in this thesis, cut their substrate near or inside of 
their recognition sequence. This makes them easier to handle, compared to randomly 
cutting enzymes, and thereby the most commonly available and used restriction enzymes. 
Due to the discovery of new enzymes that belonged to this class, but did not fulfill all 
classical criteria, a number of subfamilies were founded. One of these enzymes, DpnI, is 
able to recognize and cleave methylated and hemimethylated DNA[131]. Therefore, it was 
used to remove parental template DNA from PCR reactions (Ch. 3.2.3.8, 3.2.3.10 & 
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3.2.3.11). In most cases DpnI was supplemented as a fortieth of the PCR volume. If the PCR 
was purified before (Ch. 3.2.3.9) 10× reaction buffer was added (as a tenth of the volume) 
as well, otherwise the buffer of the PCR was also used for the digest that usually was 
performed for 1.5 h at 37 °C. 
The majority of the other endonucleases were either used to clone specific DNA fragments 
into a certain vector backbone (preparative digest) or to conduct test digests (Table 3.10) of 
prepared plasmid DNA (Ch. 3.2.3.1) from re-transformations or cloning procedures. Digests, 
especially double digests, were carried out in buffers and relation of enzymes 
recommended by the manufacturer. 
Table 3.10: Pipetting scheme for standard test and preparative digests 
Test digest  Preparative digest 
1 µL  buffer, 10× 2.5 µL  buffer, 10× 
2 µL  DNA 8 µL  DNA (∼1 µg) 
1 µL  enzyme(s) 2.5 µL  enzyme(s) 
6 µL  H2O 12 µL  H2O 
2 h, 37 °C  3 h, 37 °C 
 
Digests for cloning (preparative ones) were treated with alkaline phosphatases (0.5-1 µL, 
37 °C, 0.5-1 h, Table 3.4) afterwards, to remove 5’- (and 3’- for SAP) phosphate groups from 
digested vectors to prevent self-ligation.  
Phosphatases and restriction enzymes were inactivated by heating (65-80 °C, 15 min) 
and/or separation on an agarose gel (Ch. 3.2.3.3), which was also used to separate DNA 
fragments from digest itself.  
 
3.2.3.3 Agarose Gel Electrophoresis 
Agarose gel electrophoresis was performed to analyze size and abundance of DNA 
(fragments) from restriction digests (Ch. 3.2.3.2) and PCRs (Ch. 3.2.3.8, 3.2.3.10 & 3.2.3.11) 
as well as to purify DNA as necessary. 
Depending on the expected size of the DNA, different percentages of agarose gels were 
prepared (Table 3.11). The appropriate amount of agarose was melted and completely 
dissolved in 0.5× TBE buffer (Table 3.6) in a microwave, casted into an electrophoresis 
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chamber and supplemented with “gel red” in a concentration of 1:50,000 (v/v) after cooling 
to 50-60 °C.  
DNA samples were mixed with 10× DNA loading buffer (Table 3.6) and loaded onto the gel 
together with a DNA ladder (Ch. 3.1.4) to estimate the size of the DNA. Electrophoresis was 
performed at 200 V, 80-100 mA at RT with 0.5× TBE running buffer until the bromphenol 
blue dye migrated the length of the gel (1-2 h). 
Separated DNA bands were visualized by UV light due to the intercalated “gel red” using a 
gel documentation machine or a UV table. If DNA was needed for further steps, like cloning 
(Ch. 3.2.3.4), wavelength of the UV light was set to 365 nm instead of 254 nm. 
Table 3.11: Percentages of agarose gels depending on the size of the DNA (fragments) 
DNA (fragment) size [bp] [%] agarose in gel (w/v) 
< 500 1.5 
200 – 3,500 1.0 
700 – ≥ 10,000 0.7 
 
3.2.3.4 Extraction of DNA From Agarose Gels 
DNA required for cloning was preparatively digested (Ch. 3.2.3.2) and subsequently 
separated via agarose gel electrophoresis (Ch. 3.2.3.3). Visualized on a UV table (365 nm), 
those bands of correct size were sliced out of the gel with a scalpel. Afterwards, the DNA 
was extracted using a gel extraction kit (Ch. 3.1.11) according to manufacturer’s manual. 
The purified DNA was eluted from the silica columns with max. 30 µL of elution buffer and 
stored at -20 °C or directly used for ligations (Ch. 3.2.3.6) 
 
3.2.3.5 Separation of Multiple Plasmids 
Two methods were used for the separation of multiple plasmids isolated from cells 
(Ch. 3.2.3.1) transformed with more than one plasmid. First, plasmids were separated on 
agarose gels (Ch. 3.2.3.3) and DNA/plasmid of expected size extracted from gel 
(Ch. 3.2.3.4), subsequently. Second, unwanted plasmids were destroyed by restriction 
enzyme digestion (Ch. 3.2.3.2) prior to transformation of E. coli cells. Plasmids of interest 
were isolated from transformed cells, afterwards. 
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3.2.3.6 Ligation of Two Double-Stranded DNA Fragments 
A double-stranded DNA fragment was typically digested with two different restriction 
enzymes (Ch. 3.2.3.2) and was ligated with another double-stranded DNA fragment, 
digested with the same enzymes, using the T4 DNA ligase. Therefore, a 3-5 fold molar 
excess of the smaller fragment, e.g., a gene for a protein, called the insert is mixed with the 
bigger fragment, commonly a vector backbone (Table 3.12). For a negative control water 
replaced the insert DNA. The ligation was carried out for 2 h, at RT, or more frequently at 
16 °C overnight. The product of the ligation reaction (5-10 µL) was directly used for 
transformation (Ch. 3.2.1.3) and the success of the ligation was verified by test digests 
(Ch. 3.2.3.2) and/or sequencing (Ch. 3.2.3.13). 
Table 3.12: Pipetting scheme for a standard ligation reaction mix 
 Volume [µL] 
T4 Ligase buffer, 10× 1 
Vector DNA (big fragment) 2 
Insert DNA (small fragment)/H2O 6.5 
T4 DNA ligase 0.5 
 
3.2.3.7 Ethanol Precipitation 
Ethanol precipitations were performed to remove salts prior to transformation, if cells 
needed to be transformed with ligation reactions via electroporation due to required higher 
efficiencies, and/or to reduce the volume of large scale ligations. For this purpose, the 
ligation product was mixed in a ratio of 10:1 (v/v) with 3 M sodium acetate solution (pH 5.2) 
and subsequently supplemented with absolute EtOH equal to double the volume of the 
whole reaction mixture. After an incubation period of 30 min on ice the DNA was pelleted 
by centrifugation (16,100 × g, 4 °C, 15 min). The pellet was washed two times with 
70% EtOH equal to twice the starting volume of the ligation product and centrifuged each 
time as before. The supernatant was discarded and the DNA pellet was air dried for 5 min 
at RT. After resuspending the DNA in a small amount of ddH2O or TE buffer (Table 3.6) an 
incubation for 10 min at 60 °C followed to dissolve the pellet completely. DNA could then 
be stored at -20 °C or used for electroporation (Ch. 3.2.1.4). 
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3.2.3.8 Polymerase Chain Reaction 
The polymerase chain reaction (PCR) is a technique used to specifically and exponentially 
amplify a piece of DNA. Since this method, developed by Kary Mullis[132], relies on thermal 
cycling with periods of heating and cooling, necessary for DNA melting and enzymatic 
replication, thermostable enzymes like Taq or Phusion DNA polymerases (Table 3.4) are 
essential. In general, a PCR consists of 6 different steps in which step two to four are 
repeated in 20-40 cycles. 
1. Initial denaturation: In this step the reaction is heated up to 94-96 °C to 
ensure that the template DNA is completely melted which is important for 
step three, the annealing of the primers. Additionally, it activates DNA 
polymerases that need heat activation (hot-start PCR)[133]. 
2. Cyclic denaturation: The purpose of this step is the same as for the first 
one, melting the DNA (template and new synthesized strands) by heating 
to 94-96 °C to obtain single-stranded DNA but in a cyclic manner. 
3. Cyclic annealing: The temperature of the reaction is lowered to 50-60 °C, 
usually 5 °C lower than the melting temperature of the primers, single-
stranded oligonucleotides that serve as a starting point for the 
polymerase. The low temperature allows the primers, which are 
complementary to the template DNA, flanking the sequence that should 
be amplified, to hybridize. 
4. Cyclic elongation: In this step the polymerase synthesizes a new 
complementary DNA strand starting at a primer by adding dNTPs. 
Therefore, the temperature is changed to the appropriate optimum for 
the used polymerase (68-72 °C). The elongation time depends on the 
length of DNA to be amplified and on the speed of the particular 
polymerase. 
5. Final elongation: All remaining single-stranded DNA fragments are fully 
extended during this step at the same temperature used in step 4. 
6. Stop/cooling: The reaction mix is cooled down to “stop” enzymatic 
reactions and for short-term storage.  
The standard course for a PCR is shown in Table 3.13 and the composition for one PCR 
reaction mix is shown in Table 3.14. 
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Table 3.13: Standard course of a PCR 
Step Temperature [°C] Duration [s]  
1. Initial denaturation 95 90  
2. Cyclic denaturation 95 30 
 
30 cycles 3. Cyclic annealing 56 30 
4. Cyclic elongation 72 60/1kbp 
5. Final elongation 72 Step 4 + 60  
6. Stop/cooling 4 ∞  
 
Table 3.14: Pipetting scheme for the composition of one PCR reaction mix 
 Volume [µL] 
Taq buffer with KCl, 10× 5 
dNTPs (10 mM each), 50× 1 
Primer mix (for + rev), 10 µM 4 
MgCl2, 25 mM 4 
Template DNA 1 
Taq DNA polymerase 1 
H2O 34 
 
Before further usage, PCR products were purified using EtOH precipitation (Ch. 3.2.3.7) or 
kit systems (Ch. 3.2.3.9). 
 
3.2.3.9 Purification of PCR Products 
For the removal of enzymes, unused primers, dNTPs and salts, PCR reactions were purified 
using EtOH precipitation (Ch. 3.2.3.7) or kit systems (Ch. 3.1.11) according to 
manufacturer’s manual. The cleaned up DNA was eluted from the silica columns with max. 
30 µL of elution buffer and stored at -20 °C or directly used, e.g., restriction digests 
(Ch. 3.2.3.2). 
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3.2.3.10 QuikChange PCR 
A QuikChange (QC) is a site-directed mutagenesis (developed by Agilent, Böblingen former 
Stratagene) that allows to easily carry out vector modifications (Figure 3.1). 
 
Figure 3.1: Schematic view of QuikChange cycles. 
Figure is adapted from QuikChange II XL site-directed mutagenesis protocol (Agilent). Mutant strand DNA (grey 
and red rings) is synthesized by performing thermal cycling (PCR) to denature the DNA template (orange and 
green rings) and to anneal mutagenic primers (grey and red arrows) containing the desired mutations (black 
crosses). Primers are extended with Pfu Turbo DNA polymerase. Parental methylated and hemimethylated 
template DNA is digested by DpnI. Finally, competent cells are transformed with the mutated molecule for nick 
repair. 
 
Since these PCR reactions amplify an entire vector a high fidelity proofreading polymerase, 
Pfu Turbo, was required. Primers were designed so that forward and reverse primers both 
included the desired mutations in a complementary sequence of at least 25 bp. The 3’-ends 
of each primer were complementary to a minimum of 10-15 bp of the vector backbone to 
allow annealing to the correct positions. The composition for one QC-PCR reaction mix is 
shown in Table 3.15. 
Table 3.15: Pipetting scheme for the composition of one QuikChange PCR reaction mix 
 Volume [µL] 
Pfu buffer, 10× 2 
dNTPs (10 mM each), 50× 0.4 
Pfu Turbo DNA polymerase 0.4 
Template DNA 0.4 
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The standard course for a QC is shown in Table 3.16. Compared to a common PCR 
(Ch. 3.2.3.8) fewer cycles were used to avoid the amplification of random mutations. The 
DNA template was digested with DpnI (0.5 µL) subsequent to PCR (37 °C, 1-1.5 h), as 
depicted in Figure 3.1, followed by transformation of E. coli cells with 5-10 µl of the mixture 
(Ch. 3.2.1.3). The modified vectors were isolated from those cells (Ch. 3.2.3.1) and the 
success of the modification determined by sequencing (Ch. 3.2.3.13). 
Table 3.16: Standard course of a QC-PCR 
Step Temperature [°C] Duration [s]  
1. Initial denaturation 96 60  
2. Cyclic denaturation 95 20 
 
15 cycles 3. Cyclic annealing 56 30 
4. Cyclic elongation 72 90/1kbp 
5. Final elongation 72 Step 4 + 60  
6. Stop/cooling 4 ∞  
 
 
3.2.3.11 Inverse PCR 
Inverse PCR is a variation of the conventional PCR (Ch. 3.2.3.8) and was originally used for 
the rapid in vitro amplification of unknown DNA sequences that flank a region of known 
sequence[134]. The restriction enzyme-mediated inverse PCR incorporates unique restriction 
enzyme sites at the 5’-ends of inverse tail-to-tail primers[135]. Similar to the QC (Ch. 3.2.3.10) 
this technique can be used for site-directed mutagenesis but with a higher efficiency. The 
increase in efficiency is due to the primer design, since only one primer needs to hold the 
desired mutations, and the generation of sticky-ends by unique restriction enzyme digests 
which improve ligation efficiency of linear mutant DNA strands. This method amplifies an 
entire vector like the QC and requires also a high fidelity proofreading polymerase. The 
Expand High Fidelity Polymerase Mix (Table 3.4) was used for this purpose. The general 
procedure of the restriction enzyme-mediated inverse PCR is shown in Figure 3.2. 
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Figure 3.2: Schematic representation of the restriction enzyme-mediated inverse PCR
[135]
. 
Sense and antisense primers (grey and red arrows) are designed in such a way that they contain a unique 
restriction site, BsaI (black crosses), and anneal to the opposite ends instead of facing each other as usual. 
Desired mutations were mostly incorporated into the reverse primer, only. The template DNA (orange and 
green rings) is amplified via PCR, resulting in linear mutated DNA (grey and red rings), and subsequently 
eliminated by DpnI digestion. Blunt ends of mutant DNA are made sticky upon digest with BsaI, which improves 
the ligation efficiency and subsequent circularization of the PCR product. 
 
The composition of one inverse PCR reaction is shown in Table 3.17 and the course in Table 
3.18. For the setup of the reaction mix two mixtures were prepared as recommended by 
Roche’s protocol, one with buffer, enzyme and half of the water, the other with the rest. 
Both mixtures were combined directly before PCR. 
Table 3.17: Pipetting scheme for the composition of one inverse PCR reaction mix 
 Volume [µL] 
Expand HF Buffer (15 mM MgCl2), 10× 5 
dNTPs (10 mM each), 50× 1 
Template DNA 1 
Primer mix (for + rev), 10 µM 4 
Expand High Fidelity Polymerase Mix 1 
H2O 38 
 
PCR was followed by purification using kit systems (Ch. 3.2.3.9) and digest of parental 
template with DpnI from NEB as described in Ch. 3.2.3.2. Afterwards, mutant DNA was 
digested with BsaI (3 h, 50 °C) to achieve sticky-ends. Therefore, DNA concentration was 
measured (Ch. 3.2.3.12) and 1 µL of BsaI per 10 µg DNA added to the mixture. 
Recommended buffer was already supplemented for the DpnI digest. After cutting the 
recognition and cutting sites for BsaI (5’-GGTCTC-3’), incorporated at the 5’-ends of the 
primers, are automatically eliminated and not maintained in the final product. 
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Table 3.18: Standard course of a restriction enzyme-mediated inverse PCR. 
A touchdown PCR is performed to avoid nonspecific binding of primers and to increase yields significantly
[136,137]
. 
During the first 10 cycles annealing temperature is decreased by 1 °C causing the primers to anneal at highest 
temperature which is least-permissive for nonspecific binding. Therefore, amplification of nonspecific 
sequences is outcompeted. 
Step Temperature [°C] Duration [s]  
1. Initial denaturation 95 60  




3. Cyclic annealing 65 30 
4. Cyclic elongation 68 60/1,5kbp 
5. Cyclic denaturation 95 20 
 
25 cycles 6. Cyclic annealing 55 30 
7. Cyclic elongation 68 60/1,5kbp 
8. Final elongation 68 Step 7 + 60  
9. Stop/cooling 4 ∞  
 
Prior to ligation of the sticky-ends using T4 DNA ligase at 16 °C overnight (50 µL digested 
PCR, 35 µL H2O, 10 µL T4 Ligase buffer (10×), 5 µL T4 DNA ligase) the digested PCR was 
purified again with PCR purification kits (Ch. 3.2.3.9). 
Ligations were usually precipitated with EtOH (Ch. 3.2.3.7) and dissolved DNA used for 
transformation via electroporation (Ch. 3.2.1.4). The inoculation of big cultures (about 
500 mL) followed by the isolation of the modified plasmids allowed the amplification of the 
DNA for further experiments. A dilution series of these cultures were used to determine the 
diversity of the PCR. Therefore, 50 µL of the inoculated medium was plated directly on agar 
plates containing the appropriate antibiotic, representing a 104 dilution. Further dilutions 
up to 108 were made by diluting previous ones tenfold with medium and also plated on 
agar plates. 
 
3.2.3.12 Measuring Nucleic Acid Concentration 
DNA and RNA concentrations of aqueous solutions were measured by absorption in UV 
cuvettes using a photometer. 3 µL of the nucleic acid containing solution was diluted in 
100 µL water. Detection occurred at 260 nm (A260) with pure water (100 µL) as a reference. 
The purity of the nucleic acid was also given by the photometer, calculated by the quotient 
of A260 to A280. 
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3.2.3.13 Sequencing of Plasmids 
DNA sequencing was performed using chain-terminating inhibitors, dideoxynucleotide 
triphosphates (ddNTPs), developed by Sanger and colleagues[138,139]. 
This method works similar to a normal PCR (Ch. 3.2.3.8) and needs the same components, 
i.e., a (single-stranded) DNA template, a primer, a DNA polymerase and normal dNTPs, 
except the ddNTPs that randomly terminate the extension of the DNA strand due to the 
lack of the 3’-OH group. The use of ddNTPs each labeled with a different fluorescent dye 
emitting light of a unique wavelength allows sequencing in a single reaction. At the end of 
the PCR fragments of all possible lengths are statistically contained in the mixture which 
can be separated and analyzed by a sequencing machine subsequently.  
The sequencing mix BigDye (BigDye® Terminator v1.1 Cycle Sequencing Kit, Applied 
Biosystems, USA) used for sequencing included the DNA polymerase, normal dNTPs and 
fluorescent labeled ddNTPs as well. The complete composition for a sequencing PCR is 
shown in Table 3.19 and the course in Table 3.20. 
Table 3.19: Pipetting scheme for the composition of one sequencing PCR reaction mix 
 Volume [µL] 
Seq buffer 1 
Seq mix. BigDye 1 
Primer, 10 µM 0.8 
Template DNA, 200-400 ng 1-7.2 
H2O Adjust to 10 µL 
 
Table 3.20: Standard course of a sequencing PCR 
Step Temperature [°C] Duration [s]  
1. Initial denaturation 96 60  
2. Cyclic denaturation 96 10 
 
25 cycles 3. Cyclic annealing 55 15 
4. Cyclic elongation 60 240 
5. Final elongation 60 240  
6. Stop/cooling 4 ∞  
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The DNA products were purified subsequently to the PCR. Therefore, the mixture was 
transferred to a 1.5 mL Eppendorf tube, supplemented with 2 mM EDTA-Na2, 50 mM 
sodium acetate and 80% EtOH (final concentrations), gently mixed and incubated for 5 min 
at RT. After a centrifugation step (16,100 × g, RT, 15 min) the supernatant was discarded 
and the pellet washed with 70 µL of 70% EtOH, followed by a second centrifugation for 
5 min. The supernatant was discarded again and the pellet was dried in a 
speedvac/concentrator for 2 min. The DNA pellet was dissolved in 15 µL formamide (99.5%) 
and given to AG Pieler, Göttingen for sequencing in a capillary sequencing machine. 
 
3.2.3.14 Extraction/Isolation of RNA 
Total RNA was isolated from bacterial cells by guanidine thiocyanate-phenol-chloroform 
extraction using TRIzol Reagent® (Invitrogen, Darmstadt; registered trademark of Molecular 
Research Center, Inc.). 
TRI Reagent is the improved version of the single-step method developed by Chomczynski 
and Sacchi[140,141]. The guanidine thiocyanate lyses cells and inhibits RNases at the same 
time. The addition of chloroform (or bromochloropropane) followed by centrifugation splits 
the mixture into three phases, i.e., an upper aqueous phase containing the RNA, an 
interphase harboring the DNA and a lower organic phase including the proteins. The RNA is 
obtained by supplementing isopropanol to the aqueous phase, washed with EtOH and 
dissolved subsequently. 
The isolation was performed according to manufacturer’s manual except for the first step. 
The lysis of a recommended maximum of 107 bacterial cells per 1 mL of TRI Reagent did not 
result in a satisfying yield of RNA. Hence, the pellet of 1 mL bacterial culture with an 
average OD600 of 3 was lysed with 1 mL of TRI Reagent. The washed RNA was dissolved in 
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3.2.3.15 Northern Blot 
For the identification of specific tRNAs via northern blot total RNA extracts (Ch. 3.2.3.14) 
were separated by size using acid urea PAGE conforming to the protocol of Köhrer et al.[142] 
Table 3.21: Composition of an acid urea polyacrylamide gel for acid urea PAGE 
Ingredients Volume [mL] Final Concentration 




1 M sodium acetate, pH 5.0 3.3 0.1 M 
Urea 16 g ≙ 11.5 mL 8 M 
10% APS (w/v) 1.2 0.36% (w/v) 
99.9% TEMED 0.025 0,075% (v/v) 
 
Isolated RNA was mixed 1:1 (v/v) with acid urea sample buffer (Table 3.6) following 
extraction. Approximately 90 ng of RNA were loaded onto the gel that was subjected to a 
short pre-electrophoresis for 30 min in the cold room. Electrophoresis was performed at 
168 V and 165 mA (∼12 V/cm) for 150-210 min in the cold room with 0.1 M sodium acetate 
pH 5.0 as running buffer until the bromphenol blue dye reached the end of the gel.  
As a size standard, low range RNA and oligonucleotide ladders (Ch. 3.1.4) were also loaded 
onto the gel. In vitro RNA transcripts of the correspondent tRNA synthesized by 
T7 RNA polymerase (Ch. 3.2.3.16) served as size standard and positive control for northern 
blots. 
For the actual blot only the portion of the gel between both dyes containing small RNAs like 
tRNAs was used. RNAs were transferred to a nylon membrane using a semidry blotter in a 
similar way as described in Ch. 3.2.2.4. The transfer was carried out at 25 V and 513 mA for 
80 min in the cold room with 1× NB transfer buffer (Table 3.6). Afterwards, the gel was 
soaked in a “gel red” bath to verify the success of the transfer using a gel documentation 
machine and the RNA was immobilized through covalent linkage to the membrane by heat 
(2 h, 75 °C in a hybridization oven) or UV light (90 s, 254 nm on a UV table). 
For northern hybridization, DNA oligonucleotides were designed (Table 8.2) with a length of 
17-23 bp, 5’-labeled with Cy3, Cy5 or DIG and complementary to the anticodon stem and 
loop domain of the desired tRNA target. 
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Prior to hybridization a prehybridization in the appropriate solution (30 mL, Table 3.6) was 
executed for 6-12 h at 42 °C in a hybridizer oven, with constant rotation. Thereafter, the 
temperature was increased to 68 °C and the solution exchanged with hybridization solution 
(30 mL, Table 3.6). After incubating the membrane for 12-24 h several washing steps were 
performed at RT with 6× SSC (twice for 10 min; low stringency, Table 3.6), followed by 
washes with 4× and 2× SSC (each for 20 min; medium and high stringency). 
Northern blots with Cy3 or Cy5 labeled hybridization probes could now directly be utilized 
for the detection of tRNAs using a Typhoon imager set to the correct laser and filter 
settings. Cy3 was excited by the green laser (532 nm) and emitted light passed through a 
580 nm band-pass 30 nm (580 BP 30) filter. For Cy5 the red laser (633 nm) was used in 
combination with a 670 nm band-pass 30 nm (670 BP 30) filter. Sensitivity was set to 
normal and the voltage for the photomultiplier tube (PMT) had to be adapted for each blot 
individually. The resolution for the most scans was 200 µm per pixel, in some cases it was 
increased to 100 µm per pixel. 
For the detection of DIG-labeled probes further steps were necessary (all carried out at RT). 
First, the membrane was equilibrated with 30 mL buffer 1 (Table 3.6) for 5-10 min, followed 
by blocking with 20 mL buffer 2 (Table 3.6) for 30 min and an incubation with anti-DIG-AP-
antibody in buffer 2 for 30-60 min (or overnight at 4 °C). Unbound antibodies were 
removed by washing three times for 10 min with 30 mL buffer 1. The membrane was then 
equilibrated with 10 mL buffer 3 (Table 3.6) for 10 min and the chemiluminescence reaction 
started subsequently by adding 1 mL buffer 3 containing 5 µL CDP-Star directly onto the 
membrane. After 5 min of membrane incubation with the substrate, in an X-ray cassette, 
emitted light was captured on ECL films for several seconds, to minutes, until the desired 
band intensities were achieved. The films were developed in an automatic X-ray film 
processor. 
 
3.2.3.16 Transcription With T7 RNA Polymerase 
Positive controls for northern blots (Ch. 3.2.3.15) were made via T7 RNA polymerase (T7RP) 
transcription. First, a PCR (Ch. 3.2.3.8) was performed to build a template that contained 
the recognition site for the T7 polymerase, 5’-TAATACGACTCACTATA-3’, and the gene for 
the appropriate tRNA. The success of the PCR was verified by electrophoresis on an agarose 
gel (Ch. 3.2.3.3) and the PCR product was purified (Ch. 3.2.3.9). 
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To destroy remaining RNases, the mixture was treated with proteinase K (1 µL per 50 µL 
PCR, 30 min, 50-55 °C). Inactivation of the proteinase K was carried out at 95 °C for 10 min. 
The transcription was performed at 37 °C for 2 h. The composition for one reaction is 
shown in Table 3.22; components were received from AG Ficner, Göttingen. The mixture 
was set up at RT due to the spermidine in the buffer which causes negative effects in the 
cold[143,144]. 
Table 3.22: Pipetting scheme for the composition of one transcription reaction mix 
 Volume [µL] 
MgCl2, 100 mM 4.5 
rNTPs (40 mM each) 20 (4×5) 
Transcription buffer, 10× 5 
Template DNA 18 
T7 RNA polymerase (1 mg/mL) 2.5 
 
Transcription was stopped by the addition of 5 µL 0.5 M EDTA-Na2 and the mixture 
subsequently centrifuged to remove generated pyrophosphates (16,100 × g, RT, 3 min). The 
supernatant containing the RNA oligos was purified (Ch. 3.2.3.9), and the elution mixed 
with acid urea sample buffer (Table 3.6) and boiled at 94 °C for 5 min to denature the RNA. 
Table 3.23 gives an overview of transcripts produced. 
Table 3.23: Overview of RNA transcripts made by T7 RNA polymerase. 
Transcripts are listed with the primers used for the PCR to produce the T7 polymerase recognition site 
containing template. 
Transcript Primer Chapter 
T7 PylT C28 and C29 4.1.2 
T7 SerT C30 and C31 4.1.2 
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3.2.4 Reporter Assays 
3.2.4.1 Chloramphenicol Reporter Assay 
The chloramphenicol (Cm) reporter assay (Figure 3.3) was the standard evaluation 
procedure to classify the suppression efficiency of a given system. The more resistant the 
cells were to Cm, the more efficient the suppression worked. A system that had insufficient 
suppression activity led to cell death. The Cm assay could be utilized to evolve synthetases 
for new UAAs, for example, or to investigate optimizations on components of the genetic 
code expansion machinery. 
 
Figure 3.3: Schematic view of the chloramphenicol reporter assay. 
A synthetase containing plasmid, derived from pBK PylS
[95]
 (pCLA1) or pBK MjYRS_TAG/AGGA
[45,78,83]
 
(pCLA2/pCLA3 ), was combined with the corresponding pREP
[78,95,145]
 reporter plasmid harboring the gene for 
PylT (pCLA4) or MjYT (pCLA5/pCLA6; Table 8.1), respectively. In addition to the gene for the tRNA, the plasmid 
also comprised a gene for a chloramphenicol acetyltransferase (CAT) with either a TAG or an AGGA codon. 
E. coli cells, ususally DH10B, were transformed with both plasmids (Ch. 3.2.1.3 and 3.1.9) and plated on agar 
plates with an increasing concentration of chloramphenicol, appropriate antibiotics for the plasmids and if 
required relevant UAAs. The better a plasmid combination worked, the higher the concentration of Cm the cells 
were able to survive. Resistance genes on plasmids are indicated by the arrows: blue = Kan; red = Amp; 
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3.2.4.2 GFP Reporter Assay 
The GFP reporter assay (Figure 3.4) was another option for quantifying the suppression 
efficiency of a given system. In contrast to the Cm reporter (Ch. 3.2.4.1), weak systems did 
not cause cell death. The advantage of this reporter was due to the fluorescent trait of GFP, 
which could be easily and directly measured using a plate reader (Ch. 3.2.2.12). Since all 
GFP reporter plasmids contained a His6-tagged GFP, detection via western blot (Ch. 3.2.2.4) 
was also possible. 
 
Figure 3.4: Schematic view of the GFP reporter assay. 
Electro competent E. coli DH10B cells were prepared that already bear a plasmid for the orthogonal ribosome 
ribo-Q1
[78]
 (pCLA96; Table 8.1) and one out of four GFP reporter plasmids (pCLA105 to pCLA108; Ch. 4.4.3). 
These cells were transformed with two different sets of plasmids, either Variant 1 or Variant 2. Variant 1 
comprised a pCDF Duet-1 (Novagen; pCLA91) based vector, which holds the genes for the tRNA/aaRS pairs 
PylT/PylS (PylST) as well as MjYT_UCCU/MjYRS_AGGA (MjYRST) (pCLA95). Variant 2 included the same 
tRNA/aaRS pairs as Variant 1, but split on two plasmids - pCDF PylST
[78]
 (pCLA97) and pDULE MjYRST (this 
version decodes for UCCU and is based on the CUA version
[68,83]
; pCLA98). The suppression efficiency of amber 
and/or frameshift codons was measured by the amount of GFP produced. GFP was either detected using a plate 
reader (Ch. 3.2.2.12) or by western blot (Ch. 3.2.2.4). The better a plasmid combination worked, the more GFP 
fluorescence could be detected. Resistance genes on plasmids are indicated by the arrows: black = Sm; 
blue = Kan; red = Amp; yellow = Tet 
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3.2.4.3 Barnase Reporter Assay 
The barnase assay is used to delete non-orthogonal synthetases that charge their 
corresponding tRNAs with natural amino acids or non-orthogonal tRNAs that are 
aminoacylated by endogenous synthetases. This negative selection is based on suppression 
of amber nonsense mutations in the barnase gene as described by Wang and Schultz[146]. 
The barnase protein is an extracellular ribonuclease that originates from Bacillus 
amyloliquefaciens. Without its inhibitor, barstar, it is lethal to cells[46]. That means, 
synthetases that are using natural amino acids in the absence of the UAA will finally 
suppress the amber codons in the barnase gene and mediate the cell death. Cells having 
synthetases that are still orthogonal and only using UAAs will be selected for (Figure 3.5). 
 
Figure 3.5: Schematic view of the barnase reporter assay. 
Electro competent E. coli DH10B cells containing the barnase reporter plasmid (pCLA114; Table 8.1) were 
transformed with pCDF four library plasmids. The mixture of the library plasmids comprised undesired mutated 
aaRS or tRNAs that are no longer orthogonal and desired orthogonal aaRS and tRNAs. Cells were plated on agar 
plates with appropriate antibiotics in the absence and presence of 0.002% arabinose, to induce the expression 
of the barnase gene, and 1 mM BocK, as a negative control. If no UAA was added but the barnase expression 
induced by arabinose, cells with mutated aaRS or tRNAs are supposed to die because of the usage of natural 
amino acids or the aminoacylation by endogenous synthetases and thereby the suppression of the amber 
codons within the barnase gene. Thus, only cells with orthogonal aaRS or tRNAs should survive due to no 
expression of barnase. Resistance genes on plasmids are indicated by the arrows: black = Sm; green = Cm. 
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4 Results 
4.1 Abundance And Activity of The aaRS/tRNA Pairs PylS/PylT And 
MjYRS/MjYT 
The expansion of the genetic code allowed for the site-specific incorporation of synthetic, 
unnatural amino acids (UAAs) into proteins comprising a diversity of functionalities like 
posttranslational modifications, UV-activatable crosslinkers or photo-reactive moieties[42]. 
These modified proteins have been used to investigate biological questions, for example, 
how acetylated lysines impact chromatin dynamics[97] and gene expression[147]. The UV-
activatable crosslinker p-benzoyl-L-phenylalanine helped to understand the complicated 
but important biological process of chromosome condensation in mitosis[86].  
Although this technique is a powerful tool for investigating protein function, the 
incorporation efficiency of UAAs is limited. Several approaches aimed at optimization of the 
existing systems by addressing suppressor tRNA competition with release factor 1 (RF1) for 
binding to amber codons in the A-site. This represents one of the major reasons for 
truncated proteins and is accentuated for protein expression aimed at incorporating 
multiple identical UAAs. Johnson and colleagues overcame this issue by knocking out the 
essential RF1 and simultaneously “fixing” RF2[57]. The workgroups of Church and Isaacs 
reassigned UAG as a sense codon by genome wide replacing with the synonymous UAA 
codon[64] using multiplex automated genome engineering (MAGE)[63], permitting the 
deletion of RF1[65]. 
Other methods included the use of orthogonal ribosomes, which allowed for the formation 
of a parallel, and independent, translational machinery that was evolved to decode amber 
and quadruplet codons with a significantly enhanced efficiency[67,78]. Furthermore, a variety 
of strategies to optimize aaRS and tRNA levels have been pursued that led to improved 
yields of full-length protein[51,69,72]. 
Nevertheless, none of the approaches performed to optimize the incorporation efficiency 
of UAAs into proteins provided a systematic study on the correlation of aaRS and tRNA 
expression levels, including the loading status of the tRNA. Thus, only little insight is given 
into which of these components is the actual limiting factor. Here, we describe the 
establishment of assays for the detection of the abundance and activity of each component 
(PylS/PylT and MjYRS/MjYT) individually and of both tRNA/aaRS pairs in combination. This 
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work aims to identify and optimize the limiting factors of the genetic code expansion 
system. 
4.1.1 PylS of Methanosarcina barkeri 
The pyrrolysine synthetase (PylS) of the archaeon Methanosarcina barkeri (M. barkeri) was 
the first component being modified for visualization via western blots. Specific antibodies 
against PylS are not available, necessitating the introduction of well-characterized epitope 
tags into the protein. We decided to use the small His6-tag for the detection and, possibly, 
purification of PylS, starting with the incorporation at the N-terminus (plasmid pCLA7) by 
cloning the appropriate codons into the plasmid pBK PylS[95] (pCLA1; see Table 8.1 and 
Table 8.3). Although the DNA sequencing (Ch. 3.2.3.13) was positive, for the insertion of the 
tag, it was not possible to visualize signals on a western blot (Ch. 3.2.2.4) against the His6-
tag. Shifting the tag from the N- to C-terminus (pCLA8) also did not result in western blot 
signals (not shown). 
To find other potential positions for the introduction of the His6-tag a sequence alignment 
with the homologous PylS of Methanosarcina mazei (M. mazei) was performed (Figure 4.1). 
 
Figure 4.1: Pairwise sequence alignment with PylS from M. mazei and M. barkeri. 
Alignment was executed by the program ClustalW
[148]
 using PylS protein sequences for M. mazei (METMA, 
Q8PWY1) and M. barkeri (METBA, Q6WRH6) from UniProt database
[149]
. Similarities between both sequences 
are highlighted below the alignment, whereas an asterisk (*) indicates identical residues, a colon (:) stands for 
the conservation between groups of strongly similar properties and a period (.) for weakly similar properties 
(similarity score: 79.95). The linker between N- and C-terminus seems not to have a stringent sequence 
dependency, illustrated by the lack of 34 amino acids in the sequence of M. barkeri compared to M. mazei. 
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This alignment, as well as alignments with PylS from other organisms (data not shown), 
revealed a flexible linker region between the tRNA binding domain in the N-terminus and 
the catalytic domain of the C-terminus[150]. This linker region started around L118 and 
ended at E183 (according to the sequence of M. barkeri). This part of the protein was 
considered potentially less sensitive for mutagenesis. With the additional help of the crystal 
structure from M. mazei (Figure 4.2) we chose two positions for the incorporation of an 
internal His6-tag, flanked by glycines. One tag was directed into the “gap” between S144 
and S145, evoked by the lack of 34 amino acids in the sequence of M. barkeri compared to 
M. mazei (Figure 4.1; pCLA9) and the other one was guided into a loop which projects out 
of the structure (Figure 4.2; pCLA10). 
 
Figure 4.2: Crystal structure of the catalytic domain of PylS from M. mazei. 
This figure was made with PyMOL
[151]
 using pdb file 2ZIN
[152]
 from the RSCB PDB database
[153]
. The highlighted 
red residues indicate the loop D206 to F216 (D171 to F181 in the M. barkeri sequence) in the linker region 
between N- and C-terminus. This loop was chosen to incorporate a His6-tag because it sticks out of the structure 
away from the catalytic core. 
 
To investigate if the integration of internal His6-tags had an influence on the catalytic 
activity of the enzyme, a chloramphenicol reporter assay (Ch. 3.2.4.1) was performed. 
Hence, E. coli cells were co-transformed with the pREP PylT reporter (pCLA4) and pBK 
plasmids containing PylS genes with internal tags (pCLA9 and pCLA10), without a His6-tag 
(pCLA1) and with a C-terminal tag (pCLA8) (Figure 4.3). The assay showed that cells with 
wild type (WT) PylS and PylS with a His6-tag introduced into the “gap” between S144 and 
S145 exhibit the same growth behavior and were resistant to a Cm concentration of 
approximately 400 µg/mL. Whereas cells harboring PylS with a C-terminal tag died around 
75 µg/mL Cm, cells with the loop version survived Cm up to 150 µg/mL. 
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Figure 4.3: Cm-Assay with pBK PylS His6-tag variants. 
The catalytic activity of wild type (WT; pCLA1) PylS was compared with different His6-tagged PylS variants 
(pCLA8 to pCLA10). Therefore a chloramphenicol reporter assay (Ch. 3.2.4.1) was performed and cells were 
plated on agar plates containing Kan, Tet, increasing Cm and 1 mM BocK. PylS with a tag introduced into the 
“gap” between S144 and S145 (pCLA9) showed an activity comparable to the WT (pCLA1)since cells were able to 
grow up to a Cm concentration of 400 µg/mL. A His6-tag at the C-terminus (C-term; pCLA8) allowed the cells to 
survive a Cm concentration of 75 µg/mL, only. The loop variant (pCLA10) let the cells grow up to 150 µg/mL Cm. 
 
Thus, the PylS “gap” variant (pCLA9) was the most promising mutant and needed to be 
tested for detectability on western blots. We performed a test expression using cells 
transformed with the appropriate plasmid and took samples in exponential growth phase, 
late exponential growth phase and stationary phase (Figure 4.4). 
 
Figure 4.4: Detection of PylS His6-tag (“gap”) via western blot. 
Three individual cultures with cells harboring plasmid pCLA9 were grown. Samples were taken and normalized 
to OD600 = 1.5 in exponential growth phase (OD600 = 0.6), late exponential growth phase (OD600 = 1.6) and 
stationary phase (OD600 = 2.0). Whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto 
a PVDF membrane (Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. 
 
This position allowed for the detection of the His6-tag and thereby the PylS via western 
blot. As depicted in Figure 4.4, a decrease of the signal at late exponential growth phase 
and again at stationary phase could be observed, although the loading control (Coomassie 
stain of the gel) showed even a slight increase in total protein yield. Due to the results from 
the activity test and from western blot we decided to use the PylS “gap” variant for further 
experiments. 
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Due to the fact that no crystal structures of M. barkeri PylS are currently available, the only 
structural insights come from that of the M. mazei homologue. This structure only reveals 
the C-terminal domain[154] because the highly basic, yet hydrophobic, N-terminal domain 
was unstable and inadequate for crystallization trials[150]. Additionally, the N-terminus was 
known to be essential for in vivo activity but dispensable in vitro[155] and its overall function, 
binding of PylT, was quite recently found by Jiang and Krzycki[150]. As mentioned above, the 
linker between the N- and C-terminus varies in sequence and length[155]. Furthermore, it has 
a high content of prolines, which are responsible for the instabilities due to the inability to 
form hydrogen bonds and the introductions of bends, or kinks, that disrupt helices or 
sheets. In the case of the M. barkeri PylS, the 66 AAs of the linker region include eight 
prolines, which correlate to circa 12%. In summary, the aaRS PylS exhibits several regions 
that destabilize the protein and thus potentially decrease the activity. 
 
Figure 4.5: Truncations in the PylS “gap” (“wt”) variant to investigate the effect on the suppression efficiency. 
Truncations (∆; the number specifies the quantity of AAs deleted; CT = C-terminus; NT = N-terminus) are 
indicated by the white spaces and were made via QC on pCLA9 resulting in plasmids pCLA11 to pCLA17. The 
protein PylS is pictured by the turquois arrows with numbers indicating the length in AAs below. The linker 
region is highlighted by the brown arrow and the internal His6-tag is accentuated by the violet arrowhead. 
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In order to determine if these parts of the protein are dispensable and thereby enhance the 
suppression efficiency, we produced truncations of different lengths inside the linker of the 
PylS “gap” variant (pCLA9). All of these truncations surrounded the internal His6-tag (Figure 
4.5). In addition, the complete N- and C-terminus were deleted to investigate the effect on 
the suppression efficiency as well. 
To find out whether these truncations influence the activity and thereby the suppression 
efficiency of PylS a chloramphenicol reporter assay was performed (Figure 4.6). Therefore, 
competent E. coli cells harboring the pREP PylT reporter (pCLA4) were transformed with the 
truncation plasmids (pCLA11 to pCLA17) and compared to PylS “gap” without any changes 
(pCLA9) as a reference. 
 
Figure 4.6: Cm-Assay with truncation variants of PylS “gap” (“wt”). 
The catalytic activity of “wt” PylS “gap” variant (pCLA9) was compared with different truncations made in the 
linker region between N- and C-terminus (pCLA11 to pCLA17; Figure 4.5). Therefore a chloramphenicol reporter 
assay (Ch. 3.2.4.1) was performed and cells were plated on agar plates containing Kan, Tet, increasing Cm and 
1 mM BocK. Deletions at the beginning of the linker, ∆10 and ∆20, did not influence the suppression efficiency 
negatively but cells were also not able to survive higher Cm concentrations than cells with the “wt” variant. All 
three versions let cells grew to a Cm concentration of 250 µg/mL. Cells with the other truncated PylS variants 
started dying already between Cm 25 and 50 µg/mL. Whereas the smaller truncations in the linker regions still 
allowed survival of a few cells up to Cm 100 µg/mL, especially the deletion of the C-terminus prevented growth 
on plates with Cm higher than 25 µg/mL. 
 
We observed that the N-terminal linker truncations, ∆10 and ∆20, revealed the same 
growth behavior as the “wild type” PylS. The suppression efficiency was neither decreased 
nor significantly increased. All three versions allowed cell growth to a Cm concentration of 
250 µg/mL. Deletions in the C-terminal linker region, as well as the deletion of the whole N- 
and C-terminus, caused the cells to die between Cm 25 and 50 µg/mL. The removal of the 
C-terminus caused a severe effect because no growth on agar plates with Cm higher than 
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25 µg/mL was noticed. The truncations ∆15, ∆30, ∆50 and ∆NT permitted very weak growth 
up to 100 µg/mL chloramphenicol. 
Since truncations of the PylS “gap” variant (pCLA9) did not result in a significant 
improvement of the suppression efficiency we used the “wt” version of this variant in 
further experiments. 
 
4.1.2 PylT of Methanosarcina barkeri 
For the optimization of the aaRS PylS (Ch. 4.1.1) it was also necessary to analyze the 
cognate tRNA PylT for its abundance and loading status. We chose to approach this assay 
using Northern blotting (Ch. 3.2.3.15) techniques and therefore hybridization probes had to 
be designed. As described in Ch. 3.2.3.15, we used DNA oligonucleotides labeled with Cy3, 
Cy5 or DIG, complementary to the anticodon stem and loop domain of the desired tRNA 
target. The oligos C25 and C26 (Table 8.2) were designed to anneal to the anticodon loop of 
PylT as shown in Figure 4.7. 
 
Figure 4.7: Predicted secondary structure of PylT. 
The structure was obtained from ViennaRNA Web Services
[156]
. The region to which the probes C25 and C26 
bind is highlighted in red, representing the anticodon stem and a section of the D-loop. 
 
Initial trials for the detection of PylT were carried out with in vitro synthesized targets. 
These were the DNA oligonucleotide C27 that represented the bases 13-42 (of 72) from 
PylT and a RNA transcript of PylT (T7 PylT; Ch. 3.2.3.16). Both targets could be detected 
with signal intensities depending on the concentration of the target as depicted in Figure 
4.8-A. We first approached this detection using fluorophore labeled probes (Cy3 and Cy5) 
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for hybridization. We then altered our approach to include DIG labeled probes due to 
increased sensitivity, as shown for T7RP transcribed E. coli Ser-tRNA-1 (T7 SerT; Figure 
4.8-B).  
 
Figure 4.8: Establishing northern blots to detect specific tRNAs. 
A) To verify the ability of the hybridization probes C25 and C26 to bind to the specific target tRNA PylT, artificial 
samples were separated with acid urea PAGE and subsequently blotted (Ch. 3.2.3.15). DNA oligonucleotide C27 
(PylT_13-42) was loaded with a total amount of 2.3, 4.6 and 6.9 µg, respectively (left to right, indicated by the 
black triangle). In contrast 6.0, 12.0 and 18.0 µg of T7 PylT were loaded. A Cy3 labeled PylT probe (C25) was 
used for hybridization and visualized by a Typhoon imager (Excitation: 532 nm; Filter: 580 BP 30; PMT 400; 
Resolution: 50 µm per pixel). B) Comparison of a Cy3 labeled probe (C32; upper panel) against E. coli Ser-tRNA-1 
to a DIG labeled probe (C33; lower panel). A total amount of 13.3, 1.33, 0.48, 0.24, 0.048 and 0.024 µg T7 SerT 
was loaded, respectively (right to left). The Cy3 probe was visualized by a Typhoon imager (Excitation: 532 nm; 
Filter: 580 BP 30; PMT 460; Resolution: 200 µm per pixel) and the DIG probe by decorating with an anti-DIG-AP-
antibody followed by a chemiluminescence reaction using CDP-Star as described in Ch. 3.2.3.15. 
 
The next step was to detect the PylT in total RNA extracts from E. coli cells. Hence, different 
cell cultures harboring plasmids for either PylS only or PylS and PylT (pCLA1 and pCLA4) 
were grown in the presence, or absence, of BocK. Total RNA was isolated (Ch. 3.2.3.14) and 
separated with acid urea PAGE. Several standards (Ch. 3.1.4) were used to estimate the size 
of the isolated RNA compared to the positive control T7 PylT, described above (Figure 
4.9-A). The T7 PylT gave a signal around 70 nt which fits to the actual size of the tRNA with 
72 nt. Total RNA extracts from cells yielded a smear, as expected, due to the many distinct 
RNA fragments with different lengths, like rRNAs, mRNAs, tRNAs, riboswitches etc. 
Subsequent northern blots of separated RNA revealed positive signals for PylT only if the 
appropriate plasmid was present in the cells (Figure 4.9-B). Decreasing the concentration of 
loaded RNA samples sufficiently resulted in the emergence of a second band with different 
migratory behavior. This second band only appeared if RNA was isolated from cells grown 
in medium supplemented with BocK (Figure 4.9-C). The appearance of the second signal, 
depending on the addition of the amino acid, suggested that the upper band represented 
the aminoacylated form of PylT and the lower one the uncharged form. 
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Figure 4.9: Detection of PylT in total RNA extracts. 
A) Acid urea PAGE for the size estimation of isolated RNA from cell cultures harboring plasmids for PylS (pCLA1; 
1.4 µg loaded onto gel) and PylS/PylT (pCLA1 and pCLA4; 1.45 µg loaded). The latter one was grown in LB 
medium supplemented with 1 mM BocK. T7 PylT (T7P) with a size of 72 nt served as a positive control (0.5 µg 
loaded). Three different size standards consisting of DNA and RNA nucleotides were used to consider different 
running behavior. ONL = Oligonucleotide Ladder; RL = Low Range ssRNA Ladder; LMW = Low Molecular Weight 
Marker. The gel was soaked in a “gel red” bath (1:10,000 in H2O (v/v)) and separated DNA/RNA bands were 
visualized by UV light using a gel documentation machine. B) Northern blot of samples described in A). A total 
amount of 2.8 µg RNA from cells with PylS only was loaded. In contrast 1.45, 0.7, 0.35 and 0.17 µg RNA from 
cells with PylS and PylT (+ 1 mM BocK) were loaded (left to right, indicated by the black triangle). 0.03 µg of the 
positive control T7 PylT were used. The DIG labeled probe C26 was utilized for hybridization and 
chemiluminescence signals recorded as described in Ch. 3.2.3.15. C) Northern blot for the comparison of cell 
cultures grown in the presence and absence of 1 mM Bock in the medium. Approximately 0.045 µg RNA were 
loaded for each sample. Signals were detected as in B). The upper band (PylT
BocK
) represents the aminoacylated 
form of PylT, whereas the lower band (PylT) depicts the uncharged form. 
 
 
4.1.3 MjYRS of Methanocaldococcus jannaschii 
Analogous to PylS (Ch. 4.1.1) no antibodies against the tyrosine synthetase (MjYRS) of the 
archaeon Methanocaldococcus jannaschii (M. jannaschii) were available. Thus, we again 
took the small His6-tag as an alternative and cloned it into the N-terminus (pCLA18). We 
observed again that, similar to the modifications on PylS, no signals on a western blot 
against the His6-tag were obtained. Shifting of the tag from N- to C-terminus (pCLA19), we 
again observed no signal from a western blot (Figure 4.12). Hence, comparable to PylS, we 
chose an internal position for the His6-tag based on the crystal structure depicted in Figure 
4.10. 
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Figure 4.10: Crystal structure of tyrosyl-tRNA synthetase from M. jannaschii complexed with tRNA(Tyr) and 
L-tyrosine. 
This figure was made with PyMOL
[151]
 using pdb file 1J1U
[73]
 from the RSCB PDB database
[153]
. The highlighted 
red residues indicate the loop K25 to K29. This loop was chosen to incorporate a His6-tag because it protrudes 
from the structure away from the catalytic core. The integration into this loop should not interfere with the 
tRNA sterically. 
 
The His6-tag, again flanked by glycines, was incorporated into the loop K25 to K29 (pCLA20). 
As shown in Figure 4.10 the highlighted red loop points away from the catalytic core, 
indicated by the tyrosine, as well as from the corresponding tRNA. Thus, the mutation 
should not constrict protein activity what was verified by a chloramphenicol reporter assay 
(Ch. 3.2.4.1). Therefore E. coli cells were transformed with pBK plasmids harboring the 
genes for MjYRS WT, C-terminal and internal His6-tag (pCLA2, pCLA19 and pCLA20), 
respectively, together with the appropriate reporter plasmid (pCLA5). 
It seemed that the incorporation of the His6-tag had no negative influence on the overall 
catalytic activity. Cells were able to survive all given concentrations of chloramphenicol up 
to 500 µg/mL, independent of the MjYRS version (Figure 4.11). 
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Figure 4.11: Cm-Assay with pBK MjYRS His6-tag variants. 
The catalytic activity of wild type (WT; pCLA2) MjYRS was compared with different His6-tagged MjYRS variants 
(pCLA19 and pCLA20). Therefore a chloramphenicol reporter assay (Ch. 3.2.4.1) was performed and cells were 
plated on agar plates containing Amp, Tet and increasing Cm. The His6-tagged versions were plated in duplicates 
but no significant difference could be observed. Cells with all kinds of His6-tagged MjYRS could grow up 
500 µg/mL Cm. If at all, the C-terminal tagged versions show a slightly weaker growth at the highest Cm 
concentration. 
 
The next step was to investigate if the MjYRS “loop” variant (pCLA20) could be detected via 
western blot in contrast to the N- and C-terminal tagged variants. We performed a test 
expression using cells transformed with the appropriate plasmids and took samples in 




Figure 4.12: Detection of MjYRS His6-tag via western blot. 
Four different cultures were grown with cells harboring the plasmid for WT MjYRS (pCLA2) without a His6-tag, N-
terminal (NT) His6-tagged MjYRS (pCLA18), C-terminal tagged MjYRS (CT; pCLA19) and the “loop” variant of 
MjYRS (pCLA20). Samples were taken in exponential growth phase (OD600 = 0.8), late exponential growth phase 
(OD600 = 2.3) and stationary phase (OD600 = 3.0). Cells counts were normalized by resuspending the cell pellets in 
appropriate amounts of SDS sample buffer. Whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and 
blotted onto a PVDF membrane (Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. PylS “gap” from 
E. coli, transformed with the plasmid pCLA9, in exponential growth phase (OD600 = 0.9) served as positive 
control. 
4: Results  67 
In a similar manner to PylS, as shown in Figure 4.4, only the unconventional internal His6-
tag gave a suitable signal on a western blot against the His6-tag. The intensity is significantly 
lower compared to the PylS signal, although both proteins are expressed under the same 
promoter. As already mentioned for PylS, the signal seemed to decrease at late exponential 
growth phase and again at stationary phase. The lanes for the samples taken from the 
culture with the N-terminal tagged MjYRS also exhibit a very weak signal of the correct size, 
which decreases over time and is not present in those lanes from WT or C-terminal tagged 
MjYRS. Considering the results from the Cm assay (Figure 4.11), in which no substantial 
difference between the MjYRS variants could be observed, this could be an indication that 
the proteins have a very short but distinct half-life. This could mean that there are sufficient 
molecules for the suppression of the amber codon but not enough left for a proper 
detection via western blot. The accessibility of the epitope by antibodies should not be the 
limiting factor because the cell lysates were prepared for western blot with denaturing 
conditions using SDS. 
 
4.1.4 MjYT of Methanocaldococcus jannaschii 
The last of the four components analyzed during this study was the corresponding tRNA of 
the aaRS MjYRS (Ch. 4.1.3) and its derivatives, called MjYT. MjYT, and the corresponding 
aaRS, were available in two different versions, where one was decoding the amber stop 
codon UAG (MjYT_CUA; pCLA5) and the other the frameshift codon AGGA (MjYT_UCCU; 
pCLA6). 
 
Figure 4.13: Predicted secondary structure of MjYT_CUA. 
The structure was obtained from ViennaRNA Web Services
[156]
. The region to which the probes C40 and C41 
bind, that is the anticodon stem and in parts the D-loop, is highlighted in red. 
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For the detection of these tRNAs on northern blots we developed hybridization probes 
covering the same regions of the tRNA as shown for PylT (Figure 4.7), namely the anticodon 
stem and in parts the D-loop. The oligos C40 and C41 (Table 8.2) were designed to anneal to 
the stop codon tRNA as shown in Figure 4.13. 
Next, we extracted RNA from E. coli cells (Ch. 3.2.3.14) containing plasmids for either 
MjYRS_TAG only (pCLA2) or in combination with the cognate tRNA (pCLA2 and pCLA5). 
Additionally, RNA was isolated from cells transformed with a plasmid that held both 
components at once but in which the aaRS was decoding for p-benzoyl-L-phenylalanine[83] 
(BPA; pCLA21) instead of tyrosine. Total RNA was separated with acid urea PAGE and its 
size was estimated by size standards (Ch. 3.1.4) and T7RP transcribed M. jannaschii Tyr-
tRNA (T7 TyrT) as depicted in Figure 4.14-A. 
 
Figure 4.14: Detection of MjYT_CUA in total RNA extracts. 
A) Acid urea PAGE for the size estimation of isolated RNA from cell cultures harboring plasmids for MjYRS_TAG 
(pCLA2; 2.8 µg loaded onto gel), MjYRS_TAG/MjYT_CUA (pCLA2 and pCLA5; 2.7 µg loaded) and 
BPARS/MjYT_CUA (pCLA21; 3.0 µg loaded). The latter one was grown in LB medium supplemented with 1 mM 
BPA. T7 TyrT (T7T) with a size of 77 nt served as a positive control (0.8 µg loaded). Two different size standards 
consisting of DNA and RNA nucleotides were used to consider different running behavior. ONL = Oligonucleotide 
Ladder; RL = Low Range ssRNA Ladder. The gel was soaked in a “gel red” bath (1:10,000 in H2O (v/v)) and 
separated DNA/RNA bands were visualized by UV light using a gel documentation machine. B) Northern blot of 
samples described in A). A total amount of 1.4 µg RNA from cells with MjYRS_TAG only was loaded. In contrast 
1.35µg RNA from cells with MjYRS_TAG and MjYT_CUA and 1.5 µg RNA from cells with BPARS/MjYT_CUA 
(+1 mM BPA) were loaded. The DIG labeled probe C41 was utilized for hybridization and chemiluminescence 
signals recorded as described in Ch. 3.2.3.14. 
 
We observed a signal between 70 and 80 nt in the lane for the T7 TyrT (Figure 4.14-A). The 
actual size of the tRNA is 77 nt. Total RNA extracts from cells yielded the expected smear. 
The northern blot of the same samples (Figure 4.14-B) showed two prominent bands. The 
upper one was present in all lanes and the lower one only if the cells were transformed 
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with the plasmid for the tRNA. Since the lower one only appeared in samples with the tRNA 
and the size correlated to the signal seen in Figure 4.14-A, we assigned this band as 
MjYT_CUA. 
The appearance of the second upper band was thought to be an unspecific binding of the 
probe to other RNA fragments, especially other tRNAs, due to its presence in all lanes. Thus, 
we blasted the sequence of the probe against the genome of E. coli (using the program 
BLASTN 2.2.29+[157], data not shown). It became apparent that the last 13 bases of the 
probe used for the northern blot were complementary to several kinds of E. coli asparagine 
tRNAs. Hence, new probes binding specifically to the M. jannaschii tRNA had to be 
developed and tested. Figure 4.15 shows an alignment of the two versions of MjYT, CUA 
and UCCU, together with those asparagine tRNAs to which the probe C41 was hybridizing. 
In addition to the tRNAs, all different probes tested for a specific binding to MjYT were 
aligned, those were MjYT_AGGA_DIG_Probe1-4 (C44 to C47). We switched to the 
frameshift codon version of MjYT since this tRNA was used in further experiments in 
combination with the UAG decoding tRNA PylT. 
 
Figure 4.15: Sequence alignment of MjYT. 
The DNA sequences of both MjYT versions (CUA = pCLA5 and UCCU = pCLA6) were compared to northern blot 
hybridization probes MjYT_AGGA_DIG_Probe1-4 (C44 to C47) and E. coli tRNAs Asn, Asn1, Asn2, Asn3a and 
Asn3b. 
 
Subsequent northern blots revealed that MjYT_AGGA_DIG_Probe3 (C46; Figure 4.16-A) was 
the only hybridization probe that was able to bind to the tRNA MjYT_UCCU specifically 
without giving background signals from E. coli Asn-tRNAs (Figure 4.16-B). The other probes 
yielded very weak signals, no signals at all, or exhibited unspecific binding (not shown). 
Furthermore, Probe3 could discriminate between the two versions of MjYT, only giving 
signals if the frameshift variant was present in the cells. Comparable to PylT (Figure 4.9-C) 
we observed two bands at different heights. Since this only happened if the corresponding 
aaRS was present, the upper signal was assigned as the aminoacylated form of MjYT_UCCU, 
again.  
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Figure 4.16: Refinement of MjYT detection. 
A) Predicted secondary structure of MjYT_UCCU. The structure was obtained from ViennaRNA Web Services
[156]
. 
The region to which the probe MjYT_AGGA_DIG_Probe3 (C46) binds is highlighted in red. B) Northern blot from 
the refinement studies using probes MjYT_AGGA_DIG_Probe1-4 (C44 to C47). In this case only 
MjYT_AGGA_DIG_Probe3 (C46) is shown. Approximately 0.090 µg RNA were loaded for each sample. After 
hybridization, chemiluminescence signals were recorded as described in Ch. 3.2.3.14. The upper band (MjYT
Tyr
) 
represents the aminoacylated form of MjYT_UCCU, whereas the lower band (MjYT) depicts the uncharged form. 
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4.2 Promoter Libraries 
Based on the fact that both tRNA/aaRS pairs could now be detected quantitatively and their 
activity measured as well (Ch. 4.1), we began to optimize the suppression efficiency of both 
systems. 
One cosideration for optimizations was already discussed in the previous chapter. The 
standard promoter in front of both synthetases, a glnS promoter, was not fully active 
during the full expression time. More precisely, we discovered a decrease of the expression 
levels of PylS and MjYRS over time(Figure 4.4 and Figure 4.12). In theory, a higher 
expression level of a certain synthetase should lead to a higher rate of aminoacylation of 
the corresponding tRNA and thus, to a more efficient decoding of the appropriate codon. 
We believed this could be achieved by the introduction of a stronger synthetase promoter. 
However, a pure overexpression could also cause negative effects due to toxicity, especially 
if the component is not endogenous. The use of multiple elements in one cell could boost 
those negative effects. 
Therefore, we tried to optimize the expression levels of both aaRS and tRNAs individually 
and in combination. For this purpose synthetic promoter libraries were used to fine tune 
the expression of the appropriate genes[158,159]. 
 
Figure 4.17: Schematic overview of the synthetic promoter libraries. 
The promoters (p) of the genes for pylS, mjyrS_AGGA, pylT and mjyT_UCCU were modified randomly via inverse 
PCR (Ch. 3.2.3.11). The -10 and the -35 box, highlighted in green, remained thereby unaffected. Nx represents 
the number of exchanged nucleotides, with N standing for the bases A, T, G and C. 
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The mutagenesis of the glnS promoters in front of the aaRS and lpp promoters ahead of the 
tRNAs, was performed using inverse PCR (Ch. 3.2.3.11). As depicted in Figure 4.17, 
mutations were applied to the nucleotides that surround the predicted -10 and -35 box, 
with the boxes themselves remaining unaffected. In detail, five bases upstream of the 
-35 box and further five bases downstream the -10 region were exchanged. Additionally, 
the 17 nucleotides connecting the two boxes in the glnS promoter and the 12 nucleotides in 
the lpp promoter were randomly mutated. Jensen and Hammer observed a range of 
400-fold change in activity by randomizing another promoter’s spacer sequence between 
these two conserved boxes without affecting the length[160]. We designed the primers for 
the PCR in such a way that each modified position could be replaced randomly by any of the 
four nucleic acid bases. This yielded a theoretical diversity of 1.8*1016 different glnS 
promoters and 1.8*1013 lpp promoters. The actual diversity achieved in these experiments 
covered an average of 106 distinct clones. 
 
4.2.1 PylS Library 
The glnS promoter of the pylS gene (pCLA86; this plasmid is described in Ch. 4.4.2) was 
randomized as described above. We determined a diversity of 5*106 different clones for 
this library. For the separation of inactive clones from active ones the amplified DNA was 
combined with a reporter plasmid (pCLA4) to select on chloramphenicol (Ch. 3.2.4.1). A 
dilution of cells was plated that consisted of 5*100, 5*101, 5*102 cells on agar plates with 
0 µg/mL Cm and 5*103, 5*105, 5*107 cells on plates with 25, 50 and 100 µg/mL Cm in the 
absence and presence of BocK. This was done for a clear discrimination of the effects from 
Cm and to obtain single clones for further investigations, e.g., broader range Cm assays. No 
growth could be observed on agar plates without Bock. 
Cells were collected for the agar plates with BocK and the 5*107 cell dilution in order to 
regain library plasmids from active clones and simultaneously remove reporter plasmids 
(Ch. 3.2.3.5). We chose the high cell count plates to assure the covering of the library 
diversity. Plasmid integrity was verified by restriction endonuclease digest (not shown). 
As mentioned before, agar plates with low cell counts resulted in single colonies. In order to 
screen the diversity of the library 90 different clones from plates with 25, 50 and 100 µg/mL 
Cm were transferred onto fresh agar plates with a broader range of Cm, from 0 to 
500 µg/mL, allowing a more precise differentiation of these clones (Figure 4.18). 
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Referring to Figure 4.18, a tendency of higher resistance to chloramphenicol from left to 
right could be observed. More cells on the right side of the agar plate survived the Cm 
concentration of 400 µg/mL in the presence of BocK, but also a Cm concentration of 75 to 
100 µg/mL without BocK. This increase in resistance correlated with the amount of 
chloramphenicol that was existent in the original agar plates. Clones with the reference WT 
glnS promoter already showed a weaker growth at 250 µg/mL. 
Next, we addressed changes on the promoters that have positive effects on suppression 
efficiency. For this purpose, ten out of the 90 single library clones were analyzed by 
western and northern blots. Since all clones survived a Cm concentration of 250 µg/mL in 
the presence of BocK, we only selected clones that also survived 400 µg/mL Cm, or those 
that could not survive low concentrations of Cm without BocK. These were the clones 1D, 
2E, 3E, 4F, 6B, 7A, 8G, 10D, 11D and 12H, according to the grid in Figure 4.18. The pBK PylS 
library plasmid variants were separated from the reporter plasmid (Ch. 3.2.3.5; not shown). 
 
Figure 4.18: Cm-Assay with single colonies from PylS library. 
Cells were plated on agar plates containing Kan, Tet, increasing Cm and 1 mM BocK (A and B) or no BocK (C and 
D). A selection of two plates each is shown only. The clones 1A, 5A and 9A contained pCLA9 as a reference and 
clones 2A, 6A and 10A harbored pCLA86 as a reference. Clones in columns 1-4 originated from the library agar 
plate with 25 µg/mL Cm and 1 mM Bock, columns 5-8 from the plate with 50 µg/mL Cm and 1 mM BocK and 
columns 9-12 from the plate with 100 µg/mL Cm and 1 mM BocK. 
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The purified library plasmids (pCLA22 to pCLA31) were sequenced to assure that all 
selected clones differed in sequence, but exclusively in the promoter region. Changes in the 
expression rate of PylS should then be due to mutations in the. The sequencing showed 
that beside a few silent mutations only those parts of the promoters were mutated which 
were intended to be. A sequence alignment of all ten library clones revealed that none of 
them had the same sequence (Figure 8.1). 
Lastly, we transformed E. coli BL21 cells with the isolated library plasmids in combination 
with a vector that harbored the genes for the cognate tRNA PylT and a His6-tagged histone 
H3 with an amber stop codon at position R52 (pCLA32). For suppression of the stop codon 
during the H3 expression the medium was supplemented with BocK. In the end, two 
samples of each culture were taken with one being used for comparative western blot 
analysis of expressed PylS and histone H3. The other was used for northern blot to 
investigate if the library also had an effect on this level of the translational apparatus 
(Figure 4.19). 
 
Figure 4.19: Comparative analysis of PylS lib clones via western and northern blot. 
For the investigation of the suppression efficiency of the library clones a histone H3 R52TAG (pCLA32) 
expression was performed. 1 mM Bock was used as UAA and H3 expression was induced with 0.5 mM IPTG at 
OD600 = 0.8. A selection of six different library clones (pCLA22 to pCLA27) was compared to WT PylS, which 
comprised the unchanged glnS promoter (pCLA9). All samples were normalized by OD600. For the western blot 
whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a nitrocellulose membrane 
(Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. For the detection of the cognate tRNA PylT total 
RNA was extracted from a second aliquot (Ch. 3.2.3.14). Approximately 0.090 µg RNA were loaded for each 
sample. The DIG labeled probe C26 was utilized for hybridization and chemiluminescence signals recorded as 
described in Ch. 3.2.3.15. The upper band in the second row represents the aminoacylated form of PylT, 
whereas the lower band depicts the uncharged form. 
 
We found that the PylS promoter library exhibited a variety of different promoter 
strengths. There were clones, for instance 3E, that had an increased expression efficiency of 
the synthetase PylS compared to the WT. On the other hand, we also observed clones, such 
as 4F, which displayed a strong decrease. Furthermore, the more PylS was expressed in the 
cells, the more PylT in the aminoacylated, slower migrating form, could be observed. 
Finally, similar to the correlation of synthetase and cognate tRNA, we monitored a clear 
dependence on the amount of PylS produced and the suppression efficiency, visualized by 
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the amount of histone H3 R52TAG expressed. Hence, it was possible to influence the 
suppression efficiency of the amber stop codon with the aid of the PylS promoter library 
with an increase in PylS resulting in higher expression levels of H3. 
 
4.2.2 MjYRS_AGGA Library 
The glns promoter of the synthetase MjYRS (frameshift codon version = AGGA) was 
mutated next (pCLA72; this plasmid is described in Ch. 4.4.2.). Unfortunately, the standard 
touchdown PCR protocol resulted in two PCR products, with the minority having the 
expected size of approximately 3000 bp but the majority having a size of roughly 1200 bp. 
This effect was suspected to be due to unspecific primer annealing, despite the touchdown, 
and needed to be optimized. Therefore, we eliminated the touchdown portion of the PCR, 
i.e., the first ten cycles, and applied a gradient of increasing annealing temperatures. The 
gradient covered 54.5 to 66.5 °C, in twelve steps. This modified inverse gradient PCR was 
set up twice, with one set being supplemented with 5% DMSO, which was thought to 
reduce the formation of secondary structures of template and primer DNA[161,162]. 
 
Figure 4.20: Inverse gradient PCR for the MjYRS promoter library. 
Two sets were tested with 12 different temperatures each, ranging from 54.5 to 66.5 °C (left to right; indicated 
by the black triangles). One set was supplemented with 5% DMSO. The expected size of the PCR product is 
approximately 3000 bp. 
 
An increase of the annealing temperature caused a gain of the desired PCR product, as 
depicted in Figure 4.20. The addition of DMSO in combination with the high annealing 
temperature of 66.5 °C finally led to a shift from undesired to the desired PCR product of 
expected size. 
Cells transformed with the product of the PCR using these optimized parameters yielded 
1.5*106 different clones. Inactive clones were removed as described above for the PylS 
library using the Cm reporter (pCLA6). Since MjYRS, in the version described here, decodes 
for tyrosine, no control plates without the “UAA” could be made. However, a decreasing 
number of colonies formed on increasing Cm concentrations. The library DNA was again 
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isolated from plates with 5*107 cells and the isolation verified by restriction endonuclease 
digest (not shown). 
The screening of the library diversity was the next step. To this end, we picked 30 different 
clones each from those single colony plates with 25, 50 and 100 µg/mL of Cm and 
transferred them onto fresh agar plates with a broader range of Cm, from 0 to 500 µg/mL, 
(Figure 4.21). 
Compared to the PylS library clones no tendency of higher resistance to chloramphenicol 
from left to right could be noticed. In contrast to PylS, where the reference clones already 
showed weaker growth at 250 µg/mL Cm, the MjYRS WT promoter clones died more 
abruptly. None of the selected clones survived the highest concentration of 500 µg/mL. 
 
Figure 4.21: Cm-Assay with single colonies from MjYRS_AGGA library. 
Cells were plated on agar plates containing Amp, Tet and increasing Cm. A selection of two plates is shown only. 
The clones 1A, 5A and 9A contained pCLA3 as a reference and clones 2A, 6A and 10A harbored pCLA72 as a 
reference. Clones in columns 1-4 originated from the library agar plate with 25 µg/mL Cm, columns 5-8 from the 
plate with 50 µg/mL Cm and columns 9-12 from the plate with 100 µg/mL Cm. 
 
To investigate if the mutagenesis of the glnS promoter of the mjyrS gene had similar effects 
on the suppression efficiency as that of the mutant pylS promoter, ten clones out of the 90 
were chosen. Since all the clones survived a Cm concentration of 250 µg/mL again, we 
considered how they behaved on the Cm400 plate. The DNA of the colonies 1D, 2F, 3B, 4A, 
6D, 7E, 8G, 9F, 10B and 11E, according to the grid in Figure 4.21, was isolated, because 
these clones represented a range of growth behavior. Thus, they were supposed to be able 
to repeat the distinct promoter strengths achieved with the PylS library. Therefore, the 
reporter plasmid was removed as previously described. 
Sequencing of the purified library plasmids (pCLA33 to pCLA42) confirmed the intended 
mutagenesis of the nucleotides surrounding the predicted -10 and -35 box, with the boxes 
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themselves remaining unaffected. A sequence alignment of all ten library clones revealed, 
that none of them had the same sequence (Figure 8.2). 
For the classification of the library promoter strengths myoglobin with a frameshift codon 
at position S4 (pCLA43) was expressed. For this reason E. coli DH10B cells were transformed 
with the library plasmids pCLA33 to pCLA42 together with pCLA43, a vector that contained 
the genes for the cognate tRNA MjYT_UCCU and the His6-tagged myoglobin. Since the 
synthetase decodes for tyrosine no extra amino acid was added to the medium. Figure 4.22 
shows the comparison of the ability to suppress the AGGA codon in case of myoglobin. 
Regarding the blot in Figure 4.22 the expression levels of myoglobin fluctuated only in a 
small range, hardly distinguishable by eye. The quantification using ImageJ revealed a 
minimal signal intensity of 65% and a maximal intensity of 115% compared to wild type. In 
contrast to the PylS library (Ch. 4.2.1), the MjYRS_AGGA promoter library seemed to have 
only a small influence on the suppression efficiency. Correlations between expressed 
synthetase and the protein of interest were not possible since the aaRS was not detectable 
on the blots. 
 
Figure 4.22: Suppression efficiency of MjYRS_AGGA lib clones. 
The efficiency was determined by the expression of Myoglobin S4AGGA (pCLA43). Expression was induced with 
0.2% arabinose (w/v) at OD600 = 0.8 and analyzed by western blot (lower panel) and the relative intensities 
measured by ImageJ (blue bars; upper panel; WT was set to 100%). The ten library clones (pCLA33 to pCLA42) 
were tested with respect to WT MjYRS_AGGA, which comprised the unchanged glnS promoter (pCLA72). For the 
western blot all samples were normalized by OD600, whole cell extracts were separated with SDS PAGE 
(Ch. 3.2.2.3) and blotted onto a nitrocellulose membrane (Ch. 3.2.2.4). Anti-His-antibody was used as primary 
antibody. 
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4.2.3 PylT and MjYT_UCCU Library 
The last two promoters that had to be changed were the lpp promoters of the pylT and 
mjYT_UCCU genes. The modification of the pylT promoter (pCLA79; this plasmid is 
described in Ch. 4.4.2) resulted in a library that held 5*105 different clones. The 
mutagenesis on the M. jannaschii tRNA promoter (pCLA82; this plasmid is described in 
Ch. 4.4.2) yielded a diversity of 1.2*106 distinct clones. 
For the removal of inactive clones via Cm reporter assay the tRNA libraries had to be 
combined with their cognate aaRS. This is because they were cloned and mutated on the 
reporter plasmids themselves. The PylT library was used for transformation together with 
the PylS (pCLA1) and the MjYT_UCCU library together with the MjYRS_AGGA (pCLA3). Cells 
were plated as before (Ch. 4.2.1) with no extra UAA added to the agar plates for the 
M. jannaschii system and Bock added for the M. barkeri pair. The quantity of colonies 
generally decreased while increasing the Cm concentration. The DNA of both libraries was 
recovered and checked for correct sequence identity. In the case of PylT a strong 
contamination with the parental reporter plasmid (pCLA4) was found, which ran higher on 
an agarose gel (bands at 5625 and 4701 bp) than the mutagenized version (bands at 3928 
and 1163 bp) used for making the library (data not shown). Before repeating the whole 
procedure, the usage of the restriction enzyme NdeI, which only cuts the parental plasmid, 
helped to clean the PylT library DNA (that still included the inactive clones). Thus, both 
isolated libraries showed the correct sizes as confirmed by restriction enzyme digest (not 
shown). 
We selected a total number of 96 different clones of each library from the single colony 
plates with 25, 50 and 100 µg/mL of Cm to transfer them on fresh agar plates for the broad 
range Cm reporter assay (0 to 500 µg/mL). The results for the PylT library are shown in 
Figure 4.23 and for the MjYT_UCCU library in Figure 4.24. 
The control plates without BocK in Figure 4.23 showed that most of the PylT library clones 
were not able to survive concentrations of Cm higher than 75 µg/mL and all of them died at 
150 µg/mL. In the presence of BocK all clones could resist 250 µg/mL, but only a few 
colonies in column I withstood 400 µg/mL. These clones originated from the Cm100 single 
colony plate, a trait already observed for the PylS library, but less distinctive. 
Comparable to the MjYRS library, the MjYT_UCCU library clones displayed a wide range of 
growth efficiencies over the whole plate, independently from the original Cm concentration 
(Figure 4.24). Most of the clones resisted a Cm concentration of 400 µg/mL, but none of 
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them survived 500 µg/mL. A few colonies became less dense at lower concentrations, e.g., 
the clones B3 and B6 already at 150 µg/mL (not shown) and the clones H6 and J2 at 
250 µg/mL. 
 
Figure 4.23: Cm-Assay with single colonies from PylT library. 
Cells were plated on agar plates containing Kan, Tet, increasing Cm and 1 mM BocK (A and B) or no BocK (C and 
D). A selection of two plates each is shown only. Clones in columns A-D originated from the library agar plate 
with 25 µg/mL Cm and 1 mM Bock, columns E-H from the plate with 50 µg/mL Cm and 1 mM BocK and columns 
I-L from the plate with 100 µg/mL Cm and 1 mM BocK. 
 
 
Figure 4.24: Cm-Assay with single colonies from MjYT_UCCU library. 
Cells were plated on agar plates containing Amp, Tet and increasing Cm. A selection of two plates is shown only. 
Clones in columns A-D originated from the library agar plate with 25 µg/mL Cm, columns E-H from the plate 
with 50 µg/mL Cm and columns I-L from the plate with 100 µg/mL Cm. 
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As before, ten out of the 96 clones of each tRNA library were selected to investigate effects 
on the suppression efficiency, due to changes in the lpp promoter, with western and 
northern blots. The clones A4, C2, E7, F5, H4, I3, I6, J7, K2 and L5, according to the grid in 
Figure 4.23, were chosen for the PylT library and their DNA separated from the synthetase 
plasmid (Ch. 3.2.3.5). Full separation was assured by the use of the restriction enzymes 
NdeI and StuI, which only cut the pBK synthetase plasmids (pCLA1 and pCLA3) but not the 
modified tRNA containing reporter plasmids (pCLA79 and pCLA82). The same was done for 
MjYT library clones B3, B8, D4, E1, G4, G7, I2, I8, K6 and L1, according to the grid in Figure 
4.24. This procedure failed for PylT clone H4 and for MjYT clone G4, thus only nine clones 
per library were available (data not shown). 
Finally, the sequencing of all purified tRNA library plasmids (pCLA44 to pCLA61) revealed 
that for both libraries, beside a few minor mutations, only those nucleotides surrounding 
the predicted -10 and -35 box were altered. The sequence alignment of each library 
illustrated and confirmed the diversity of the selected clones, with all of them being 
divergent (Figure 8.3 and Figure 8.4). 
In conclusion, promoter libraries for each component of the two tRNA/aaRS pairs 
originating from the organisms M. barkeri and M. jannaschii have been prepared. The PylS 
library revealed a strong dependence of expressed synthetase on the expression of the 
protein of interest. When more synthetase was expressed it leads to an increased 
expression level for the desired protein. The MjYRS library did not display such a clear 
depenence. Individual studies of the tRNA library clones with western and northern blots 
have not been done, yet. Both libraries were used in combination with the synthetase 
libraries, as described in a later chapter (Ch. 4.4.4).  
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4.3 Defined (Standard) Promoters 
In chapter 4.2 we found that alterations of the PylS synthetase promoter also effected the 
suppression efficiency of the amber codon inside a gene of a protein of interest and 
thereby the level of expression itself. The promoter of library clone 3E was among others 
the most powerful one and increased the levels of expressed PylS and histone H3 at least 
twofold (Figure 4.19). Hence, it was known that the promoter was stronger than the wild 
type glnS variant, which was classified as a promoter of moderate strength[163].  
Two questions arose then: Is it possible to enhance the performance of the system once 
more by the usage of promoters characterized as strong, versus weak, and how can the 
library promoter be categorized in comparison to defined standard promoters like the 
E. coli lac promoter or the lambda (λ) phage promoter? To this end a collection of different 
promoters was made whose strengths were already evaluated in literature. This set of 
promoters included endogenous E. coli promoters and their derivatives, coliphage 
promoters, as well as synthetic promoter variants. Their relative strength was mainly 
specified by so called Pbla-units
[164]. These units represent the ratio of RNA transcribed from 
a certain gene under the control of a promoter of interest with the transcripts of the β-
lactamase gene (bla) under its endogenous promoter (Pbla). For instance, the promoter PA1 
of the phage T7, with 76 ± 9 Pbla-units, was the strongest one found by Deuschle
[164] and 
thereby 76-fold more efficient than Pbla with 1 Pbla-unit. To avoid the need of a DE3 cell 
background, what means to be independent of the T7 RNA polymerase, no promoters of 
phage T7 were chosen. A list of the selected promoters together with their Pbla-units, if 
available, is shown in Table 4.1. 
The sequences of the compiled promoters were cloned in front of the pylS gene (pCLA85; 
this plasmid is described in Ch. 4.4.2) while exchanging the glnS promoter at the same time. 
We tested the capacity of these defined standard promoters concerning the suppression 
efficiency in the same way as we did for the PylS promoter library (Ch. 4.2.1) by expressing 
a His6-tagged histone H3 with an amber stop codon at position R52. Thus, E. coli BL21 cells 
were transformed with the relevant pBK plasmids, including WT glnS (pCLA9) and library 3E 
promoter (pCLA24) as references, again in combination with the PylT and H3 R52TAG genes 
containing pCDF plasmid (pCLA32). The expression was performed with BocK and the 
addition of IPTG started the synthesis of H3 as well as of PylS if provided with a Plac derived 
promoter. All other promoters are constitutive and do not need an inducer. The 
comparative western blot is depicted in Figure 4.25. 
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Table 4.1: Relative in vivo strength of selected promoters. 
The strength of the promoters (P) from various origins is given in Pbla-units. The sequences were obtained from 
the mentioned references. No Pbla-units were found for Plac1-6 Mt5 and Pcp25. Plac1-6 Mt5 was described to have a 
relative transcription efficiency of 112% and is consequently 56-fold stronger than Plac that exhibited only 
2%
[165]
. The synthetic promoter Pcp25 was merely characterized as “quite strong” without showing the data
[160]
. 
The strength of Pλ found by Deuschle
[164]
 was corrected upwards by Knaus
[166]
. 




PH207 55 ± 4 Deuschle
[164] 
PD/E20 56 ± 8 Deuschle
[164] 
Phage lambda (λ) 
Pλ 37 ± 7 / 53 ± 8 Deuschle
[164]/ Knaus[166] 
Pλcon/N25DSR 65 ± 9 Knaus
[166] 
E. coli 
Plac 5.7 ± 0.5 Deuschle
[164] 
PtacI 17 ± 2 Deuschle
[164] 
Plac1-6 Mt5 “56-fold of Plac” Liu
[165] 
Synthetic 
Pcon 4 ± 0.2 Deuschle
[164] 
Pcp25 “quite strong” Jensen
[160] 
 
Our initial observations suggested that the expression of the synthetase PylS worked for all 
the different promoters tested except Pcp25, Pλcon/N25DSR and PH207 ( Figure 4.25). For Pcp25 no 
signal could be detected, but the Pλcon/N25DSR promoter samples revealed a relatively intense 
band smaller than the expected size of 48 kDa probably due to degradation. The PH207 lane 
showed a very weak signal of the same reduced size. 
The various promoters were in control of a broad spectrum of produced PylS, ranging from 
small amounts, in the case of the WT promoter, up to a multiple fold increases of these 
signals, as in the case of the phage T5 promoter PD/E20. The yield of PylS correlated with 
most of the relative promoter strengths given in Table 4.1. We noticed the lowest 
abundances for the glnS WT promoter, which was characterized as moderate[163] before, 
and the library promoter Plib3E followed by the consensus sequence based Pcon, which had 
the fewest Pbla-units of all. Plac was the next strongest candidate referring to Pbla-units, what 
also coincided with the signal intensities on the blot. The modified lac promoter variant 
Plac1-6 Mt5 seemed to be more powerful than its precursor, but not to that extent as stated by 
Liu[165]. The phage promoters appeared to be the overall strongest ones, as expected by Pbla-
units. In previously performed experiments (not shown) Pλcon/N25DSR already turned out to be 
the most powerful promoter, according to the 65 Pbla-units, assuming that the mass of 
degraded PylS protein had a high transcription rate as a cause. However, despite its 
strength this promoter was not successful because no full-length PylS was produced in the 
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end. Regarding the blot, the promoter hybrid PtacI revealed higher PylS intensities as 
anticipated with respect to Pbla-units, arranging between Pλ and PD/E20. 
We then observed a strong correlation of produced PylS and expressed histone H3 R52TAG, 
similar to the PylS library clones (Figure 4.19). This means, that with an increasing level of 
PylS the level of histone increased as well. Nevertheless, there seemed to be a certain limit 
since even a moderate increase of PylS (compare Pcon, lane 1, and PglnS, lane 10) was already 
beneficial, while yields of histone H3 were not further improved, if more PylS was 
expressed. In contrast to the current result Plac has been shown in previous trials (not 
shown) to mediate histone H3 amounts similar to Pcon. 
 
Figure 4.25: Comparative analysis of defined standard promoters with WT glnS and library clone 3E promoter. 
The suppression efficiency in histone H3 R52TAG (pCLA32) expression of systems under the control of defined 
standard promoters (pCLA62 to pCLA70) was compared to systems where the aaRS PylS was expressed under 
the control of the WT glnS (pCLA9) or library clone 3E promoter (pCLA24). 1 mM Bock was used as UAA and H3 
expression was induced with 0.5 mM IPTG at OD600 = 0.8 as well as PylS that was dependent on Plac promoter 
and its derivatives. All samples were normalized by OD600. For the western blot whole cell extracts were 
separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a PVDF membrane (Ch. 3.2.2.4). Anti-His-antibody was 
used as primary antibody. 
 
Referring to the two questions at the beginning of this chapter, the library promoter 3E and 
also the WT glnS promoter could be classified as weak, if compared to the power of the 
other standard promoters. Furthermore, it was possible to significantly improve the 
suppression efficiency of the given system by using strong promoters. However, we 
considered Pcon and Plac to use in later experiments (Ch. 4.4.6) because the former one 
provided an enhancement of the system comparable to the strongest promoters and the 
latter one offered the advantage of an inducible promoter, what could be essential if a 
product is (very) toxic to the host cell.  
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4.4 The Modular Genetic Tool 
4.4.1 The Concept of The Modular Genetic Tool 
In chapters 4.2 and 4.3 we tried to optimize the suppression efficiency of amber stop 
codons or frameshift codons by the use of promoter libraries. A change of the accordant 
synthetase expression level was intended to have an effect on the expression rate of a 
protein of interest that contains the nonsense or quadruplet codon in its gene. Several 
promoters were found, especially for PylS, which improved the suppression efficiency. 
Whereas the optimization trials mentioned above focused on the incorporation of a single 
UAA, the simultaneous insertion of two or more UAAs was the greater goal. For the 
production of proteins containing multiple UAAs there requires an equivalent number of 
tRNA/aaRS pairs. These pairs are typically harbored on a single plasmid, where one would 
need two plasmids to accommodate for the suppression of two unique amino acids. In 
conjunction with the plasmid for the protein of interest, a minimum of three different 
plasmids is needed to produce a protein with two UAAs. Three plasmids also imply the use 
of three distinct antibiotics leading to increased stress levels in host cells. 
Moreover, the incorporation of two different UAAs decreases the expression efficiency 
once more. Neumann and colleagues showed an approach to overcome this deficit by the 
application of an evolved orthogonal ribosome that efficiently decodes a series of 
quadruplet codons as well as the amber codon[78]. The disadvantage of this method is the 
necessity for yet another plasmid that contains the orthogonal ribosomal RNA. In summary, 
although the expression efficiency is improved, the total count of plasmids and antibiotic 
stress is increased in host cells. 
Hence, another possibility for the optimization of the genetic code expansion system is 
given by reducing the number of plasmids used. This should be achieved by combining both 
tRNA/aaRS pairs on a single vector based on pCDF Duet-1 as depicted in Figure 4.26-A. 
Furthermore, this plasmid should provide the opportunity to exchange each component for 
other tRNA/aaRS pairs, individually, to introduce new UAAs. Finally, even the replacement 
of each promoter and terminator sequence of all four components should be available, 
resulting in a highly modular genetic tool (Figure 4.26-B). The Schultz laboratory pursued a 
similar approach by combining an amber codon suppressing MjTyr pair and an ochre 
suppressing pyrrolysine pair on an evolved suppressor plasmid[72]. They were able to 
efficiently incorporate BocK and p-acetyl-L-phenylalanine (pAcF) into GFP albeit GFP levels 
did not exceed those if both suppression systems were split on two vectors. 
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Figure 4.26: Schematic overview of the modular genetic tool. 
A) The genes mjyrS_AGGA, pylS, pylT and mjyT_UCCU will be combined on a single vector based on pCDF Duet-1 
(Novagen). This will reduce the number of plasmids required for the incorporation of two UAAs and the needed 
antibiotics at the same time by one. B) For the construction of the modular genetic tool that allows the 
replacement of every single component, including their promoters (P1-4; light green) and terminators (T1-4, 
orange), a series of unique restriction sites is mandatory. 
 
4.4.2 The Construction of The Modular Genetic Tool 
The construction of the modular genetic tool started with the incorporation and/or the 
exchange of the numerous unique restriction sites according to Figure 4.26-B. To this end, a 
series of twelve different QuikChanges (Ch. 3.2.3.10) was performed that mutated the basic 
pBK synthetase plasmids pCLA9 (PylS His6-tagged “gap” variant) and pCLA3 (MjYRS_AGGA) 
as well as the pREP plasmids for the tRNAs PylT (pCLA4) and MjYT_UCCU (pCLA6). Table 4.2 
shows a list of all applied QCs including plasmids that were used for mutagenesis. Every 
cloning step was checked for success via restriction digest using the appropriate enzymes 
(data not shown) and sequencing data revealed that all twelve QCs were successfully 
mutated. 
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Table 4.2: Overview of all QuikChanges performed in order to construct the modular genetic tool. 
Twelve different QCs were made in total. The number of the QC is aligned with the used template, the purpose 
of the QC and the resulting plasmid. Except for pCLA77 and pCLA80 all produced plasmids were sequenced. 
Details of the construction (primers and sequencing primers) can be found in Table 8.3. 











1 pCLA3 C-terminal His6-tag on 
MjYRS_AGGA 
pCLA71 






3 pCLA9 NdeI restriction site in front of 
PylS start codon changed to KpnI 
pCLA73 
4 pCLA73 PstI restriction site behind PylS 
stop codon changed to SacI 
pCLA74 
5 pCLA74 SalI restriction site in front of 
PylS promoter 
pCLA75 






7 pCLA4 deletion of genes for T7 RNA 
Polymerase, AraC and GFP 
pCLA77 
8 pCLA77 NotI restriction site in front of 
PylT promoter 
pCLA78 










 10 pCLA6 deletion of genes for T7 RNA 
Polymerase, AraC and GFP 
pCLA80 
11 pCLA80 MfeI restriction site in front of 
MjYT_UCCU promoter 
pCLA81 




The extent of the mutagenesis in the preparation of the modular genetic tool holds a 
certain amount of risk because one or more mutations could influence the efficiency of the 
system negatively. Thus, chloramphenicol reporter assays were made to test the final 
plasmids pCLA72, pCLA76, pCLA79 and pCLA82 as well as the intermediate steps. Most of 
the plasmids revealed the same suppression efficiency as the basic plasmid (data not 
shown), except for PylS (Figure 4.27). Independent of the plasmid used for transformation, 
the cells were not able to survive Cm concentrations higher than 25 µg/mL. However, cells 
that harbored the unchanged basic plasmid (pCLA9) were still able to grow on agar plates 
with 400 µg/mL chloramphenicol. 
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Figure 4.27: Cm-Assay with final pBK PylS plasmid and intermediate steps from preparation for the modular 
genetic tool. 
The catalytic activity of PylS His6 “gap” on the basic plasmid (pCLA9) was compared to PylS on the mutated 
plasmids pCLA73 to pCLA76 from QC#3-6 (Table 4.2). Therefore a chloramphenicol reporter assay (Ch. 3.2.4.1) 
was performed and cells were plated on agar plates containing Kan, Tet, increasing Cm and 1 mM BocK. Only 
cells with the basic plasmid were able to survive Cm concentrations higher than 25 µg/mL. 
 
Since the activity already decreased after the first QC that exchanged the NdeI restriction 
with KpnI and the resulting plasmid served as precursor for the following QCs, we needed 
to determine if the catalytic activity of PylS itself was disturbed or if there was another 
cause for this effect. For this reason QC#5 and #6 (Table 4.2) were repeated using the basic 
plasmid (pCLA9) as template this time (QC#5B: pCLA83 and #6B: pCLA84), in order to 
incorporate the corresponding sites in a different order. Additionally, two further clones of 
QC#3 were tested in a subsequent Cm reporter assay (Figure 4.28). 
 
Figure 4.28: Cm-Assay to detect the stage responsible for PylS activity loss. 
The catalytic activity of PylS His6 “gap” on the basic plasmid (pCLA9) was compared to PylS on the mutated 
plasmids pCLA73, pCLA83 and pCLA84 from QC#3, #5B and #6B (two clones each). Therefore a chloramphenicol 
reporter assay (Ch. 3.2.4.1) was performed and cells were plated on agar plates containing Kan, Tet, increasing 
Cm and 1 mM BocK. Only cells with the plasmid from QC#3 were not able to survive Cm concentrations of 
25 µg/mL. 
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It could be stated that the incorporation of the restriction sites SalI and NotI alone did not 
perturb the suppression efficiency of PylS as depicted in Figure 4.28. In contrast, the two 
other clones of QC#3 tested, showed the same phenotype as before. Hence, the 
replacement of the NdeI site upstream of the PylS start codon by KpnI seemed to be the 
reason for the PylS activity loss. 
It was necessary to exchange, or at least to destroy, the NdeI site at the PylS gene for the 
construction of the modular genetic tool because the gene for MjYRS_AGGA also possesses 
an NdeI site. We then asked two questions. First, is it possible to restore the PylS activity on 
pCLA76 by mutating the KpnI site back to NdeI? Second, is it possible to restore the activity 
and destroy the NdeI site simultaneously? A series of six different QCs was applied to 
pCLA76, one to restore the NdeI site and the other ones to restore the site while 
introducing point mutations (pCLA85 to pCLA90). The NdeI-restore mutants were again 
screened via Cm reporter assay (Figure 4.29). 
 
Figure 4.29: Cm-Assay of the PylS NdeI restore mutants. 
The catalytic activity of PylS His6 “gap” on the basic plasmid (pCLA9) was compared to PylS on the mutated 
plasmids pCLA73 (QC#3), pCLA85 (NdeI restore) and pCLA86 to pCLA90 (NdeI restore Point Mutations (PM) 1-5). 
Therefore a chloramphenicol reporter assay (Ch. 3.2.4.1) was performed and cells were plated on agar plates 
containing Kan, Tet, increasing Cm and 1 mM BocK. Only cells with the plasmid from QC#3 were not able to 
survive Cm concentrations of 25 µg/mL. 
 
The activity of PylS could be almost restored by reinstalling the NdeI site in front of the PylS 
start codon. The PylS activity of the point mutation variants of NdeI was similar to the fully 
reconstituted NdeI site, as shown in Figure 4.29. Moreover, the point mutated NdeI sites 
were not digested by the restriction enzyme NdeI any more (data not shown). Due to the 
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highest PylS activity of all point mutation clones, pCLA86 (NdeI-restore_PM1) was chosen 
for further experiments. 
Since all needed restriction sites were cloned into the basic pBK and pREP vectors, 
according to Figure 4.26-B and Table 4.2, we performed digests in a preparative scale 
(Ch. 3.2.3.2; Table 4.3) to cut out the genes for both tRNA/aaRS pairs and combined it on a 
pCDF Duet-1 backbone (Novagen; pCLA91). 
Table 4.3: Overview of preparative digests performed in order to construct the modular genetic tool. 
Plasmids for inserts and backbones were digested with the same enzymes. The insert is equal to the component 
mentioned in the table. The plasmid pCLA86 had to be cut by three restriction enzymes to assure the full 
separation of backbone and insert on a subsequent agarose gel. Cutting with SalI and NotI only would yield 
bands with sizes of 1555 and 1707 bp, which are difficult to excise from gel precisely. 
Plasmid Enzymes Component Product 
Insert Backbone 
pCLA72 pCLA91 BamHI + SalI MjYRS_AGGA pCLA92 
pCLA86 pCLA92 SalI + NotI (+ XhoI) PylS pCLA93 
pCLA79 pCLA93 NotI + MfeI PylT pCLA94 
pCLA82 pCLA94 MfeI + XhoI MjYT_UCCU pCLA95 
 
All four components could be successfully transferred into the pCDF Duet-1 vector. Plasmid 
integrity was verified by restriction enzyme digests (Figure 4.30) and sequencing. 
 
Figure 4.30: Restriction digests of the final modular genetic tool. 
The final plasmid pCLA95 that contains all four components (digests 1, 3, 5 and 7) was compared to the insert 
plasmids (Table 4.3) pCLA72 (digest 2), pCLA86 (digest 4), pCLA79 (digest 6) and pCLA82 (digest 8). Enzymes and 
sizes: BamHI and SalI (1 = 5618 and 1206; 2 = 1820 and 1206); SalI and NotI (3 =5269 and 1555; 4 = 1555, 890 
and 817); NotI and MfeI (5 = 6612 and 212; 6 = 4879 and 212); MfeI and XhoI (7 = 6506 and 318; 8 = 4776 and 
318). 
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4.4.3 Monitoring The Power of The Modular Genetic Tool 
In order to determine if the modular genetic tool had benefits compared to the classical 
system using four different plasmids, it had to be tested using a reporter system. Therefore, 
we established a second reporter in parallel to the Cm assay – the GFP reporter assay 
(Ch. 3.2.4.2). This assay exists in two variants, with variant 1 consisting of three plasmids, 
namely the modular genetic tool (pCLA95), a plasmid for the orthogonal ribosome ribo-
Q1[78] (pCLA96) and finally one out of four different GFP reporter plasmids (pCLA105 to 
pCLA108). The second variant only differed by the separation of the four components of the 
genetic tool onto two plasmids, namely pCDF PylST[78] (pCLA97) and pDULE MjYRST (this 
version decodes for UCCU and is based on the CUA version[68,83]; pCLA98). 
For the construction of the GFP reporter a plasmid made by Wang and others, called 
pO-gst-malE[67] (pCLA99), was taken as a basis. This vector contains a mutated Shine-
Dalgarno sequence that is only bound by orthogonal ribosomes (ORBS = orthogonal 
ribosomal binding site), in this case the ribo-Q1 provided on pCLA96. As a first step the 
gene for the fusion protein GST-MBP was removed, except for the first five triplet codons to 
assure that the binding of the orthogonal ribosome is not perturbed in any way. 
Simultaneously, a small multiple cloning site (MCS) was introduced, including the unique 
restriction sites for NcoI, BamHI, NotI and HindIII. The latter one was embedded in the final 
ochre stop codon of the open reading frame. The plasmid (pCLA100) was controlled by 
restriction digest and sequencing. Next, we amplified the actual reporter genes encoding 
for superfolder GFP[167] from pBAD sfGFP vectors, made by Stokes et al.[168], including four 
different genes for a wild type version, a gene with an amber codon at position N150, a 
frameshift codon at position D134 or both substitutions on one gene at the same time. All 
versions contained a C-terminal His6-tag and the former restriction site, XhoI, at the end of 
the gene, was changed to HindIII during the PCR, allowing the cloning into the ORBS 
reporter pCLA100 subsequent to restriction digest (pCLA105 to pCLA108). 
Four sets of electro competent cells were prepared (Ch. 3.2.1.2), with all of them containing 
the plasmid for the orthogonal ribosome ribo-Q1 (pCLA96) and one out of the four different 
ORBS GFP reporter plasmids (pCLA105 to pCLA108). For the comparison of the three 
plasmid system, variant 1, and the four plasmid system, variant 2, these competent cells 
were transformed with appropriate plasmids and grown in medium supplemented with 
BocK for the suppression of the amber codon. The suppression efficiency of amber and/or 
frameshift codons was measured by the amount of GFP produced. We expected that the 
better a plasmid combination worked, the higher the concentration of GFP would be. In 
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Figure 4.31 a comparison of the modular genetic tool to the four plasmid system is shown. 
Additionally, a variant of the genetic tool was tested harboring a gene for MjYT_UCCU with 
a mismatch in the anticodon stem (C29-A44 instead of C29-G44, pCLA109). 
 
Figure 4.31: Comparison of the modular genetic tool to the four plasmid system. 
The expression efficiencies of WT GFP (pCLA105), GFP with a frameshift codon (pCLA108) and GFP with a 
frameshift and an amber codon (pCLA107) were investigated via fluorescence measurement in a plate reader 
(lower panel; Ch. 3.2.2.12) and western blot (upper panel; Ch. 3.2.2.4). Three systems were compared: 
GTC = Genetic Tool Control (mismatch in MjYT_UCCU; pCLA109), GTF = Genetic Tool Final (pCLA95), 
4Pl = 4 Plasmid system (pCLA97 and pCLA98). All orthogonal mRNA translations were driven by ribo-Q1 
(pCLA96). A final concentration of 1 mM Bock was added to the medium. Two distinct samples were taken of 
each condition tested at different time points (GTC and GTF after 7 and 15 h; 4Pl after 72 h (pre-culture), 20 and 
26.5 h (main culture) because they grew much slower than variant 1-cells), with one being normalized to OD600 
of 1.5 for usage with western blots and one being normalized to OD600 of 0.5 for the detection of GFP in a plate 
reader (Ch. 3.2.2.12). For the western blot whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and 
blotted onto a PVDF membrane (Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. Fluorescence 
measurements were always performed in duplicates. The mean values of GFP WT were set to 100% for each 
system individually. 
 
The employment of the modular genetic tool resulted in higher expression levels of GFP 
compared to the four plasmid system (Figure 4.31). Although the general translation 
efficiency was similar as shown for GFP WT, the decoding of an AGGA codon performed up 
to three fold more efficiently. The combination of an AGGA and a UAG codon yielded five 
times more protein. Results could be confirmed by western blot. Cells with the control 
mismatch tRNA seemed to be almost completely inactive. 
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Using the modular genetic tool increased the expression level of the reporter protein GFP 
significantly. Beside this, we observed that the viability of cells transformed with the 
genetic tool, and thereby with one plasmid less than those cells transformed with the four 
plasmid system, was three to five times better (for details see Ch. 4.4.6). Concerning these 
findings the modular genetic tool already demonstrated a powerful tool that optimized the 
established system. 
 
4.4.4 The Combination of The Modular Genetic Tool and The Promoter 
Libraries 
The promoter libraries explained in Ch. 4.2, especially for the aaRS PylS, already showed 
improvements for the incorporation of UAAs into proteins. The positive effect by using the 
modular genetic tool instead of the four plasmid system was illustrated in Ch. 4.4.3. 
Consequently, the next step was to test the combination of both optimization trials to 
obtain an even more efficient genetic tool with enhanced promoters to balance the 
simultaneous expression of both tRNA/aaRS pairs in the cell. 
To this end, large scale preparative digests with 10 to 30 µg of DNA, from backbone and 
insert vectors, were performed to cover the diversities of the distinct libraries. The same 
restriction enzymes described in Table 4.3 were used because the library plasmids were 
based upon the plasmids (pCLA72, pCLA86, pCLA79 and pCLA82) used to construct the 
modular genetic tool. To avoid contaminations with wild type promoters, the libraries were 
cloned into a fresh pCDF Duet-1 (pCLA91) vector instead of exchanging the existing WT 
versions on the final plasmid (pCLA95). The ligation and transformation efficiency was 
checked by dilution series for each cloning step. 
First, we cloned the PylS and PylT promoter libraries into pCDF Duet. The transformations 
of E. coli DH10B via electroporation yielded with 106 to 107 different clones. However, the 
cloning of the PylT library revealed a strong background, defined by the number of colonies 
counted on agar plates with clones from the negative control (ligation of vector backbone 
and water instead of insert DNA). Since these background clones were thought to be due to 
re-ligation of the digested backbone vector, we presumed to eliminate them using a 
modified chloramphenicol reporter harboring the gene for the chloramphenicol 
acetyltransferase with an amber codon but no tRNA (pCLA110). That means clones should 
only be able to grow on Cm if both libraries were successfully cloned into the pCDF vector. 
Hence, electro competent cells containing the modified reporter were prepared and 
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transformed with up to 10 µg of the combined pCDF PylS-PylT library plasmids. Afterwards, 
cells were selected on chloramphenicol (Figure 4.32). 
 
Figure 4.32: Cm-Assay for the background reduction of combined PylS and PylT promoter library. 
Cells harboring the delta tRNA Cm reporter (pCLA110) and the pCDF PylS-PylT promoter library plasmids were 
plated (2 mL cell culture with an OD600 of 2.6 each) on agar plates containing Sm, Tet, increasing Cm and 1 mM 
BocK (A to C) or no BocK (D to F). 
 
Assuming that cells without any PylT did not survive the Cm assay, the background 
reduction for the combination of the PylS and PylT library conferred amino acid 
dependency, since only a fraction of cells survived without the UAA BocK, as depicted in 
Figure 4.32. The cells from the agar plate with a Cm concentration of 50 µg/mL and BocK 
were scraped off for plasmid isolation, as already described in Ch. 4.2.1. The purified pCDF 
PylS-PylT library plasmids were subsequently used for the cloning of the MjYRS_AGGA and 
MjYT_UCCU libraries. Both yielded, on average, 106 different clones. Thus, all four libraries 
described in Ch. 4.2 were successfully cloned into pCDF Duet, confirmed by restriction 
digests in comparison to the wild type modular genetic tool (pCLA95; Figure 4.33). 
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Figure 4.33: Restriction digests of the modular genetic tool with wild type and library promoters. 
The final modular genetic tool with wild type glnS and lpp promoters (pCLA95; digests 1, 4, 7 and 10) was 
compared to two sets of the tool containing the promoter libraries of all four components (sets differed in 
diversity only: set1 had 5*10
5
 clones (digests 2, 5, 8 and 11); set2 had 3*10
6
 clones (digests 3, 6, 9 and 12). 
Enzymes and sizes: BamHI and SalI (13 = 5618 and 1206); SalI and NotI (4-6 =5269 and 1555); NotI and MfeI 
(7-9 = 6612 and 212); MfeI and XhoI (10-12 = 6506 and 318). 
 
The quantification of the suppression efficiency for the modular genetic library tool was 
performed by GFP reporter assay (Ch. 3.2.4.2), as previously described for the WT promoter 
version (Ch. 4.4.3). Therefore, previously prepared competent cells that held the plasmids 
pCLA96 and pCLA107 for the orthogonal ribosome ribo-Q1 and the ORBS GFP reporter 
comprising the frameshift codon AGGA and the amber codon UAG, respectively, were 
transformed with the pCDF PylS-PylT-MjYRS-MjYT library plasmids. The enormous variety of 
different promoter sequences made it impossible to investigate the GFP expression levels 
separately via plate reader or western blot. The method of choice used for this purpose was 
the fluorescence-activated cell sorting (FACS) which was established by the workgroup of 
Herzenberg[129]. FACS (Ch. 3.2.2.13) was performed at the MRC Laboratory of Molecular 
Biology, Cambridge. Cells transformed with plasmids pCLA96 and pCLA105, expressing GFP 
WT, were used as a positive control. In order to set a threshold for the suppression of the 
AGGA and TAG codon in the GFP gene (pCLA107) that had to be exceeded by more efficient 
library clones, cells were prepared that contained the modular genetic tool with wild type 
promoters (pCLA95) as a reference. The results of the FACS are shown in Figure 4.34 in 
summary. 
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Figure 4.34: FACS to identify the best combination of all 4 libraries on the Genetic Tool at once (GT4L). 
A) sfGFP WT (pCLA105) expression to set up the screening area. Positive fluorescence signals are found on the 
right side of the plot. Each dot illustrates a measurement of a single cell/event by the FACS machine. 
Cells/events chosen to be collected are found within the rectangle and colored red. R1 represents the relative 
amount of cells/events within the rectangle compared to the total amount of cells/events tested. B) sfGFP 
harboring a TAG and an AGGA codon in the gene (pCLA107) was expressed using the GTF (Genetic Tool Final 
(pCLA95) – standard glnS (aaRS)/lpp (tRNAs) promoter) to identify maximum fluorescence/expression level 
using the standard system. C) Screening for high fluorescence signals (green rectangle) resulting from sfGFP 
expression using the GT4L plasmids. D) Second round of screening cells with GT4L plasmids using isolated cells 
from C). It seemed the machine sorted out mainly false positive ones, thus no improved GFP signals could be 
detected. 
 
We did not observe clones from the four library plasmids that displayed enhanced GFP 
expression compared to the standard WT promoter genetic tool (pCLA95). In Figure 4.34-A 
the majority of the events, which ideally represent the fluorescence measurements of 
single cells, are arranged on the right side of the plot. This represents an intense 
fluorescence signal due to high expression levels of sfGFP. In order to exclude false positive 
events by virtue of more than one cell measured at the same time, the screening and 
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collecting area (rectangles) was not set to the most right. This setting still included about 
78% of all cells tested. In contrast, the expression of the GFP gene with an amber and a 
frameshift codon by the aid of the standard modular genetic tool (pCLA95) reduced the 
number of positive clones to roughly 19% (Figure 4.34-B). The majority of these clones was 
less active, or inactive, indicated by the shift to the left side of the plot. The employment of 
the four library plasmids (Figure 4.34-C) had an even more dramatic effect on the 
fluorescence intensities. A minority, of less than 2% of the cells tested, was active and 
located within the rectangle. To obtain the clones that were able to produce more GFP than 
those with the standard genetic tool, the screening area was shifted to the right (green 
rectangle). In the end, performing a second round of FACS with those collected cells (Figure 
4.34-D) revealed no improvements. 
 
4.4.5 Alternative Strategies For Screening The Modular Genetic Library Tool 
Although FACS is an established method for sorting cells based on their fluorescent 
characteristic, it was not possible to find any better library composition that exceeded the 
performance of the standard modular genetic tool. Moreover, a lot of clones seemed to be 
completely inactive (Figure 4.34). Considering these facts, the search for alternative 
strategies to screen the four library plasmids led back to the already established 
chloramphenicol reporter system, which should eliminate inactive clones. To keep the 
expression system comparable to the GFP reporter used in the last chapters, we made a 
new Cm reporter including an orthogonal ribosomal binding site based on a reporter 
produced by Wang[67] (pCLA111). This plasmid contained the gene for the CAT only but not 
for a tRNA. We exchanged the codons for T6 and D111 in the CAT gene for TAG and AGGA, 
respectively (pCLA112 and pCLA113). 
Similar to the GFP reporter previously prepared competent cells harboring the ORBS CAT 
reporter plasmid (pCLA113) and the orthogonal ribosome plasmid (pCLA96) were 
transformed with the four library plasmids. Three library plasmid variants, missing the 
library for MjYT, and the standard genetic tool (pCLA95) were transformed as negative and 
positive control, respectively. In addition, we investigated differences between a CAT gene 
with TAG alone and together with the AGGA codon. After a low stringency selection on 
chloramphenicol colonies were counted to determine the reliability of the reporter (Table 
4.4). 
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Table 4.4: Cm-Assay for the sorting of the four library plasmids. 
Competent cells harboring plasmids for the orthogonal ribosome ribo-Q1 (pCLA96) and either the ORBS CAT 
reporter with T6TAG alone (pCLA112) or together with D111AGGA (pCLA113) were transformed with the 
standard modular genetic tool (pCLA95; GTF), the four library plasmids (GT4L) or the three library variants 
(GT3L; MjYT library missing). In case of the library plasmids up to 5*10
7
 cells were plated and up to 1000 cells 
were plated for the standard genetic tool on agar plates containing Sm, Tet, increasing Cm in the absence and 
presence of 1 mM BocK. Plates were incubated at 37 C for two days due to slow growth of the cells. 
MSC = “many single colonies” 

















0 ≈960 872 1088 ≈864 Lawn Lawn Lawn 
10 ≈788 0 507 0 Lawn Lawn 37 
25 420 0 30 0 MSC MSC 12 
50 2 0 1 0 ≈1000 >1000 3 
75 0 0 0 0 78 ≈500 1 
100 0 0 0 0 25 75 0 
150 0 0 0 0 9 8 0 
 
The orthogonal CAT reporters (pCLA112 and pCLA113) both worked as demonstrated in 
Table 4.4 by the quantity of colonies for the standard modular genetic tool. Cells were able 
to survive treatment with Cm only in the presence of the UAA BocK. The additional AGGA 
codon in the CAT gene reduced the growth of the bacteria 10-fold concerning the plates 
with 25 µg/mL Cm. The reporter itself seemed not to be that strong than the pREP 
reporters used earlier since the cutoff was around 50 µg/mL instead of 250 to 400 µg/mL. 
The majority of cells lacking the MjYT library died upon Cm treatment, confirming that no 
other endogenous tRNA/aaRS pairs suppressed the AGGA codon. Considering the four 
library plasmids, no dependence on the UAA could be observed. Approximately the same 
numbers of colonies survived on plates with and without BocK. 
These findings led us to the assumption that even if inactive clones were eliminated using 
the chloramphenicol reporter assay, collateral mutations during the mutagenesis of the 
promoter regions could have caused the use of natural amino acids by the synthetases, 
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especially PylS. Therefore, the four library plasmids from the agar plate with 25 µg/mL Cm 
and BocK were separated from the orthogonal CAT reporter and ribosome plasmids by 
destroying the unwanted plasmids with the restriction enzyme SphI and removing them by 
transformation of E. coli DH10B with the intact library plasmids. In order to get rid of PylS 
synthetases which used natural amino acids as substrate to charge PylT, a negative 
selection was performed based on suppression of amber nonsense mutations in the 
barnase gene as described by Wang and Schultz[146]. Without its inhibitor, barstar, it is lethal 
to cells[46]. That means, synthetases that are using natural amino acids in the absence of the 
UAA will finally suppress the amber codons in the barnase gene and mediate the cell death. 
Cells with synthetases that are still orthogonal and only using UAAs will be filtered 
(Ch. 3.2.4.3). To this end, electro competent cells containing the plasmid with the amber 
mutated barnase gene (pCLA114) were transformed with the purified four library plasmids 
as well as the standard modular genetic tool (pCLA95) as a comparison. A total number of 
5*107 transformed cells were plated on agar plates with the appropriate antibiotics in the 
absence and presence of 0.002% arabinose, to induce the expression of the barnase gene, 
and BocK, as a negative control. 
We observed nearly the same growth behavior on all plates regardless of conditions (data 
not shown). A small tendency of less growth in the presence of UAA BocK could be stated. 
Thus, we were not able to solve the problem of the amino acid independent suppression of 
amber codons by using the barnase assay. 
A second alternative strategy was then used. This method relied on the direct monitoring of 
GFP expression via western blot. 96 colonies were picked for this purpose from the 
remaining agar plates of the ORBS CAT reporter assay mentioned at the beginning of this 
chapter – including two clones for four library plasmids from plates without BocK and two 
clones from the three library plasmid plate. These 96 single clones were put again on agar 
plates with increasing Cm for re-phenotyping. Finally, a selection of 20 clones for the four 
library plasmids including the two clones from plates without BocK and the two clones for 
the three library plasmids were further analyzed. Isolated library plasmids were 
investigated by restriction digest (not shown) and sequencing. The digest revealed that only 
half of the clones had the correct banding pattern, indicating the absence of the MjYRS 
library. However, the sequencing confirmed that the majority of mutations were located in 
the promoter regions, as desired. Next, similar to the procedure described in Ch. 4.4.3 
competent cells were prepared that held plasmids for the orthogonal ribosome ribo-Q1 
(pCLA96) and the ORBS GFP reporter comprising the frameshift codon AGGA and the amber 
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codon UAG (pCLA107), respectively, were transformed with all 22 plasmids to perform the 
GFP reporter assay (Ch. 3.2.4.2). The standard modular genetic tool (pCLA95) served as a 
reference for the GFP expression level. The comparative western blot is shown in Figure 
4.35. 
 
Figure 4.35: Comparison of the modular genetic tool (GTF) to single four library plasmid clones. 
The expression efficiencies of GFP with a frameshift and an amber codon (pCLA107) were investigated via 
western blot (Ch. 3.2.2.4). The modular genetic tool (GTF; pCLA95) was compared to 22 different library clones. 
Clone number 5 and 15 originated from four library plasmid plates without 1 mM Bock. Clone number 10 and 20 
were picked from three library plasmid plates. The rest of the clones came from four library plasmid agar plates 
with BocK and different concentrations of Cm. All orthogonal mRNA translations were driven by ribo-Q1 
(pCLA96) with 1 mM of BocK to suppress the UAG codon. Samples taken at the end were normalized to OD600 of 
1.5. For the western blot whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a 
PVDF membrane (Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. 
 
Figure 4.35 clearly shows that most of the selected clones did not express any sfGFP. Those 
clones that did were, in the end, not better than the wild type modular genetic tool (GTF; 
pCLA95). For clone number 10 and 20 no GFP was expected due to the lack of MjYT. We 
noticed again the correlation of produced PylS and protein of interest observed in earlier 
chapters (Ch. 4.2.1 and 4.3), with more PylS leading to more GFP in this case. However, it 
seemed that a strong expression level of PylS caused a negative effect as depicted by clone 
number 12. This clone revealed the highest levels of expressed PylS but only a very small 
amount of GFP. 
In summary, it was not possible to isolate a clone out of the four component library 
plasmids that exceeded the standard modular genetic tool’s suppression efficiency for a 
UAG and AGGA codon at the same time. 
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4.4.6 The Combination of The Modular Genetic Tool And Defined (Standard) 
Promoters 
Since the combination of the modular genetic tool and the promoter libraries brought no 
significant improvements in the end (Ch. 4.4.4 and 4.4.5), we thought to incorporate the 
defined standard promoters introduced in Ch. 4.3 into the tool. The most promising ones 
were selected, i.e., Plib3E, Pcon and Plac, and cloned into pCLA95 exchanging the glnS promoter 
thereby.  
The effect of the promoter exchanges was tested with the GFP reporter assay in the same 
way as described in Ch. 4.4.3. GFP expression levels were determined by western blots 
(Ch. 3.2.2.4) and by in-cell fluorescence of sfGFP in a plate reader (Ch. 3.2.2.12). In a first 
attempt we found a strong degradation of PylS on western blot (not shown). To exclude 
that bands at the height of GFP were due to PylS degradation, background controls with the 
synthetase containing pCDF vectors alone were also analyzed (Figure 4.36). 
Both the western blot and the fluorescence measurements in Figure 4.36 revealed that the 
change of the glnS wild type promoter to Pcon and Plac drastically increased the GFP 
expression as well for the amber codon only version as for the combined amber and 
frameshift codon version. In detail, Pcon was at least 1.5 to 2-fold better and Plac 2.5 to 3-fold 
compared to the standard promoter in terms of fluorescence measured (Figure 4.36-B). 
Interestingly, Plib3E, which was shown to be significantly stronger than Pstd in earlier chapters 
(Ch. 4.2.1), was found to be weaker after changing the plasmid from pBK to pCDF. It could 
be excluded that signals at the height of GFP detected on the western blot in Figure 4.36-A 
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Figure 4.36: Comparison of the standard modular genetic tool to variants with defined promoters. 
The expression efficiencies of WT GFP (pCLA105), GFP with an amber codon (pCLA106) and GFP with a 
frameshift and an amber codon (pCLA107) were investigated A) via western blot (Ch. 3.2.2.4) and B) via 
fluorescence measurement in a plate reader (Ch. 3.2.2.12). Four variants of the modular genetic tool were 
compared, only differing in the promoter in front of the pylS gene: Pstd = wild type glnS promoter on pCLA95; 
Plib3E = PylS library promoter 3E on pCLA115; Pcon = consensus promoter on pCLA116; Plac = lac promoter on 
pCLA117. All orthogonal mRNA translations were driven by ribo-Q1 (pCLA96). E. coli DH10B transformed with 
pCLA95, pCLA115, pCLA116 and pCLA117 only, were used as a background control. A final concentration of 
1 mM Bock was added to the growth medium for the suppression of the amber codon. In case of the lac 
promoter, expression was induced with 1 mM IPTG Two distinct samples were taken of each condition tested, 
with one being normalized to OD600 of 1.5 for usage with western blots and one being normalized to OD600 of 
0.5 for the detection of GFP in a plate reader (Ch. 3.2.2.12). For the western blot whole cell extracts were 
separated with SDS PAGE (10 µL loaded for each sample, except for GFP WT with 5 µL; Ch. 3.2.2.3) and blotted 
onto a PVDF membrane (Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. Fluorescence 
measurements were always performed in duplicates. 
 
As a proof of principle, to demonstrate that the effects on the suppression efficiencies 
observed for GFP due to the changes in the PylS promoter were also valid for other 
proteins, we did a final experiment comparing Pstd, Pcon, Plac and the previously used four 
plasmid system (with standard glnS and lpp promoters). The GFP reporter plasmid was 
exchanged with a variant of its original vector pO-gst-malE[67] which harbored an AGGA 
codon at position Y17 and a TAG codon at position N234 in the malE gene (pCLA118). We 
kept the conditions for the expression the same, except for the scale. A 50 mL small scale 
expression was performed and the GST-MBP fusion proteins were purified from cell lysates 
(Ch. 3.2.2.6) to visualize differences in protein levels by SDS-PAGE instead of a western blot 
(Figure 4.37). 
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Figure 4.37: Small scale expression and purification of GST-MBP comparing different genetic tool variants and 
the 4 plasmid system. 
The expression efficiency of gst-malE harboring an AGGA codon at position Y17 and a TAG codon at position 
N234 in the malE gene (pCLA118) was compared in four different systems: Pstd = wild type glnS promoter on 
pCLA95; Pcon = consensus promoter on pCLA116; Plac = lac promoter on pCLA117; 4Pl = 4 Plasmid system 
(pCLA97 and pCLA98). All orthogonal mRNA translations were driven by ribo-Q1 (pCLA96). A final concentration 
of 1 mM Bock was added to the growth medium for the suppression of the amber codon. Expression was 
performed in a 50 mL scale and cell densities normalized by OD600 after pelleting. GST-MBP fusion proteins were 
purified from cell lysates using glutathione sepharose beads (Ch. 3.2.2.6).Proteins were separated with SDS 
PAGE (15 µL loaded for each sample; Ch. 3.2.2.3). Ft = Flowthrough; E = Elution; P = Pellet. 
 
The small scale expression and purification experiment shown in Figure 4.37 validated our 
previous experiments. The four plasmid system offered the lowest expression and thereby 
suppression efficiency of all the conditions tested. The use of the standard modular genetic 
tool increased the full-length GST-MBP level substantially. However, when the glnS 
promoter of the pylS gene is exchanged for Pcon or Plac the yield of full-length GST-MBP was 
again boosted enormously. 
Beside the fact that cells with the four plasmid system had the lowest expression 
efficiencies, another observation already showed that their growth rate was at least three 
to five times lower compared to the three plasmid system with the modular genetic tool 
variants (Ch. 4.4.3). To visualize these differences we made a growth curve with the three 
modular genetic tool variants Pstd, Pcon, Plac and the four plasmid system. For this reason, 
competent cells that harbored the plasmids for the orthogonal ribosome ribo-Q1 (pCLA96) 
and the ORBS GFP reporter, comprising the frameshift codon AGGA and the amber codon 
UAG (pCLA107), respectively, were transformed with the appropriate plasmids in order to 
monitor the growth rate and the production of GFP, simultaneously, by using a plate 
reader. The results of the growth assay and the fluorescence measurements are plotted in 
one graph (Figure 4.38). 
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Figure 4.38: Growth curve and GFP fluorescence measurement comparing different genetic tool variants and 
the 4 plasmid system. 
The growth rates and the expression efficiencies of sfGFP harboring an AGGA codon at position D134 and a UAG 
codon at position N150 (pCLA107) was compared in four different systems: Pstd = wild type glnS promoter on 
pCLA95; Pcon = consensus promoter on pCLA116; Plac = lac promoter on pCLA117; 4Pl = 4 Plasmid system 
(pCLA97 and pCLA98). All orthogonal mRNA translations were driven by ribo-Q1 (pCLA96). Expression was 
performed in a 50 mL scale. Full-length GFP expression was initiated by the addition of the UAA BocK to a final 
concentration of 1 mM after 3 hours for Pstd, Pcon and Plac and after 3.5 hours for 4Pl due to the slow growth. A 
final concentration of 1 mM IPTG was supplemented for Plac as well. Samples for fluorescence measurements of 
Pstd, Pcon and Plac were taken every hour upon UAA addition corresponding to 4, 5, 6, 7, 8 and 9 hours and 
normalized to OD600 of 0.5 for the detection of GFP in a plate reader (Ch. 3.2.2.12). Samples for 4Pl were taken 
after 4, 6 and 20 hours upon UAA addition corresponding to 7.5, 9.5 and 23.5 hours. OD600 was measured every 
30 min for Pstd, Pcon and Plac over a period of 9.5 hours. OD600 for 4Pl was measured every 30 min for the first 
2.5 hours, every 60 min for the next 7 hours and finally one sample was taken after overnight incubation at 
23.5 hours. All samples were taken in triplicates from three individual cultures. 
 
The growth assay depicted in Figure 4.38 confirmed the observations made before. The 
viability of cells using the four plasmid system is several magnitudes lower than the cells 
with one of the three plasmid systems Pstd, Pcon or Plac. The fluorescence intensity was 
indeed higher than for Pstd but this was only achieved after overnight incubation. When 
comparing the three plasmid variants, Pstd had the fastest growth rates but also the lowest 
fluorescence intensities with a maximum already reached after 2 hours. Cells with the Pcon 
modular genetic tool were almost as viable as Pstd, with a medium to high expression of 
GFP. Plac mediated a medium growth rate but produced, by far, the highest fluorescence 
intensities.To summarize, the use of the modular genetic tool improved the suppression 
efficiencies of amber and frameshift codons in protein expressions performed with the aid 
of the orthogonal ribosome ribo-Q1. The introduction of Pcon and Plac further increased this 
effect, with having one constitutively active and one inducible promoter for different 
purposes. Furthermore, the viability of the cells could be drastically enhanced by the 
reduction of plasmids from four to three, leading to better results in shorter expression 
times.  
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5 Applications And Side Projects 
5.1 Evolution of A Quadruplet Decoding MjAzFRS 
A large variety of UAAs with different functionalities can be incorporated into proteins 
facilitated by the expansion of the genetic code. All previous experiments described in 
Ch. 4.1 to 4.4 were performed using the efficient substrate analogue BocK[169] and/or 
tyrosine. Both amino acids do not provide any special functions because the Boc-protected 
lysine is not useful for further modifications and the tyrosine can also be incorporated using 
endogenous codons and tRNA/aaRS pairs. In contrast, aryl-azide, a photocrosslinking agent 
that was used first in a biological context by Fleet and colleagues who photochemically 
labeled antibodies with hapten[170], represents one notably interesting group for 
incorporation into proteins. Furthermore, this group has been used to irreversibly 
inactivate enzymes[171] and to probe protein-protein interactions[172,173].  
Chin and others enabled the site-specific incorporation of the azide containing UAA 
p-azido-L-phenylalanine (AzF) in good yield with high fidelity by evolving the M. jannaschii 
tyrosyl-tRNA synthetase (MjYRS) to an orthogonal synthetase that incorporates AzF 
(MjAzFRS)[80]. Once incorporated into proteins the azide can be easily modified via 
bioorthogonal “click chemistry” even in cells and living organisms[114]. Whereas the 
paradigm of all click reactions, the Cu(I)-catalyzed cycloaddition between an azide and a 
terminal alkyne[115], is problematic due to its requirement for the cytotoxic copper[42], the 
Cu(I)-free alternative with cyclooctyne derivatives employs ring strain for alkyne 
activation[116,117]. Chin and co-workers encoded AzF in combination with 
N6-[(2-propynyloxy)carbonyl]-L-lysine (CAK) in GST-calmodulin forming a redox-insensitive, 
crosslink by bioorthogonal cycloaddition that can be used to specifically constrain protein 
structure on the nanometer scale[78]. The Ebright laboratory coupled fluorescent probes by 
Staudinger ligation to genetically encoded AzF to investigate the opening and closing of the 
bacterial RNA polymerase clamp[118]. 
The original tRNA/aaRS pair was designed to incorporate AzF in response to the amber 
codon UAG. In order to combine the M. jannaschii derived pair with similar amber decoding 
M. barkeri tRNA/aaRS pairs on the modular genetic tool we needed to change the codon 
specificity. In collaboration with the bachelor students Miguel Sánchez[174] and Julia 
Motz[175] the tRNA anticodon recognizing region of MjAzFRS was evolved to accept the 
expanded anticodon of the MjYT_UCCU tRNA as described by Neumann et al[78,79]. 
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To this end, the open reading frame (ORF) of pBK PylS (pCLA1) was replaced by MjAzFRS 
(pCLA119) and subsequently used to create a library of 3*106 mutant clones by randomizing 
the codons for residues Y230, C231, P232, F261, H283 and D286 (on pCLA120) in the tRNA 
anticodon recognizing region.  
We analyzed 96 clones after an AzF dependent low stringency selection on chloramphenicol 
via broad range Cm reporter assay (0 to 500 µg/mL). The 20 most promising clones 
(pCLA121 to pCLA140) were transferred to new Cm containing agar plates for re-
phenotyping (Figure 5.1) and sequenced to monitor codon changes (Table 5.1). 
 
Figure 5.1: Cm-Assay with the 20 best clones from the MjAzFRS library. 
Cells were plated on agar plates containing Kan, Tet, increasing Cm and 1 mM AzF (B) or no AzF (A). A selection 
of two plates is shown only. Clones were plated in duplicates. Numbers ascend from left to right. 
 
The clones with number 2, 3, 5, 6, 11, 17 and 18 (marked orange in Table 5.1) showed a 
growth clearly dependent on the presence of the amino acid AzF allowing them to survive a 
chloramphenicol concentration up to 250 µg/mL. Without AzF they were not able to resist 
Cm at concentrations higher than 150 µg/mL. The other clones grew on plates with a high 
Cm concentration even in the absence of AzF. 
The amino acid sequence of the selected 20 clones revealed the common mutations Y230K, 
C231K and P232K, but divergent mutations at positions F261, H283 and D286. This 
observation was also made by Neumann and colleagues[78] who suggested that amino acids 
230, 231 and 232 grant affinity and specificity for the anticodon, and that 261, 283 and 286 
may link the identity of the anticodon to the amino acid identity. 
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Table 5.1: Amino acid sequence of the 20 best clones from the MjAzFRS library. 
The mutated six amino acids are compared to the wild type amino acid sequence. Clones that showed an 




  WT Y230 C231 P232 F261 H283 D286 
  






 1 K K K T G C 
 2 P P A M F A 
 3 Y C P G G A 
 4 K K M T G L 
 5 R K E F S W 
 6 K K K P R Y 
 7 K K K F L Q 
 8 K K K F S F 
 9 T P P Q G G 
 10 K K K S P S 
 11 R A H F V M 
 12 P K L S G A 
 13 K K K G A T 
 14 R K R F P H 
 15 K K K F A T 
 16 K K K W G Y 
 17 K K K W G Y 
 18 K K K F        frameshift @ K280 
 19 K K K S P Y 
 20 K K K S P Y 
 
To confirm the ability of the synthetases to suppress AGGA codons by charging the 
corresponding tRNA with AzF, we performed test expressions of GFP (pCLA108) and histone 
H3 (pCLA143) in combination with the orthogonal ribosome ribo-Q1 (pCLA96), depicted in 
Figure 5.2. In order to include the genes for the evolved MjAzFRS synthetases on one 
plasmid with the appropriate tRNA MjYT_UCCU, these were cloned into pDULE (pCLA144 to 
pCLA150). 
 
Figure 5.2: Incorporation of AzF into GFP and H3 using MjAzFRS library clone 17 (pCLA149). 
Expressions of GFP 134AGGA (pCLA108) and H3 T6AGGA (pCLA143) were performed in the absence and 
presence of 1 mM AzF. All orthogonal mRNA translations were driven by ribo-Q1 (pCLA96). For the western blot 
whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a PVDF membrane 
(Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. 
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The MjAzFRS library clone 17 exhibited the best amino acid dependent expression and 
thereby AGGA codon suppressing efficiency. The gene for this mutant synthetase was 
finally cloned into the modular genetic tool (pCLA155). 
 
5.2 Labeling of Proteins For FRET 
Förster/Fluorescence resonance energy transfer (FRET) is a powerful tool to investigate 
conformational changes of biomolecules like proteins and DNA, even on a single-molecule 
(sm) level[122,123]. Uemura et al. used FRET to study the transit of tRNAs on single translating 
ribosomes at codon resolution in real-time[176]. smFRET experiments aided the 
understanding of the mechanism of Rrp44 (Dis3), a key catalytic subunit of the yeast 
exosome[177], and to obtain an experimentally derived model of the synaptotagmin 1-SNARE 
fusion complex[178].  
However, the precise and site-specific labeling of the proteins with suitable fluorophores is 
essential for FRET experiments but remains a challenging task and often the limiting factor. 
A combination of chemical ligations of fluorophores and proteins using maleimide 
conjugations and bioorthogonal labeling has been successfully used to study T4 lysozyme 
folding[124]. Nevertheless, this technique is restricted in its applicability to single-cysteine 
proteins. The incorporation of two distinct and suitable UAAs into the same protein[72,78] 
and the subsequent bioorthogonal labeling of these provides an elegant method for the 
site-specifically installation of FRET pairs. 
Genetically encoded UAAs with azide function are among those suitable, where they can be 
utilized as crosslinkers or be altered with bioorthogonal “click chemistry”. Disadvantages of 
incorporating azides are that they suffer from intracellular reduction and, in the case of 
fluorescent labeling, the endangered design of a fluorogenic labeling scheme[119]. 
Alternative approaches are based on inverse electron-demand Diels-Alder cycloaddition 
reactions between genetically encoded strained alkenes and alkynes[119], like 
norbornenes[120], bicyclononynes[121] and trans-cyclooctenes[121], and tetrazines and/or 
azides. Besides not having the disadvantages mentioned above, these kinds of 
bioorthogonal reactions have reported rate constants that are orders of magnitude faster 
than other established methods[179–182]. Furthermore, fluorophores conjugated to strongly 
quenching tetrazines can become intrinsically fluorogenic[119,183], a trait difficult to attain if 
the tetrazines are genetically incorporated into proteins[119,184], instead. 
5: Applications And Side Projects  108 
The lysine derivatives Nε-5-norbornene-2-yloxycarbonyl-L-lysine (NorK) and 
bicyclo[6.1.0]non-4-yn-9-ylmethanol-L-lysine (BCNK) have been successfully incorporated 
into proteins by the Chin laboratory, followed by labeling with fluorophores conjugated to 
tetrazines[120,121]. Whereas the NorK could be incorporated using the wild type PylS/PylT 
pair, BCNK required a mutant PylS (BCNRS) with the three amino acid substitutions Y271M, 
L274G, and C313A in the enzyme active site.  
We performed an expression of an amber codon containing myoglobin (S4TAG; pCLA156) 
to test the incorporation of theses amino acids (Figure 5.3). The necessary mutations 
needed for PylS to accept BCNK as a substrate were previously introduced by Heinz 
Neumann (pCLA158). 
 
Figure 5.3: Incorporation of BCNK and NorK into myoglobin. 
Expressions of wild type (Myo WT; pCLA157) and amber codon containing myoglobin (Myo S4TAG; pCLA156) 
were induced with arabinose (0.2% final concentration) and tested in the absence of UAAs and presence of 
1 mM BocK, BCNK or NorK, respectively. Two different clones of the BCNK accepting PylS (pCLA158) were 
tested. For the western blot whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a 
PVDF membrane (Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. 
 
We observed specific incorporation of BCNK in response to the amber codon for both 
BCNRS synthetases. Although published, the wild type PylS was only tolerating the 
substrate analogue BocK but not the desired lysine derivative NorK. 
To find another potential synthetase that is able to mediate the suppression of the amber 
codon with NorK without creating a new library, we tested a selection of existing PylS 
derivatives. These included the wild type PylS (pCLA1), the BCNK employing BCNRS 2-1 
(pCLA158), an evolved synthetase for photocaged lysine (pcKRS; pCLA159), an azido-
photocaged lysine using variant (AzpcKRS; pCLA160) and two synthetases optimized for the 
incorporation of acetyllysine (AcK), namely AcKRS1 (pCLA161) and AcKRS3 (pCLA162). We 
chose an amber codon containing variant of histone H3 (K56TAG; pCLA163) as the target 
protein for the incorporation of NorK (Figure 5.4). 
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Figure 5.4: Incorporation of NorK into histone H3. 
A) Expression of amber codon containing histone H3 (K56TAG; pCLA163) in E. coli BL21 was induced with IPTG 
(1 mM final concentration) and tested in the absence of UAAs and presence of 1 mM BocK, NorK or AcK, 
respectively. Six different PylS derivatives were tested, including wild type (pCLA1), BCNRS 2-1 (pCLA158), pcKRS 
(pCLA159), AzpcKRS (pCLA160), AcKRS1 (pCLA161) and AcKRS3 (pCLA162). For the western blot whole cell 
extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a PVDF membrane (Ch. 3.2.2.4). Anti-His-
antibody was used as primary antibody. B) Same samples as in A) but five times less volume loaded onto gel. 
 
The wild type PylS did not recognize NorK as a substrate, as already shown before (Figure 
5.3). This means that no full-length histone could be detected (Figure 5.4-A). The 
synthetases for the photocaged lysine (pcKRS) as well as the acetyllysine (AcKRS3) were 
also not able to bind NorK. AcKRS1 showed some NorK dependent expression of H3 but 
clearly less than H3 with the actual corresponding amino acid AcK. BCNRS 2-1 seemed to 
incorporate NorK as efficient as the AcKRSs their substrate AcK. The azido-photocaged 
lysine aaRS revealed good yields of NorK dependent full-length histone H3. Expression 
levels were hard to compare with BocK dependent H3 expression using PylS due to 
overexposure on the western blot. A second blot with less sample loaded (Figure 5.4-B) 
verified that AzpcKRS is able to encode NorK with an efficiency approximately threefold 
lower than BocK encoded by wild type PylS. 
As a preparation for future FRET experiments we incorporated the amino acids BocK, BCNK 
and NorK into the single-cysteine protein histone H3 (V35TAG, F78C, C110A; pCLA164), in 
order to test the combination of tetrazine conjugated fluorophores with maleimide 
conjugations for in-gel pseudo FRET measurements. Therefore, the H3 histones were 
purified from E. coli inclusion bodies (Ch. 3.2.2.7) yielding 1.4 mg protein with BocK, 1.1 mg 
with NorK and 0.4 mg with BCNK from 0.5 L culture each. Afterwards, the histones were 
consecutively labeled with fluorophores coupled to tetrazines and maleimides 
(Ch. 3.2.2.11). Labeling was verified and visualized using a Typhoon imager (Figure 5.5). 
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Figure 5.5: Labeling of histone H3 for (pseudo) FRET. 
NorK and BocK were incorporated into histone H3 (V35TAG, F78C, C110A; pCLA164) with BocK serving as a 
negative control. Histone H3-NorK was labeled with the fluorophore Abberior Star635 (Abb. 635) conjugated 
with a tetrazine. BocK showed only weak interactions respective to protein level. For (pseudo) FRET an Atto565 
dye conjugated with a maleimide was bound to the one cysteine. The SDS-PAGE gel was scanned using a 
Typhoon imager (Abb.635 – excitation (ex.): 633 nm (red laser) and emission (em.): Filter 670 nm BP30 / 
Atto565 - excitation: 532 nm (green laser) and emission: Filter 580 nm BP30). 
 
With respect to the amount of protein loaded onto the gel only little background was 
observed. The tetrazine conjugated fluorophore Abberior Star635 could be specifically 
“clicked” to the strained alkene containing protein. The labeling of the protein, especially 
the double-labeling, caused a small shift of 1-2 kDa in the gel. This fits with the sizes of the 
dyes that have a molecular mass of approximately 1 kDa each. The most shifted band 
belonged to H3 with NorK incorporated and double labeled with both dyes and showed a 
clear signal for pseudo FRET. That means the emission of the excited Atto565 fluorophore 
provoked the excitation of Abberior Star635 whose emission was finally detected. We 
obtained comparable results for labeling experiments with histones comprising BCNK 
instead of NorK (data not shown). 
Finally, three additional tetrazine conjugated fluorescent dyes were tested for labeling 
using the same protein purifications as above (Figure 5.6). 
The Typhoon scan showed only weak background signals for all four dyes tested as 
demonstrated by histones with non-reactive BocK incorporated. The labeling efficiencies 
for histones with NorK and BCNK were similar with Abberior Star635 and KK114 giving the 
brightest signals. It seemed that the four dyes did not have the same concentration, 
although properly dissolved with regard to their indicated weight, leading to distinct 
labeling efficiencies and thereby signal intensities. 
5: Applications And Side Projects  111 
 
Figure 5.6: Labeling of histone H3 with four different tetrazine conjugated fluorophores. 
NorK, BCNK and BocK were incorporated into histone H3 (V35TAG, F78C, C110A; pCLA164) with BocK serving as 
a negative control. Histones were labeled with the tetrazine conjugated fluorophores Abberior (Abb.) Star635, 
Abberior Star635P, KK9046 and KK114
[125]
. BocK showed only weak interactions respective to protein level. The 
SDS-PAGE gel was scanned using a Typhoon imager (Excitation: 633 nm (red laser) and emission: Filter 670 nm 
BP30). 
 
In conclusion, the strained alkyne BCNK and alkene NorK could be genetically encoded into 
proteins that then could be site-specifically labeled with different fluorophores. We cloned 
the genes for both corresponding synthetases into the modular genetic tool substituting 
the wild type PylS gene (pCLA165 and pCLA166). The UAA NorK can be combined with AzF, 
encoded by AGGA, whereas BCNK would cross-react with the azide. To potentially optimize 
the incorporation efficiency of both UAAs the wild type glnS promoter in front of both 
synthetases was replaced by the promising alternatives Pcon, Plac (see Ch. 4.3 and 4.4.6; 
pCLA171 to pCLA174) and will ultimately be tested in future experiments. 
 
5.3 Fluorescently Labeled Nanobodies 
In 1993 Hamers and co-workers discovered antibodies in the camel serum that have 
naturally evolved to be devoid of light chains[185]. Later, these very small single-domain 
antibodies, about 15 kDa[186], were shown to be adaptable to other desired antigens by 
immunizing dromedaries followed by a screening process that led to extremely stable, 
highly soluble minimum sized antigen binders. These binders, termed nanobodies (Nb) by 
the Ablynx company, could be recombinantly expressed in E. coli and were proven to react 
specifically and with high affinity to the antigens[187]. 
Due to their advantageous properties nanobodies have been used in a broad range of 
applications as research and diagnostic tools as well as therapeutics[188]. Saerens et al. 
found Nbs to sense conformational changes on different prostate-specific antigen isoforms 
which could be helpful to discriminate the stages of prostate cancer[189]. Nanobodies served 
as tools for molecular tumor imaging[190,191] and were further developed for in vivo imaging 
of specific immune cell types[186]. The Leonhardt laboratory engineered an anti-GFP 
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nanobody that allows the purification of GFP-fusion proteins and their interacting partners 
for biochemical studies on, e.g., DNA binding, enzymatic activity and complex formation[192]. 
The Rizzoli group (ENI, Göttingen) is interested in synaptic vesicle function, with an 
emphasis on synaptic vesicle recycling, and therefore combines fluorescently labeled 
nanobodies and high resolution imaging provided by stimulated emission depletion 
(STED[193,194]) microscopy. Chemical ligations of fluorophores and Nbs prevent a quantitative 
analysis due to multiple but erratic binding. Here, we show a collaborative approach for the 
site-specific incorporation of fluorophores, suitable for STED[125], by applying the principles 
of genetic code expansion as described in Ch. 5.2. 
First, a set of α-synuclein targeting Nbs[195] (NbSyn2), including wild type and the amber 
codon containing mutants S44TAG, K70TAG, R72TAG, K93TAG, K115TAG and S153TAG 
(provided by Felipe Opazo from AG Rizzoli),were expressed in the absence and presence of 
BocK and NorK to test the overall incorporation of UAAs into nanobodies (Figure 5.7). 
 
Figure 5.7: Incorporation of BocK and NorK into NbSyn2. 
A) Expression of wild type (WT) and amber codon containing nanobodies NbSyn2 (pCLA175 to pCLA181) in 
E. coli BL21 was induced with IPTG (1 mM final concentration) after two hours of incubation at 37 °C. BocK 
(1 mM final concentration) was added subsequently and temperature was shifted to 28 °C for overnight 
expression (∼16 h). PylS and PylT were used as aaRS and tRNA pair (pCLA97). For the western blot whole cell 
extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a PVDF membrane (Ch. 3.2.2.4). Anti-His-
antibody was used as primary antibody. B) Same experiment as in A) but NorK was used as UAA instead of BocK 
together with the appropriate aaRS AzpcKRS (pCLA166). WT and R72 samples on the right side originate from 
A). 
 
We found UAA dependent expression of NbSyn2 with BocK being incorporated with higher 
efficiencies than NorK yielding more full-length protein, as seen before (Figure 5.4-B). The 
clones with amber codons at positions K70 and R72 revealed the best expression levels. 
Both mutations are located in the same loop opposite the target binding pocket, according 
to the crystal structure of the nanobody (pdb file 2X6M[195], not shown). 
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We finally chose the NbSyn2 K70TAG clone for large scale expression and subsequent 
labeling with the Abberior Star635 fluorophore. Since the nanobody was cloned behind a 
secretion signal its production occurred in the periplasm, where the oxidizing environment 
is optimal for the required disulfide formation[188]. Secreted proteins were purified from the 
medium (1 L; Ch. 3.2.2.8) yielding 0.11 mg full-length protein and then labeled with the 
tetrazine conjugated fluorophore (Ch. 3.2.2.11). Labeling was verified and visualized using a 
Typhoon imager (Figure 5.8). 
 
Figure 5.8: Fluorescently labeled NbSyn2. 
NorK was incorporated into nanobody NbSyn2 (K70TAG; pCLA177). NbSyn2-NorK was labeled with the 
fluorophore Abberior Star635 (Abb. 635) conjugated with a tetrazine. The SDS-PAGE gel was scanned using a 
Typhoon imager (Excitation: 633 nm (red laser) and emission: Filter 670 nm BP30). 
 
NbSyn2 could be successfully labeled with the tetrazine conjugated fluorophore Abberior 
Star635 and was given to Felipe Opazo for the removal of unbound dye and further 
experiments. 
Due to the low yield of purified NbSyn2 from medium, we tested a second nanobody 
targeting GFP [192] (NbGFP). NbGFP is expressed in good yields and exhibits excellent binding 
to its target. Additionally, the cell line was changed from E. coli BL21 to E. coli SHuffle. 
SHuffle cells were engineered to assist disulfide bond formation in the cytoplasm, e.g., in 
nanobodies, rendering the transport of proteins into the periplasm unnecessary (see 
NbSyn2). This is achieved by the simultaneous deletion of the reductases trxB and gor and 
the constitutive expression of a chromosomal copy of the disulfide bond isomerase DsbC 
which promotes the correction of mis-oxidized proteins into their correct form[196–198]. This 
cell line also possesses a disadvantage in that a chromosomal copy of the resistance gene 
for spectinomycin, which is also present on the pCDF plasmids used for the modular genetic 
tools. 
To this end, we cloned the resistance genes for chloramphenicol and ampicillin from the 
Duet vectors pACYC and pET, respectively, into the modular genetic tools pCLA116 and 
pCLA171, replacing the spectinomycin resistance genes (pCLA184 to pCLA187). 
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In order to test the genetic code expansion system in the SHuffle cell line, we prepared 
competent cells harboring the optimized modular genetic tool with an ampicillin resistance 
gene and encoding BocK in response to an amber codon (pCLA185). These cells were 
transformed with plasmids for NbGFP containing amber codons at positions Q13 and R76 
(pCLA189 and pCLA192; provided by Felipe Opazo from AG Rizzoli). Nanobodies were 
expressed in the absence and presence of BocK (Figure 5.9). 
 
Figure 5.9: Incorporation of BocK into NbGFP. 
Expression of amber codon containing nanobodies NbGFP (pCLA189 and pCLA192) in E. coli SHuffle was induced 
with IPTG (1 mM final concentration) after 2.5 hours of incubation at 30 °C. BocK (1 mM final concentration) 
was added subsequently and temperature was shifted to 28 °C for overnight expression (∼16 h). PylS and PylT 
were used as aaRS and tRNA pair (pCLA185). Control cells (ctrl) contained only pCLA185 but no NbGFP plasmid. 
For the western blot whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a PVDF 
membrane (Ch. 3.2.2.4). Anti-Myc-antibody was used as primary antibody. 
 
The adapted modular genetic tool containing the ampicillin resistance gene allowed the 
incorporation of the UAA BocK into NbGFP. We found UAA dependent expression with 
clone R76TAG showing more full-length protein. Since the Myc-tag is cloned to the 
C-terminus of the protein only full-length nanobodies should be detected by the antibody. 
Therefore, the intense signals of smaller sizes are probably due to strong degradation. 
In summary, we were able to encode UAAs in both nanobody proteins, NbSyn2 and NbGFP. 
NbSyn2 was successfully labeled with a fluorophore suitable for STED, opening an avenue 
for highly specific binding to its target followed by quantifiable high resolution microscopy. 
First experiments with NbGFP expression in E. coli SHuffle cells looked promising 
concerning high yield expression. The use of this cell line will simplify the purification of the 
nanobodies enormously. 
 
5.4 Orthogonal Ribosome Assisted In-Cell NMR Spectroscopy 
Living organisms are highly complex biological systems with intricate networks of biological 
processes, simultaneously exercised by an enormous number of macromolecules like 
proteins. The complexity is not only determined by the quantity of proteins expressed, but 
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also by the combinatorial interactions between them. Deciphering these interactions and 
putting them into a meaningful context is required to fully understand how life works. 
The in vivo investigation of proteins in their natural cellular environment within cells 
assures the perpetuation of structural conformations, which are of biological importance 
but not reproducible in vitro. Techniques like X-ray crystallography and high-resolution 
electron microscopy are usually confined to artificial, dilute, and isolated in vitro 
experimental setups because of their necessity for pure samples and crystalline or vitrified 
specimen[199]. Among several attempts to find new in vivo techniques for structural biology 
and cellular imaging[200], in-cell nuclear magnetic resonance (NMR) technologies have been 
developed[201] allowing the direct monitoring of conformational changes at the atomic level 
of proteins with “NMR-active” atomic nuclei. Since protein purification is unnecessary, 
in-cell NMR spectroscopy can be applied to studies of proteins that are difficult to purify. 
Proteolytically labile proteins would be advantageous for this method because they are 
better protected from the proteolytic machinery whose tight regulation in cells is lost in 
lysates [202]. Furthermore, in contrast to lysates, less protein amount is needed in intact cells 
due to higher local concentrations of interacting partners, thus increasing the likelihood of 
detecting weaker interactions[203]. Both qualitative structural[204] and quantitative 
dynamic[205,206] data of proteins in living prokaryotic cells has been collected using high 
resolution NMR measurements. 
The characterization of only one protein at a time was a limitation of the first developed 
in-cell NMR techniques[201] because the simultaneous overexpression of more than one 
protein inside the cell led to extremely intricate NMR spectra. In order to study ubiquitin 
interactions, the Shekhtman laboratory used sequential protein expression in a time-
controlled manner to overcome this issue[203]. Here, we show an approach in collaboration 
with the Zweckstetter group (MPI BPC, Göttingen) that also regulates protein expression in 
a time-controlled fashion with the aid of an orthogonal ribosome evolved in the Chin 
laboratory[78]. The idea was to block protein synthesis by the endogenous ribosome using 
spectinomycin but to maintain translation of the desired protein by the mutant ribosome, 
which is spectinomycin resistant by virtue of a C1192U mutation in 16S rRNA[66]. 
First trials of in-cell NMR experiments were performed in E. coli BL21 transformed with 
plasmids for the orthogonal ribosome ribo-Q1 (pCLA96) and an orthogonal mRNA coding 
for sfGFP (pCLA105). Labeling experiments were grown in M9 minimal medium containing 
15N labeled ammonium chloride for isotopic labeling of GFP (Ch. 3.2.2.10). 15N labeling 
schemes have been shown to exhibit negligible background levels[207] compared to other 
5: Applications And Side Projects  116 
labeling schemes using, e.g., 13C-isotopes. Purified 15N labeled GFP (1.534 mg protein out of 
250mL culture; Ch 3.2.2.9) and cells grown without the GFP mRNA were used as references. 
Despite a clear difference in GFP expression levels detected by western blot (Figure 5.10), 
in-cell NMR measurements, carried out by Martin Schwalbe from AG Zweckstetter, did not 
result in distinguishable NMR spectra for the GFP control or the control cells. 
 
Figure 5.10: sfGFP expression for in-cell NMR measurements. 
Expression of sfGFP in E. coli BL21 using an orthogonal mRNA (ORBS GFP; pCLA105) and the orthogonal 
ribosome ribo-Q1 (pCLA96). Samples were taken and normalized to OD600 = 1.5 from cells used for the 
purification of 
15
N labeled GFP (Purif. GFP; Ch 3.2.2.9) and for in-cell NMR measurements, each with samples 
from overnight cultures grown in LB medium and main cultures grown in M9 minimal medium. Cells for in-cell 
NMR were grown in M9 medium with unlabeled NH4Cl (unlab.) to OD600 = 0.6 to 0.8 and subsequently 
transferred to M9 medium supplemented with 
15
N labeled (lab.) 
15
NH4Cl and 150 µg/mL spectinomycin 
(Ch. 3.2.2.10) to block protein synthesis by the endogenous ribosome. For the western blot whole cell extracts 
were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a PVDF membrane (Ch. 3.2.2.4). Anti-GFP-
antibody was used as primary antibody. 
 
Although expression of GFP in M9 minimal medium yielded considerably less protein 
compared to expressions in LB medium, it was still sufficient to be clearly detected by 
western blot. However, using this method it was not possible to discriminate between the 
labeled and unlabeled form of GFP, with the latter being produced constitutively. To this 
end, we generated an arabinose inducible variant of the plasmid containing the orthogonal 
mRNA coding for sfGFP (pCLA193) allowing the simultaneous blocking of the endogenous 
ribosome and the induction of orthogonal ribosome mediated 15N labeled GFP expression 
(Figure 5.11). 
 
Figure 5.11: Arabinose inducible promoter for the orthogonal translational machinery. 
Arabinose induced expression of sfGFP in E. coli BL21 using an orthogonal mRNA (ind. ORBS GFP; pCLA193) in 
combination with the orthogonal ribosome ribo-Q1 (pCLA96) and a non-orthogonal mRNA (ind. GFP; pCLA101). 
Black triangle indicates decreasing concentrations of arabinose (0.2%, 0.04% and 0.008%). For the western blot 
whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted onto a PVDF membrane 
(Ch. 3.2.2.4). Anti-GFP-antibody was used as primary antibody. 
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We observed GFP expression that was dependent on the arabinose concentration only in 
the presence of the orthogonal ribosome. The expression efficiency was approximately 
eightfold lower in comparison to the original non-orthogonal pBAD vector, as depicted in 
Figure 5.11 and as confirmed by in-cell fluorescence measurement (not shown). In contrast, 
compared to the non-inducible orthogonal GFP encoding plasmid (pCLA105) we found a 
2.5-fold decrement only (data not shown). 
Both the non-orthogonal and the orthogonal inducible variants were used to investigate 
the effect of spectinomycin on cells and ribosomes, respectively, since the applied 
concentration of 150 µg/mL was supposed to be too harsh in order to produce acceptable 
amounts of 15N labeled GFP. Therefore, in-cell fluorescence of sfGFP was monitored over 
time in the absence and presence of 150 µg/mL spectinomycin (Figure 8.5) and samples 
were periodically taken for western blot analysis (Figure 5.12). 
 
Figure 5.12: Effect of spectinomycin on sfGFP expression. 
Arabinose induced expression of sfGFP in E. coli BL21 using an orthogonal mRNA (ind. ORBS GFP; pCLA193; 
0.2% arabinose) in combination with the orthogonal ribosome ribo-Q1 (pCLA96) and a non-orthogonal mRNA 
(ind. GFP; pCLA101; 0.02% arabinose). Expressions were performed in the absence and presence of 150 µg/mL 
spectinomycin. For the western blot whole cell extracts were separated with SDS PAGE (Ch. 3.2.2.3) and blotted 
onto a PVDF membrane (Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. 
 
The in-cell fluorescence measurements (Figure 8.5) as well as the western blot (Figure 5.12) 
verified the expected effect of spectinomycin on non-orthogonal translational components 
with GFP levels being tremendously reduced. The combination of an inducible promoter 
and an orthogonal ribosomal binding site has been shown to produce less GFP than the 
non-orthogonal or non-inducible systems (Figure 5.11). However, it seems that the use of 
150 µg/mL spectinomycin also had a strong negative influence on the orthogonal ribosome 
and thereby on the GFP expression efficiency. 
In order to find a spectinomycin concentration that offers sufficient blocking of the 
endogenous ribosome while the orthogonal one is still mostly active, we repeated the 
in-cell fluorescence experiment with spectinomycin being titrated (Figure 8.6). A 
concentration of 10 µg/mL spectinomycin already decreased the final GFP fluorescence of 
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cells with the non-orthogonal system by approximately 30%. At 40 µg/mL spectinomycin 
only 35% of the fluorescence intensity from cells with unblocked ribosomes remained. 
Further increase of spectinomycin yielded only a moderate decrease in GFP levels to a 
maximum of approximately 17%. Cells transformed with plasmids for the orthogonal 
components revealed that at 40 µg/mL spectinomycin there was still a fluorescence 
intensity of circa 56% compared to cells grown in medium without spectinomycin. Further 
supplements of spectinomycin led to a maximum loss of fluorescence of 60%. Thus, a 
spectinomycin concentration of 40 µg/mL seemed to be sufficient for blocking endogenous 
ribosomes but keeping the orthogonal ones active enough. This was confirmed in a final 
experiment that analyzed GFP expression levels of cells grown in medium with the selected 
spectinomycin concentrations of 0, 20 and 40 µg/mL by western blot (Figure 5.13). After 
normalizing cells according to in-cell fluorescence in the absence of spectinomycin (data 
not shown) only those containing the orthogonal mRNA coding for GFP and the orthogonal 
ribosome revealed GFP expression past treatment with 40 µg/mL spectinomycin.  
 
Figure 5.13: sfGFP expression with selected spectinomycin concentrations. 
Arabinose induced expression of sfGFP in E. coli BL21 using an orthogonal mRNA (ind. ORBS GFP; pCLA193; 
0.2% arabinose) in combination with the orthogonal ribosome ribo-Q1 (pCLA96) and a non-orthogonal mRNA 
(ind. GFP; pCLA101; 0.001% arabinose). Expressions were performed in the absence and presence of 20 or 
40 µg/mL spectinomycin. Cells using orthogonal and non-orthogonal components were normalized by in-cell 
fluorescence of GFP (data not shown). For the western blot whole cell extracts were separated with SDS PAGE 
(Ch. 3.2.2.3) and blotted onto a PVDF membrane (Ch. 3.2.2.4). Anti-His-antibody was used as primary antibody. 
 
The size of sfGFP, roughly 28 kDa, could present another reason that the previously 
described in-cell NMR experiment (Figure 5.10) did not work. The Zweckstetter group 
suggested testing the small peptide -NYHLENEVARLKKLVG-, representing the amino acids 
16 to 31 of the yeast transcriptional activator GCN4, that has been used for NMR 
experiments before[208]. The peptide was expressed and 15N labeled as described for sfGFP 
but under the control of the arabinose inducible promoter (pCLA194) and with optimized 
conditions using only 40 µg/mL spectinomycin. However, we were again not able to detect 
the isotopically labeled peptide by NMR in living cells. 
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6 Discussion 
 
Studies on biological processes usually involve the examination of its participating proteins, 
which may be difficult, or impossible in some cases, using standard methods. In recent 
years, the expansion of the genetic code has become a powerful tool for biological studies. 
This technique provides the ability to incorporate unnatural amino acids, site-specifically 
into proteins, establishing new side chain possibilities and protein properties. The ongoing 
progress of this approach facilitated the expansion of the genetic code in several 
prokaryotic and eukaryotic organisms. However, the creation of proteins with (multiple) 
UAAs is significantly limited by the UAA incorporation efficiency. Efforts made to optimize 
this drawback are lacking in systematic studies that correlate aaRS and tRNA expression and 
aminoacylation levels with the efficiency of UAA incorporation[42,48,49,77]. This thesis focused 
on these issues by the establishment of assays to detect the abundance and activity of each 
component. We ultimately determined that the synthetase PylS was responsible for 
restraining the performance of the system. Furthermore, we lowered the metabolic burden 
for the cell by balancing the expression levels of distinct components and by reducing the 
number of plasmids used. This enhanced cell viability and also provided a 5-10 fold increase 
in yields of proteins containing UAAs. 
 
6.1 Balancing An Expanded Genetic Code System 
One could suppose that the low efficiency of UAA incorporation could be easily adjusted by 
simply overexpressing the required components, i.e., the tRNA/aaRS pairs, and/or by 
increasing the UAA concentration in the media. However, the overexpression of 
endogenous components could also provoke toxic ancillary effects and exhaust biosynthetic 
energy. Moreover, UAAs, especially those that are not commercially obtainable, have to be 
used as economically as possible. 
In order to determine optimal expression and aminoacylation levels of the tRNA/aaRS pairs, 
which guarantee sufficient suppression of the blank codons without distressing the cells, 
we developed assays for their detection. The absence of specific antibodies against the 
aaRS PylS and MjYRS led us introduce the well-characterized small His6-tag into these 
proteins but neither the addition to the N- nor the C-terminus allowed for clear detection of 
the synthetases by western blot using antibodies against the His6-tag. Since the cell lysates 
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were treated under denaturing conditions for the blot, using SDS and heat, the accessibility 
of the terminal epitopes by antibodies should not be restricted. This was proven by the 
Schultz group which obtained a relatively weak but distinct signal of a C-terminal His6-
tagged BPARS, a mutant MjYRS that decodes for BPA, in cell lysates by western blot 
analysis[69]. The detection of His6-tagged PylS also failed for them, until they used a variant 
that was codon-optimized for expression in E. coli[72]. Considering the crystal structures of 
both aaRS (Figure 4.2 and 4.10), their C-termini are exposed to the protein surfaces and in 
case of MjYRS not directed towards the tRNA. This holds also true for the N-terminus of 
MjYRS, but concerning PylS no statement can be made because structural data in 
combination with PylT and for the N-terminal domain is missing. However, unless there are 
unknown interactions with other components and as long as the proteins are properly 
folded, the His6-epitope should be accessible even under native conditions. Srinivasan et al. 
were therefore able to purify PylS using an N-terminal His6-tag
[33]. An observation made by 
Chatterjee et al.[72] and, independently by ourselves, is that PylS is mostly found in the 
insoluble fraction, probably due to misfolding in E. coli. Improper folded proteins are prime 
targets for proteolysis[209] and could thereby represent one explanation for the poor 
detectability of (tagged) PylS. We tried to solve this problem by using chaperones, reducing 
the temperature during expression and deleting parts of the proline-rich linker (Figure 4.1, 
4.5 and 4.6) without success (data not shown). 
In addition to these findings, we discovered that MjYRS accepted a His6-tag at the 
C-terminus without losing catalytic activity (Figure 4.11), whereas PylS revealed a grave loss 
of activity upon addition of this tag (Figure 4.3). By contrast, shifting the His6-tag into the 
flexible linker region of PylS, between the N-terminus tRNA binding domain and the 
C-terminus catalytic domain, proved beneficial because we were then able to detect the 
non-codon-optimized protein by western blot without severely impairing its enzymatic 
functionality (Figure 4.3 and 4.4). The introduction of an unconventional internal His6-tag 
also helped us to determine MjYRS expression levels by western blot, which were many 
times lower than PylS levels, although under the control of the same glnS promoter (Figure 
4.12). When expressed from the same tacI promoter Chatterjee et al. observed MjYRS to be 
stronger expressed than PylS[72]. This demonstrates how important different promoters can 
be for the regulation of certain protein levels and, in the case of these two aaRSs, very likely 
for the suppression efficiency of the blank codons. 
When we quantified PylS and MjYRS expression levels at different stages of growth in rich 
medium under the control of a glnS promoter, we found both proteins exhibited 
6: Discussion  121 
diminished expression levels when the cultures reached high cell densities (Figure 4.4 and 
4.12). This was consistent with previous reports stating that, in E. coli, the enzyme level of 
the naturally regulated glutaminyl-tRNA synthetase increases with increasing growth 
rate[210], because cultures that approach saturation exhibit decreased growth rates. Thus, 
the aaRSs may become limiting in their ability to charge their cognate tRNAs with UAAs, 
and thereby for suppression of blank codons in recombinant proteins, during prolonged 
expressions. This, in turn, renders the wild type glnS promoter amendable for this purpose. 
Indeed, the Schultz laboratory achieved a fivefold improved suppression efficiency using a 
mutant glnS promoter (glnS’) that led to a twofold increase in BPARS expression[69]. 
Additional improvements were made by further raising the expression levels of different 
MjYRS derivatives using a dual glnS′/araBAD promoter system or a single tacI-driven aaRS 
expression cassette[51,70,72]. 
We decided to use promoter libraries for optimization, which have been shown to provide a 
broad range of promoter activities[158–160,211]. We determined, that for the PylS, there was a 
direct positive dependency upon promoter strength for enzyme level, tRNA aminoacylation 
and suppression efficiency (Figure 4.19). Whereas Jensen and Hammer directly measured 
the effect of their synthetic promoter library in Lactococcus lactis and E. coli by 
β-galactosidase activity, obtaining up to 400-fold variation in promoter strength[160], we 
performed indirect measurements and observed a fivefold variation, only. This was 
determined by the ability of the PylS to suppress an amber codon in the genes of CAT or 
histone H3, with the most efficient promoter being two to threefold more efficient than the 
wild type glnS variant. In the case of the MjYRS the promoter libraries did not reveal a 
similar tendency (Figure 4.22), leading to the assumption that the PylS constrains the 
performance of the current system for the incorporation of two distinct UAAs. The 
replacement of the wild type glnS promoter in front of the PylS gene with some well-
defined standard promoters of different strength, including the most promising candidate 
used by the Schultz group, i.e., tacI[72], permitted us to enhance the performance of the 
system once more (Figure 4.25). Furthermore, we could characterize the glnS promoter and 
also its strongest library variant, 3E, as relatively weak. However, we discovered modest 
increases in PylS levels already being advantageous, yielding higher amounts of UAA 
containing proteins. Promoters with stronger activities, like tacI, did not prove more useful 
and likely consumed biosynthetic resources, particularly if more than one component is 
controlled by these regulatory elements. To this end, we performed subsequent 
experiments using the constitutive promoter Pcon or the IPTG inducible Plac to carry out PylS 
expression. 
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In order to optimize the expression levels of the appropriate tRNAs, PylT and MjYT_UCCU, 
the original lpp promoters were also exchanged by promoter libraries. DIG labeled 
hybridization probes were created for the simultaneous detection of their abundance and 
loading status by northern blot analysis. We obtained specific signals for both tRNAs and 
were able to distinguish their aminoacylated form from their free form by means of a 
mobility shift in acid urea gels (Figure 4.9 and 4.16), as demonstrated by Polycarpo et 
al.[39,212] or Köhrer and Rajbhandary[142]. However, the effect of the tRNA promoter libraries 
on the suppression efficiency has not yet been investigated by western and northern blot. 
They were merely used in combination with the two aaRS promoter libraries to construct a 
four component suppressor plasmid (see Ch. 6.2). According to the results of the Schultz 
laboratory, where they replaced the weak lpp promoter of MjYT_CUA by the stronger proK 
promoter[69], one could expect improved suppression efficiencies by increasing the tRNA 
expression levels. While they initially observed a positive correlation between suppression 
efficiency and increased copies of tRNA, up to six tRNA copies per plasmid organized in two 
clusters under the control of proK, they later stated that these increases caused toxicity 
effects to rise to significant levels, leading to considerably slowed growth rates of E. coli. 
They could show that a single copy of an optimized M. jannaschii amber suppressor tyrosyl-
tRNA[71] exceeded the performance of multiple non-optimized tRNAs, while the cell growth 
was less affected[51]. 
In summary, it was shown by us, and others, that raising expression levels of both aaRS and 
tRNA to a certain limit provides benefits to the genetic code expansion system. Expression 
levels beyond these limits are either producing toxic side effects or do not further enhance 
suppression efficiencies and are probably exhausting biosynthetic energy. Instead of 
increasing the component’s abundance, additional opportunities to optimize the system 
could focus on the functionalities of the components. This is exemplified by the work of 
Kobayashi et al. who created a MjYRS mutant that aminoacylates its cognate tRNA 65 times 
more efficiently than its wild type variant, mainly due to improved recognition of the amber 
anticodon[73]. 
 
6.2 Reducing The Metabolic Burden 
The efficient incorporation of two distinct unnatural amino acids, which can be altered by 
bioorthogonal “click chemistry”, is an important intermediate step for the creation of 
proteins that can be double labeled with fluorophores for smFRET studies. Developed by 
the Chin laboratory, the original orthogonal ribosome assisted system for the dual 
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suppression of an amber and a frameshift codon consisted of six exogenous components 
(two cognate pairs of tRNA/aaRS, an O-mRNA and the O-ribosome) distributed on four 
different plasmids[78]. This number of plasmids, harboring potentially toxic components and 
corresponding antibiotics for their maintenance, impairs cell growth rates significantly 
(Figure 4.38) and thus limits the possibilities of this system. By merging a tRNA/aaRS pair 
from two vectors into a single one, the reduction of required plasmids has already been 
shown to be advantageous for the incorporation of a single UAA into proteins[68,69]. 
Chatterjee et al. demonstrated the feasibility of a dual nonsense (amber and ochre) 
suppressor plasmid that was used to efficiently install two UAAs into GFP. This system did 
not take benefits from an O-ribosome; hence, only five exogenous components were 
present, distributed on two plasmids. However, protein yields were not improved 
compared to a three plasmid system[72]. 
In contrast, we intended to optimize the six component system introduced by Chin and 
co-workers to profit from the evolved O-ribosome ribo-Q1 that facilitates UAA 
incorporation in response to both amber and frameshift codons, with the latter one 
providing 256 new possibilities to encode UAAs. We therefore constructed a modular 
genetic tool that also works as a dual suppressor plasmid by expressing both required 
tRNA/aaRS pairs, in order to reduce the metabolic burden provoked by the four plasmids of 
the original system. Furthermore, this tool permits the exchange of individual parts 
(including tRNAs, aaRS and their promoters and terminators) by a series of unique 
restriction sites to adapt the system for new UAAs (Figure 4.26). Compared to the 
established four plasmid system, we indeed observed significantly enhanced growth rates 
(Figure 4.38) and improved yields of UAA containing proteins (Figure 4.31) by employing 
our three plasmid system. 
Trials to optimize our first version of the tool by replacing the original glnS and lpp promters 
of the aaRS and tRNAs with promoter libraries, to balance the expression levels of each 
individual component, failed so far. It seemed that the replacement generated a multitude 
of less active or even inactive clones, which were difficult to separate from more efficient 
clones using FACS (Figure 4.34). The observed higher GFP expression levels from putatively 
optimized clones were possibly due to the simultaneous measurement of more than one 
cell by virtue of the small size of E. coli cells. In some cases a strong overexpression of PylS 
was found, while only tiny amounts of UAA containing GFP were produced (Figure 4.35). 
This is consistent with the aforementioned hypothesis that overexpressing one component 
is likely to produce toxicity and consume biosynthetic energy. 
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By contrast, when we exchanged the glnS promoter of the PylS on the modular genetic tool 
with Pcon or Plac, we observed enhanced amber suppression efficiency, on its own and in 
combination with a frameshift codon. Pcon was at least 1.5 to 2-fold more efficient and Plac 
2.5 to 3-fold compared to the standard glnS promoter (Figure 4.36). In comparison with the 
original four plasmid system, these second optimized versions of our tool provided a 5-10 
fold increase in yields of proteins containing UAAs, while the improved growth rates, due to 
the reduced metabolic burden, were maintained (Figure 4.37 and 4.38). 
 
6.3 The Avenue To FRET Measurements 
For a start to demonstrate the feasibility that the existing system can be optimized, all 
previously described optimizations were performed with the wild type PylS and MjYRS 
using the commercially obtainable but unremarkable UAAs BocK and tyrosine as a 
substrate. The site-specific labeling of proteins with fluorophores by bioorthogonal “click 
chemistry” requires the incorporation of suitable UAAs and in some cases the evolution of 
the aaRS’ specificity towards them. Chin et al. evolved MjYRS to incorporate one of these 
suitable UAAs, the azide containing UAA p-azido-L-phenylalanine (AzF), in response to an 
amber codon[80]. Later on, Neumann et al. changed the decoding property of this mutant 
aaRS (MjAzFRS) from UAG to AGGA by randomizing the tRNA anticodon recognizing region 
to accept the expanded anticodon of the MjYT_UCCU tRNA[78,79]. Since the amber codon is 
exclusive for the M. barkeri PylS/PylT pair in our optimized dual suppressor system, we also 
needed to evolve MjAzFRS (provided by the Chin laboratory) to incorporate AzF in response 
to AGGA. Using the published procedure[78,79], we successfully obtained a MjAzFRS mutant 
that suppressed AGGA codons in GFP and histone H3 with high specificity for AzF (Figure 
5.2). Sequencing of this, and other clones, revealed the common amino acid substitutions 
Y230K, C231K and P232K, but divergent mutations at positions F261, H283 and D286. This 
observation was also made by Neumann et al. who suggested that amino acids 230, 231 
and 232 grant affinity and specificity for the anticodon, and that 261, 283 and 286 may link 
the identity of the anticodon to the amino acid identity[78]. 
Furthermore, we were able to incorporate the strained alkyne bicyclo[6.1.0]non-4-yn-9-
ylmethanol-L-lysine (BCNK; Figure 5.3) and alkene Nε-5-norbornene-2-yloxycarbonyl-L-
lysine (NorK; Figure 5.4) into proteins in response to amber codons using evolved variants 
of PylS. Whereas BCNK incorporation was successful by means of issued PylS mutations[121], 
we could not produce NorK containing proteins with the aid of wild type PylS as 
published[120], but by the use of an alternative PylS mutant originally designed to recognize 
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an azido-photocaged lysine as substrate. The poor substrate specificity of wild type PylS for 
NorK was also found by Plass et al., who incorporated this amino acid and other strained 
alkene and alkyne UAAs using a rationally designed PylS double mutant[119]. 
However, both BCNK and NorK contain chemical handles that can react with tetrazines 
and/or azides, allowing the labeling of proteins with fluorophores conjugated to these 
functional groups even in living cells[119–121]. To test this, as a preparation for future FRET 
experiments, we successfully labeled histone H3 proteins with different tetrazine 
conjugated fluorophores (Figure 5.5 and 5.6), which have been reported to exhibit superior 
performance in STED microscopy[125]. We even double labeled H3 by using a second 
maleimide conjugated fluorophore, permitting us to perform in-gel (pseudo) FRET 
measurements (Figure 5.5). Moreover, in collaboration with the Rizzoli group (ENI, 
Göttingen) we successfully expressed, and site-specifically labeled, the α-synuclein 
targeting nanobody NbSyn2[195] with Abberior Star635, which is one of the tetrazine 
conjugated fluorophores (Figure 5.8). In contrast to classical chemical ligations of 
fluorophores and nanobodies, which occur protein wide and erratically, this approach will 
facilitate quantitative analyses in their research on synaptic vesicle function by STED 
microscopy. 
In summary, we demonstrated the incorporation of the UAAs AzF, BCNK and NorK into 
different proteins in response to the frameshift codon AGGA or the amber codon UAG, 
respectively. Thereby, functional groups for bioorthogonal conjugations were introduced 
into these proteins, allowing us to site-specifically label them with fluorophores. 
Each of the corresponding aaRS was cloned into our optimized genetic tool substituting the 
wild type MjYRS and PylS genes. In order to produce proteins with two distinct UAAs that 
can be double labeled with fluorophores for smFRET studies, one could combine NorK and 
AzF but BCNK would cross-react with the azide of AzF. Initial trials to express proteins 
containing NorK and AzF yielded only tiny amounts of full-length protein, barely detectable 
by western blot (data not shown). This could have been due to the poor incorporation 
efficiency of NorK, which therefore have to be optimized for future experiments. 
 
6.4 Applications And Side Projects: Nanobodies And In-Cell NMR 
Improving proteins yields is generally important and desirable for most studies, including 
the production of fluorescently labeled nanobodies and the orthogonal ribosome assisted 
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in-cell NMR spectroscopy. Since both applications/side projects were not part of the main 
focus of this thesis their optimization will only be briefly discussed. 
We demonstrated that our optimized genetic tool was conducive to increase expression 
levels of proteins containing UAAs. However, the purification of the NorK containing 
nanobody NbSyn2 resulted only in very small amounts of protein (0.11 mg full-length 
protein out of 1 L medium). This was probably due to the poor incorporation efficiency of 
NorK but also due to the intricate but necessary production of NbSyn2 in the cell’s 
periplasm[188] and its release to the medium from which it was purified. Besides enhancing 
protein yields by optimizing the incorporation of NorK or using a more efficiently 
incorporated UAA, one could simplify the production and purification of the nanobody. Our 
first approach using the specialized E. coli SHuffle cell line turned out to be useful for the 
high yield expression of proteins that contain disulfide bonds (Figure 5.9). 
The production of uniquely 15N labeled proteins for in-cell NMR experiments was based on 
the spectinomycin resistance of the used orthogonal ribosome[66]. We found that the 
initially applied concentration of 150 µg/mL Sm was even too harsh for the O-ribosome, 
preventing an efficient protein synthesis (Figure 5.12). The reduction to 40 µg/mL Sm 
showed a sufficient blocking of the endogenous ribosomes while the orthogonal ones were 
still active (Figure 5.13). However, a detection of isotopically labeled polypeptides by NMR 
in living cells was not possible. Maybe the amount of 15N labeled protein was too low to be 
detected despite optimized conditions. Additional mutations in the O-ribosome may 
increase the resistance to spectinomycin and thereby improve protein yields. We observed 
that the expression of the protein from the modified pBAD vector containing an ORBS was 
approximately eightfold lower in comparison to the original pBAD vector (Figure 5.11). This 
could perhaps be overcome by the use of a stronger inducible promoter, for example the 
IPTG driven lac or tacI promoter, or by optimizing the expression level of the O-ribosome. 
 
6.5 Concluding Remarks And Outlook 
Since synthetic biologists initiated the expansion of the genetic code more than a decade 
ago, it has become a powerful tool for basic and applied scientific research. Numerous 
efforts have been made to expand the catalogue of useful UAAs in several organisms, 
including prokaryotes and eukaryotes. We expect future developments to further extend 
the existing system by evolving new tRNA/aaRS pairs for the incorporation of novel UAAs in 
response to additional blank codons even in higher eukaryotes. Optimizing the translational 
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apparatus for a more efficient production of proteins with multiple different UAAs will 
possibly allow its reprogramming to create fully synthetic unnatural polymers. 
In this study, we described a part of these optimizations by significantly improving the 
reliability and yield of UAA containing proteins produced with the aid of orthogonal 
ribosomes. Our analysis of the limiting factors revealed bottlenecks of the existing system 
and will be helpful for future studies. For instance, the integration of some components 
into the host’s chromosome for a further reduction of the metabolic burden, if one can find 
a solution to compensate the loss in copy numbers compared to plasmids. Optimized 
expression levels of O-ribosomes will also prove beneficial for the performance of the 
system. One approach, which addressed both concerns, was recently published by the Chin 
laboratory. That work combined the orthogonal ribosomal RNA of ribo-Q1 and the O-mRNA 
of the protein of interest on a single vector, reducing the number of required plasmids by 
one[213]. Furthermore, they evolved a series of quadruplet-decoding PylT variants that 
showed enhanced UAA specific decoding of their corresponding codons on ribo-Q1 in 
combination with PylS or some of its derivatives in comparison with quadruplet-decoding 
pairs derived from MjYT/MjYRS. Both strategies together led to improved incorporation 
efficiencies of two distinct UAAs into the same protein and thus to the efficient genetically 
encoded installation of FRET pairs[213]. Moreover, the combination of their recent work and 
the work presented in this study will most likely lead to an extremely more efficient genetic 
code expansion system. 
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8 Appendix 
8.1 Plasmids 
Table 8.1: List of plasmids. 
Details for the construction of plasmids made during this thesis (method, primers, template etc.) are listed in 
Table 8.3. Plasmids labeled with “Cambridge” were kindly provided by the Chin laboratory (MRC Laboratory of 
Molecular Biology, Cambridge). The remaining plasmids were made by other group members of AG Neumann as 
indicated. 
No. Name Resistance Source 
pCLA1 pBK PylS Kan Cambridge 
pCLA2 pBK MjYRS_TAG Amp Cambridge 
pCLA3 pBK MjYRS_AGGA (2D12) Amp Cambridge 
pCLA4 pREP PylT Tet Cambridge 
pCLA5 pREP YC JYCUA (MjYT_CUA) Tet Cambridge 
pCLA6 pREP YC JYCUA AGGA2 (MjYT_UCCU) Tet Cambridge 
pCLA7 pBK His6 PylS Kan Thesis 
pCLA8 pBK H6C PylS Kan Thesis 
pCLA9 pBK H6 34AA lack to mazei (gap) PylS  Kan Thesis 
pCLA10 pBK H6 Loop206-216 in mazei PylS Kan Thesis 
pCLA11 pBK H6 PylS linker delta 10 Kan Thesis 
pCLA12 pBK H6 PylS linker delta 20 Kan Thesis 
pCLA13 pBK H6 PylS linker delta 15 Kan Thesis 
pCLA14 pBK H6 PylS linker delta 30 Kan Thesis 
pCLA15 pBK H6 PylS linker delta 50 Kan Thesis 
pCLA16 pBK H6 PylS linker delta C-terminus Kan Thesis 
pCLA17 pBK H6 PylS linker delta N-terminus Kan Thesis 
pCLA18 pBK His6 MjYRS_TAG Amp Thesis 
pCLA19 pBK H6C MjYRS_TAG Amp Thesis 
pCLA20 pBK H6 Loop25-29 MjYRS_TAG Amp Thesis 
pCLA21 pDULE BPA (BPA aaRS + MjYT_CUA) Tet Cambridge 
pCLA22 pBK H6 gap PylS_Prom Lib 1D Kan Thesis 
pCLA23 pBK H6 gap PylS_Prom Lib 2E Kan Thesis 
pCLA24 pBK H6 gap PylS_Prom Lib 3E Kan Thesis 
pCLA25 pBK H6 gap PylS_Prom Lib 4F Kan Thesis 
pCLA26 pBK H6 gap PylS_Prom Lib 6B Kan Thesis 
pCLA27 pBK H6 gap PylS_Prom Lib 7A Kan Thesis 
pCLA28 pBK H6 gap PylS_Prom Lib 8G Kan Thesis 
pCLA29 pBK H6 gap PylS_Prom Lib 10D Kan Thesis 
pCLA30 pBK H6 gap PylS_Prom Lib 11D Kan Thesis 
pCLA31 pBK H6 gap PylS_Prom Lib 12H Kan Thesis 
pCLA32 pCDFDuet-PylT H3 R52TAG Sm Liljan Hahn 
pCLA33 pBK H6C MjYRS_AGGA_Prom Lib 1D Amp Thesis 
pCLA34 pBK H6C MjYRS_AGGA_Prom Lib 2F Amp Thesis 
pCLA35 pBK H6C MjYRS_AGGA_Prom Lib 3B Amp Thesis 
pCLA36 pBK H6C MjYRS_AGGA_Prom Lib 4A Amp Thesis 
pCLA37 pBK H6C MjYRS_AGGA_Prom Lib 6D Amp Thesis 
pCLA38 pBK H6C MjYRS_AGGA_Prom Lib 7E Amp Thesis 
pCLA39 pBK H6C MjYRS_AGGA_Prom Lib 8G Amp Thesis 
pCLA40 pBK H6C MjYRS_AGGA_Prom Lib 9F Amp Thesis 
pCLA41 pBK H6C MjYRS_AGGA_Prom Lib 10B Amp Thesis 
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pCLA42 pBK H6C MjYRS_AGGA_Prom Lib 11E Amp Thesis 
pCLA43 pMyo4AGGA MjtRNAYuccu-3 Tet Cambridge 
pCLA44 pREP PylT short_Prom Lib A4 Tet Thesis 
pCLA45 pREP PylT short_Prom Lib C2 Tet Thesis 
pCLA46 pREP PylT short_Prom Lib E7 Tet Thesis 
pCLA47 pREP PylT short_Prom Lib F5 Tet Thesis 
pCLA48 pREP PylT short_Prom Lib I3 Tet Thesis 
pCLA49 pREP PylT short_Prom Lib I6 Tet Thesis 
pCLA50 pREP PylT short_Prom Lib J7 Tet Thesis 
pCLA51 pREP PylT short_Prom Lib K2 Tet Thesis 
pCLA52 pREP PylT short_Prom Lib L5 Tet Thesis 
pCLA53 pREP MjYT_UCCU short_Prom Lib B3 Tet Thesis 
pCLA54 pREP MjYT_UCCU short_Prom Lib B8 Tet Thesis 
pCLA55 pREP MjYT_UCCU short_Prom Lib D4 Tet Thesis 
pCLA56 pREP MjYT_UCCU short_Prom Lib E1 Tet Thesis 
pCLA57 pREP MjYT_UCCU short_Prom Lib G7 Tet Thesis 
pCLA58 pREP MjYT_UCCU short_Prom Lib I2 Tet Thesis 
pCLA59 pREP MjYT_UCCU short_Prom Lib I8 Tet Thesis 
pCLA60 pREP MjYT_UCCU short_Prom Lib K6 Tet Thesis 
pCLA61 pREP MjYT_UCCU short_Prom Lib L1 Tet Thesis 
pCLA62 pBK H6 gap PylS_con Prom Kan Thesis 
pCLA63 pBK H6 gap PylS_cp25 Prom Kan Thesis 
pCLA64 pBK H6 gap PylS_lac1-6 Mt5 Prom Kan Thesis 
pCLA65 pBK H6 gap PylS_lacP1 Prom Kan Thesis 
pCLA66 pBK H6 gap PylS_lambda ConN25 Prom Kan Thesis 
pCLA67 pBK H6 gap PylS_lambda Prom Kan Thesis 
pCLA68 pBK H6 gap PylS_T5 D/E20 Prom Kan Thesis 
pCLA69 pBK H6 gap PylS_T5 H207 Prom Kan Thesis 
pCLA70 pBK H6 gap PylS_tacI Prom Kan Thesis 
pCLA71 pBK H6C MjYRS_AGGA (2D12) Amp Thesis 
pCLA72 pBK H6C MjYRS_AGGA_SalI-Term Amp Thesis 
pCLA73 pBK H6 gap PylS_NdeI to KpnI Kan Thesis 
pCLA74 pBK H6 gap PylS-KpnI_PstI to SacI Kan Thesis 
pCLA75 pBK H6 gap PylS-KpnI-SacI_SalI Kan Thesis 
pCLA76 pBK H6 gap PylS-KpnI-SacI-SalI_NotI Kan Thesis 
pCLA77 pREP PylT short Tet Thesis 
pCLA78 pREP PylT short_NotI Tet Thesis 
pCLA79 pREP PylT short-NotI_MfeI Tet Thesis 
pCLA80 pREP MjYT_UCCU short Tet Thesis 
pCLA81 pREP MjYT_UCCU short_MfeI Tet Thesis 
pCLA82 pREP MjYT_UCCU short-MfeI_XhoI Tet Thesis 
pCLA83 pBK H6 gap PylS_SalI Kan Thesis 
pCLA84 pBK H6 gap PylS_NotI Kan Thesis 
pCLA85 pBK H6 gap PylS_NdeI-restore Kan Thesis 
pCLA86 pBK H6 gap PylS_NdeI-restore_PM1 Kan Thesis 
pCLA87 pBK H6 gap PylS_NdeI-restore_PM2 Kan Thesis 
pCLA88 pBK H6 gap PylS_NdeI-restore_PM3 Kan Thesis 
pCLA89 pBK H6 gap PylS_NdeI-restore_PM4 Kan Thesis 
pCLA90 pBK H6 gap PylS_NdeI-restore_PM5 Kan Thesis 
pCLA91 pCDF Duet-1 Sm Novagen 
pCLA92 pCDF_H6C MjYRS_AGGA Sm Thesis 
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pCLA93 pCDF_H6C MjYRS_H6 gap PylS Sm Thesis 
pCLA94 pCDF_H6C MjYRS_H6 gap PylS_PylT Sm Thesis 
pCLA95 pCDF_H6C MjYRS_H6 gap PylS_PylT_MjYT_UCCU Sm Thesis 
pCLA96 pSC101*-ribo-Q1 Kan Cambridge 
pCLA97 pCDF PylST Sm Cambridge 
pCLA98 pDULE MjYRST (AGGA) Tet Cambridge 
pCLA99 pO-gst-malE Amp Cambridge 
pCLA100 pO-delta-gst-malE_MCS Amp Thesis 
pCLA101 pBAD sfGFP WT Amp Cambridge 
pCLA102 pBAD sfGFP 150TAG Amp Cambridge 
pCLA103 pBAD sfGFP 134AGGA 150TAG-1 Amp Cambridge 
pCLA104 pBAD sfGFP 134AGGA-1 Amp Cambridge 
pCLA105 pO-sfGFP WT Amp Thesis 
pCLA106 pO-sfGFP 150TAG Amp Thesis 
pCLA107 pO-sfGFP 134AGGA 150TAG-1 Amp Thesis 
pCLA108 pO-sfGFP 134AGGA-1 Amp Thesis 
pCLA109 pCDF_MjYRS_PylS_PylT_MjYT_UCCU-mismatch Sm Thesis 
pCLA110 pREP YC JYCUA delta tRNA Tet Cambridge 
pCLA111 pO-CAT Tet Cambridge 
pCLA112 pO-CAT T6TAG Tet Thesis 
pCLA113 pO-CAT T6TAG D111AGGA Tet Thesis 
pCLA114 pYOBB2 PylT-1 Cm Cambridge 
pCLA115 pCDF_GTF_PylS_Prom Lib 3E Sm Thesis 
pCLA116 pCDF_GTF_PylS_con Prom Sm Thesis 
pCLA117 pCDF_GTF_PylS_lacP1 Prom Sm Thesis 
pCLA118 G9GSTMBP Y17AGGA N234TAG-1 Amp Cambridge 
pCLA119 pDULE AzFRS (TAG) Tet Cambridge 
pCLA120 pBK AzFRS (TAG) Kan Thesis 
pCLA121 pBK AzFRS_AGGA Lib1 Kan Thesis 
pCLA122 pBK AzFRS_AGGA Lib2 Kan Thesis 
pCLA123 pBK AzFRS_AGGA Lib3 Kan Thesis 
pCLA124 pBK AzFRS_AGGA Lib4 Kan Thesis 
pCLA125 pBK AzFRS_AGGA Lib5 Kan Thesis 
pCLA126 pBK AzFRS_AGGA Lib6 Kan Thesis 
pCLA127 pBK AzFRS_AGGA Lib7 Kan Thesis 
pCLA128 pBK AzFRS_AGGA Lib8 Kan Thesis 
pCLA129 pBK AzFRS_AGGA Lib9 Kan Thesis 
pCLA130 pBK AzFRS_AGGA Lib10 Kan Thesis 
pCLA131 pBK AzFRS_AGGA Lib11 Kan Thesis 
pCLA132 pBK AzFRS_AGGA Lib12 Kan Thesis 
pCLA133 pBK AzFRS_AGGA Lib13 Kan Thesis 
pCLA134 pBK AzFRS_AGGA Lib14 Kan Thesis 
pCLA135 pBK AzFRS_AGGA Lib15 Kan Thesis 
pCLA136 pBK AzFRS_AGGA Lib16 Kan Thesis 
pCLA137 pBK AzFRS_AGGA Lib17 Kan Thesis 
pCLA138 pBK AzFRS_AGGA Lib18 Kan Thesis 
pCLA139 pBK AzFRS_AGGA Lib19 Kan Thesis 
pCLA140 pBK AzFRS_AGGA Lib20 Kan Thesis 
pCLA141 pCDF Duet-PylT H3opt Q76C (pCHR029) Sm C. Hoffmann 
pCLA142 pCDF Duet-PylT H3opt Q76C_T6AGGA Sm Thesis 
pCLA143 pO-H3opt Q76C_T6AGGA Amp Thesis 
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pCLA144 pDULE AzFRS_AGGA Lib2 Tet Thesis 
pCLA145 pDULE AzFRS_AGGA Lib3 Tet Thesis 
pCLA146 pDULE AzFRS_AGGA Lib5 Tet Thesis 
pCLA147 pDULE AzFRS_AGGA Lib6 Tet Thesis 
pCLA148 pDULE AzFRS_AGGA Lib11 Tet Thesis 
pCLA149 pDULE AzFRS_AGGA Lib17 Tet Thesis 
pCLA150 pDULE AzFRS_AGGA Lib18 Tet Thesis 
pCLA151 pBK AzFRS_BamHI_SalI (TAG) Kan K. Halder 
pCLA152 pCDF_AzFRS_BamHI_SalI (TAG) Sm Thesis 
pCLA153 pCDF_AzFRS_BamHI_SalI (TAG)_PylT_MjYT_UCCU Sm Thesis 
pCLA154 pCDF_PylT_MjYT_UCCU_AzFRS (AGGA) Sm Thesis 
pCLA155 pCDF_PylT_MjYT_UCCU_AzFRS (AGGA)_PylS Sm Thesis 
pCLA156 pMyo4TAG PylT Tet Cambridge 
pCLA157 pMyo 4K PylT-1 (amber reverted to AAA (Lys)) Tet Cambridge 
pCLA158 pBK BCNRS Kan H. Neumann 
pCLA159 pBK pcKRS-1 Amp Cambridge 
pCLA160 pBK AzpcK2-3 Amp Cambridge 
pCLA161 pBK AcKRS1 Kan Cambridge 
pCLA162 pBK AcKRS3 Kan Cambridge 
pCLA163 pCDF PylT1 H3K56TAG-1 Sm Cambridge 
pCLA164 pCDF Duet-PylT H3opt V35TAG F78C C110A Sm Liljan Hahn 
pCLA165 pCDF_PylT_MjYT_UCCU_AzFRS (AGGA)_BCNRS Sm Thesis 
pCLA166 pCDF_PylT_MjYT_UCCU_AzFRS (AGGA)_AzpcKRS Sm Thesis 
pCLA167 pBK BCNRS_con Prom Kan Thesis 
pCLA168 pBK BCNRS_lacP1 Prom Kan Thesis 
pCLA169 pBK AzpcKRS_con Prom Kan Thesis 
pCLA170 pBK AzpcKRS_lacP1 Prom Kan Thesis 
pCLA171 pCDF_PylT_MjYT_AzFRS_BCNRS_con Prom Sm Thesis 
pCLA172 pCDF_PylT_MjYT_AzFRS_BCNRS_lacP1 Prom Sm Thesis 
pCLA173 pCDF_PylT_MjYT_AzFRS_AzpcKRS_con Prom Sm Thesis 
pCLA174 pCDF_PylT_MjYT_AzFRS_AzpcKRS_lacP1 Prom Sm Thesis 
pCLA175 pHEN6_NbSyn2_Thrombin_His6-tag Amp AG Rizzoli 
pCLA176 pHEN6_NbSyn2_Thrombin_His6-tag_S44TAG Amp AG Rizzoli 
pCLA177 pHEN6_NbSyn2_Thrombin_His6-tag_K70TAG Amp AG Rizzoli 
pCLA178 pHEN6_NbSyn2_Thrombin_His6-tag_R72TAG Amp AG Rizzoli 
pCLA179 pHEN6_NbSyn2_Thrombin_His6-tag_K93TAG Amp AG Rizzoli 
pCLA180 pHEN6_NbSyn2_Thrombin_His6-tag_K115TAG Amp AG Rizzoli 
pCLA181 pHEN6_NbSyn2_Thrombin_His6-tag_K153TAG Amp AG Rizzoli 
pCLA182 pACYC Duet Cm Novagen 
pCLA183 pET Duet Amp Novagen 
pCLA184 pCDF_GTF_PylS_con Prom_CatR Cm Thesis 
pCLA185 pCDF_GTF_PylS_con Prom_AmpR Amp Thesis 
pCLA186 pCDF_PylT_MjYT_AzFRS_BCNRS_con Prom_CatR Cm Thesis 
pCLA187 pCDF_PylT_MjYT_AzFRS_BCNRS_con Prom_AmpR Amp Thesis 
pCLA188 K63_GFP_VHH_optimized_Nanobody Kan AG Rizzoli 
pCLA189 K63_GFP_VHH_optimized_Nanobody_Q13TAG Kan AG Rizzoli 
pCLA190 K63_GFP_VHH_optimized_Nanobody_S17TAG Kan AG Rizzoli 
pCLA191 K63_GFP_VHH_optimized_Nanobody_R19TAG Kan AG Rizzoli 
pCLA192 K63_GFP_VHH_optimized_Nanobody_R76TAG Kan AG Rizzoli 
pCLA193 pBAD_ORBS_sfGFP WT Amp Thesis 
pCLA194 pBAD_ORBS_GCN4p 16-31 Amp Thesis 
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8.2 Oligonucleotides 
Oligonucleotides like primers and probes for RNA hybridization were ordered from 
Sigma-Aldrich (Steinheim) and dissolved with ddH2O as indicated on manufacturer’s 
technical datasheet to a final concentration of 10µM. 
Table 8.2: List of oligos (primers and probes). 
For/f = forward; rev/r = reverse. 
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C24 PylS_H6L_dNT_r GTGCCCGCTGTTCATATGGGATTCCTCAAAG
CGTAAAC 
C25 Mbarkeri_PylT_Probe [CY3]GATTTAGAGTCCATTCGATC 
C26 Mbarkeri_PylT_DIG_Probe [DIG]GATTTAGAGTCCATTCGATC 
C27 PylT_13-42 ATGTAGATCGAATGGACTCTAAATCCGTTC 
C28 T7P_PylT_for GAAATTAATACGACTCACTATAGGGAACCTG
ATCATGTAG 
C29 T7P_PylT_rev TGGCGGAAACCCCGGGAATCTAAC 
C30 T7P_EcSerT_for GAAATTAATACGACTCACTATAGGGAGTGTG
GCCGAGCGGTTG 
C31 T7P_EcSerT_rev TGGCGGGAGCGCAGAGATTCGAAC 
C32 Ecoli_serT_Probe [CY3]GTTTTCAAGACCGGTGCCTT 













C40 MjYT_CUA_Probe [CY5]GATTTAGAGTCCGCCGTTCT 
C41 MjYT_CUA_DIG_Probe [DIG]GATTTAGAGTCCGCCGTTCT 
C42 T7P_MjTyrT_for GAAATTAATACGACTCACTATAGGGGCGGTA
GTTCAGCAGGGCAG 
C43 T7P_MjTyrT_rev TGGTGGGGCGGGCCGGATTTG 
C44 MjYT_AGGA_DIG_Probe1 [DIG]GGATTAGGAAGTCCGCCGTTCT 
C45 MjYT_AGGA_DIG_Probe2 [DIG]CAGCGCCATGCGGATTAGGAAG 
C46 MjYT_AGGA_DIG_Probe3 [DIG]GCCATGCGGATTAGGAAGTCCG 










C52 pBK_MjYRS-lib_seqf TAAAAGGATCTAGGTGAAG 








C57 pREP_tRNA_seq_r GGGAGAGCGTCTGGCGAAAG 
  
























































































































C108 T7seqf TAATACGACTCACTATAGG 
C109 pCDF43_PylS_seqfII CCAATGGATTTAAAAAATG 
C110 pCDF_4comp_seq1f ATAGATTGGCTTTAAAAAC 
C111 pCDF_4comp_seq2f AGATTTTAGAGCCAATTAG 
C112 pCDF_4comp_seq3f AGATATCAACAACTTTCTG 
C113 pCDF_4comp_seq4f CCTGTGCCTGCGTCCGATG 





C117 ORBS_rep_seq_f CACTCATTAGGCACCCCAG 













C125 pCATseq1750rv CAGCCTTTTTTCTCCTGCCAC 
C126 pCATseq1100rv ATCTGCAGAATTCGCCCTTC 































C141 pCDF_resi_seqf CTGAAACCTCAGGCATTTG 
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8.3 Construction of Plasmids 
Table 8.3: Details of the construction of plasmids made during this thesis. 
Plasmids that are listed in Table 8.1 and made during this thesis are aligned with the method used, primers 
(listed in Table 8.2), the template and the purpose of the mutagenesis. The corresponding sequencing primers 
(Seq. Primer) can also be found in the list. Methods: QC = Quik Change (Ch. 3.2.3.10); Inv = Inverse PCR 
(Ch. 3.2.3.11); Sub = Subcloning (Ch. 3.2.3.1 to 3.2.3.6). 
Product Method Primer Template Purpose Seq. 
Primer 
pCLA7 QC C1 + C2 pCLA1 N-terminal His6-tag on PylS C3 
pCLA8 QC C4 + C5 pCLA1 C-terminal His6-tag on PylS C3/C6 
pCLA9 QC C7 + C8 pCLA1 Internal His6-tag in the “gap” 
between S144 and S145 on PylS 
C3/C6 
pCLA10 QC C9 + C10 pCLA1 Internal His6-tag in the loop 
D171 to F181 on PylS 
C3/C6 
pCLA11 QC C11 + C12 pCLA9 deletion of 10 AAs of the linker 
region (in front of internal His6-
tag) 
C3/C6 
pCLA12 QC C13 + C14 pCLA9 deletion of 20 AAs of the linker 
region (in front of internal His6-
tag) 
C3/C6 
pCLA13 QC C15 + C16 pCLA9 deletion of 15 AAs of the linker 
region (behind internal His6-tag) 
C3/C6 
pCLA14 QC C17 + C18 pCLA9 deletion of 30 AAs of the linker 
region (behind internal His6-tag) 
C3/C6 
pCLA15 QC C19 + C20 pCLA9 deletion of 50 AAs of the linker 
region (in front of and behind 
internal His6-tag) 
C3/C6 
pCLA16 QC C21 + C22 pCLA9 deletion of C-terminal part 
beginning behind internal His6-
tag 
C3/C6 
pCLA17 QC C23 + C24 pCLA9 deletion of N-terminal part up 
to internal His-Tag 
C3/C6 
pCLA18 QC C34 + C35 pCLA2 N-terminal His6-tag on 
MjYRS_TAG 
C3 
pCLA19 QC C36 + C37 pCLA2 C-terminal His6-tag on 
MjYRS_TAG 
C3/C6 
pCLA20 QC C38 + C39 pCLA2 Internal His6-tag in the loop K25 
to K29 on MjYRS_TAG 
C3/C6 
pCLA22 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA23 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA24 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA25 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA26 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA27 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA28 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA29 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA30 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA31 Inv C48 + C49 pCLA86 PylS promoter library C6/C50 
pCLA33 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
pCLA34 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
pCLA35 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
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pCLA36 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
pCLA37 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
pCLA38 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
pCLA39 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
pCLA40 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
pCLA41 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
pCLA42 Inv C48 + C51 pCLA72 MjYRS_AGGA promoter library C52/C53 
pCLA44 Inv C54 + C55 pCLA79 PylT promoter library C57 
pCLA45 Inv C54 + C55 pCLA79 PylT promoter library C57 
pCLA46 Inv C54 + C55 pCLA79 PylT promoter library C57 
pCLA47 Inv C54 + C55 pCLA79 PylT promoter library C57 
pCLA48 Inv C54 + C55 pCLA79 PylT promoter library C57 
pCLA49 Inv C54 + C55 pCLA79 PylT promoter library C57 
pCLA50 Inv C54 + C55 pCLA79 PylT promoter library C57 
pCLA51 Inv C54 + C55 pCLA79 PylT promoter library C57 
pCLA52 Inv C54 + C55 pCLA79 PylT promoter library C57 
pCLA53 Inv C56 + C55 pCLA82 MjYT_UCCU promoter library C57 
pCLA54 Inv C56 + C55 pCLA82 MjYT_UCCU promoter library C57 
pCLA55 Inv C56 + C55 pCLA82 MjYT_UCCU promoter library C57 
pCLA56 Inv C56 + C55 pCLA82 MjYT_UCCU promoter library C57 
pCLA57 Inv C56 + C55 pCLA82 MjYT_UCCU promoter library C57 
pCLA58 Inv C56 + C55 pCLA82 MjYT_UCCU promoter library C57 
pCLA59 Inv C56 + C55 pCLA82 MjYT_UCCU promoter library C57 
pCLA60 Inv C56 + C55 pCLA82 MjYT_UCCU promoter library C57 
pCLA61 Inv C56 + C55 pCLA82 MjYT_UCCU promoter library C57 
pCLA62 Inv C58 + C59 pCLA85 glnS promoter in front of pylS 
exchanged for Pcon 
C50/C53 
pCLA63 Inv C60 + C61 pCLA85 glnS promoter in front of pylS 
exchanged for Pcp25 
C50/C53 
pCLA64 Inv C62 + C63 pCLA85 glnS promoter in front of pylS 
exchanged for Plac1-6 Mt5 
C50/C53 
pCLA65 Inv C64 + C65 pCLA85 glnS promoter in front of pylS 
exchanged for Plac 
C50/C53 
pCLA66 Inv C66 + C68 pCLA85 glnS promoter in front of pylS 
exchanged for Pλcon/N25DSR 
C50/C53 
pCLA67 Inv C67 + C68 pCLA85 glnS promoter in front of pylS 
exchanged for Pλ 
C50/C53 
pCLA68 Inv C69 + C70 pCLA85 glnS promoter in front of pylS 
exchanged for PD/E20 
C50/C53 
pCLA69 Inv C71 + C72 pCLA85 glnS promoter in front of pylS 
exchanged for PH207 
C50/C53 
pCLA70 Inv C73 + C74 pCLA85 glnS promoter in front of pylS 
exchanged for PtacI 
C50/C53 
pCLA71 QC C36 + C37 pCLA3 C-terminal His6-tag on 
MjYRS_AGGA 
C3/C6 
pCLA72 QC C75 + C76 pCLA71 SalI restriction site behind 
MjYRS terminator 
C3/C53 
pCLA73 QC C77 + C78 pCLA9 NdeI restriction site in front of 
PylS start codon changed to KpnI 
C3/C6 
pCLA74 QC C79 + C80 pCLA73 PstI restriction site behind PylS 
stop codon changed to SacI 
C50/C53 
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pCLA75 QC C81 + C82 pCLA74 SalI restriction site in front of 
PylS promoter 
C6/C50 
pCLA76 QC C83 + C84 pCLA75 NotI restriction site behind PylS 
terminator 
C50/C53 
pCLA77 QC C85 + C86 pCLA4 deletion of genes for T7 RNA 
Polymerase, AraC and GFP 
digest only 
pCLA78 QC C87 + C88 pCLA77 NotI restriction site in front of 
PylT promoter 
C89 
pCLA79 QC C90 + C91 pCLA78 MfeI restriction site behind PylT 
terminator 
C89 
pCLA80 QC C85 + C86 pCLA6 deletion of genes for T7 RNA 
Polymerase, AraC and GFP 
digest only 
pCLA81 QC C92 + C93 pCLA80 MfeI restriction site in front of 
MjYT_UCCU promoter 
C57 
pCLA82 QC C94 + C95 pCLA81 XhoI restriction site behind 
MjYT_UCCU terminator 
C57/C89 
pCLA83 QC C81 + C82 pCLA9 SalI restriction site in front of 
PylS promoter 
C6/C50 
pCLA84 QC C83 + C84 pCLA9 NotI restriction site behind PylS 
terminator 
C50/C53 
pCLA85 QC C96 + C97 pCLA76 NdeI site on pCLA76 restored C50/C53 
pCLA86 QC C98 + C99 pCLA76 point mutation in restored NdeI 
site 
C50/C53 
pCLA87 QC C100 + C101 pCLA76 point mutation in restored NdeI 
site 
C50/C53 
pCLA88 QC C102 + C103 pCLA76 point mutation in restored NdeI 
site 
C50/C53 
pCLA89 QC C104 + C105 pCLA76 point mutation in restored NdeI 
site 
C50/C53 
pCLA90 QC C106 + C107 pCLA76 point mutation in restored NdeI 
site 
C50/C53 
pCLA92 Sub - pCLA72 MjYRS_AGGA gene cloned with 
BamHI + SalI into pCLA91 
C79/C89/ 
C108-C114 
pCLA93 Sub - pCLA86 PylS gene cloned with SalI + 
NotI (+ XhoI) into pCLA92 
C79/C89/ 
C108-C114 
pCLA94 Sub - pCLA79 PylT gene cloned with NotI + 
MfeI into pCLA93 
C79/C89/ 
C108-C114 
pCLA95 Sub - pCLA82 MjYT_UCCU gene cloned with 
MfeI + XhoI into pCLA94 
C79/C89/ 
C108-C114 
pCLA100 QC C115 + C116 pCLA99 deletion of the GST-MBP gene 
and incorporation of a MCS 
C117/C118 
pCLA105 Sub C119 + C120 pCLA101 sfGFP WT gene cloned with NcoI 
+ HindIII into pCLA100 
C117/C118 
pCLA106 Sub C119 + C120 pCLA102 sfGFP 150TAG gene cloned with 
NcoI + HindIII into pCLA100 
C117/C118 
pCLA107 Sub C119 + C120 pCLA103 sfGFP 134AGGA 150TAG gene 
cloned with NcoI + HindIII into 
pCLA100 
C117/C118 
pCLA108 Sub C119 + C120 pCLA104 sfGFP 134AGGA gene cloned 
with NcoI + HindIII into pCLA100 
C117/C118 
pCLA112 QC C121 + C122 pCLA111 Codon for T6 in the CAT gene 
exchanged for TAG 
C125-C127 
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pCLA113 QC C123 + C124 pCLA112 Codon for D111 in the CAT gene 
exchanged for AGGA 
C125-C127 
pCLA115 Sub - pCLA24 pylS with PglnS exchanged for 
pylS with Plib3E by cloning into 
pCLA95 with SalI + NotI (+ XhoI) 
C111 
pCLA116 Sub - pCLA62 pylS with PglnS exchanged for 
pylS with Pcon by cloning into 
pCLA95 with SalI + NotI (+ XhoI) 
C111 
pCLA117 Sub - pCLA65 pylS with PglnS exchanged for 
pylS with Plac by cloning into 
pCLA95 with SalI + NotI (+ XhoI) 
C111 
pCLA120 Sub C128 + C129 pCLA119 MjAzFRS gene cloned with NdeI 
+ PstI into pCLA1 
C3/C6 
pCLA121 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR  
C6 
pCLA122 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA123 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA124 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA125 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA126 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA127 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA128 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA129 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA130 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA131 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA132 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA133 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA134 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA135 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA136 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA137 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA138 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA139 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
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pCLA140 Inv C130 and  
C131 + C132 
pCLA120 MjAzFRS library in two rounds 
of inverse PCR 
C6 
pCLA142 QC C133 + C134 pCLA141 Codon for T6 in the H3opt gene 
exchanged for AGGA 
C108 
pCLA143 Sub C135 + C136 pCLA142 H3opt T6AGGA gene cloned with 
NcoI + HindIII into pCLA100 
C117 
pCLA144 Sub - pCLA122 MjYRS gene on pCLA98 replaced 
by MjAzFRS gene (clone #2) with 
NdeI + StuI 
digest only 
pCLA145 Sub - pCLA123 MjYRS gene on pCLA98 replaced 
by MjAzFRS gene (clone #3) with 
NdeI + StuI 
digest only 
pCLA146 Sub - pCLA125 MjYRS gene on pCLA98 replaced 
by MjAzFRS gene (clone #5) with 
NdeI + StuI 
digest only 
pCLA147 Sub - pCLA126 MjYRS gene on pCLA98 replaced 
by MjAzFRS gene (clone #6) with 
NdeI + StuI 
digest only 
pCLA148 Sub - pCLA131 MjYRS gene on pCLA98 replaced 
by MjAzFRS gene (clone #11) 
with NdeI + StuI 
digest only 
pCLA149 Sub - pCLA137 MjYRS gene on pCLA98 replaced 
by MjAzFRS gene (clone #17) 
with NdeI + StuI 
digest only 
pCLA150 Sub - pCLA138 MjYRS gene on pCLA98 replaced 
by MjAzFRS gene (clone #18) 
with NdeI + StuI 
digest only 
pCLA152 Sub - pCLA151 MjAzFRS (TAG) gene cloned into 
pCLA91 with BamHI + SalI 
C3/C6 
pCLA153 Sub - pCLA95 tRNA cassette (PylT and 
MjYT_UCCU) cloned into 
pCLA152 with NotI + XhoI 
C89/C109 
pCLA154 Sub - pCLA137 MjAzFRS (TAG) gene on pCLA153 
replaced by MjAzFRS (AGGA, 
clone #17) with NdeI + StuI 
C3/C6 
pCLA155 Sub - pCLA95 PylS gene cloned into pCLA154 
with SalI + NotI 
C111-C113 
pCLA165 Sub C81 + C84 pCLA158 BCNRS gene cloned into pCLA154 
with SalI + NotI 
C111-C113 
pCLA166 Sub C81 + C84 pCLA160 AzpcKRS gene cloned into 
pCLA154 with SalI + NotI 
C111-C113 
pCLA167 Sub - pCLA158 PylS gene on pCLA62 replaced by 
BCNRS gene with NdeI + StuI 
C6/C50 
pCLA168 Sub - pCLA158 PylS gene on pCLA65 replaced by 
BCNRS gene with NdeI + StuI 
C6/C50 
pCLA169 Sub - pCLA160 PylS gene on pCLA62 replaced by 
AzpcKRS gene with NdeI + StuI 
C6/C50 
pCLA170 Sub - pCLA160 PylS gene on pCLA65 replaced by 
AzpcKRS gene with NdeI + StuI 
C6/C50 
pCLA171 Sub - pCLA167 BCNRS gene with Pcon cloned into 
pCLA154 with SalI + NotI (+ XhoI) 
C111-C114 
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pCLA172 Sub - pCLA168 BCNRS gene with Plac cloned into 
pCLA154 with SalI + NotI (+ XhoI) 
C111-C114 
pCLA173 Sub - pCLA169 AzpcKRS gene with Pcon cloned 
into pCLA154 with SalI + NotI 
(+ XhoI) 
C111-C114 
pCLA174 Sub - pCLA170 AzpcKRS gene with Plac cloned 
into pCLA154 with SalI + NotI 
(+ XhoI) 
C111-C114 
pCLA184 Sub C137 + C138 pCLA182 SmR gene on pCLA116 replaced 
by CatR gene with AgeI + NheI 
C111/ 
C141/C142 
pCLA185 Sub C139 + C140 pCLA183 SmR gene on pCLA116 replaced 
by AmpR gene with AgeI + NheI 
C111/ 
C141/C142 
pCLA186 Sub C137 + C138 pCLA182 SmR gene on pCLA171 replaced 
by CatR gene with AgeI + NheI 
C111/ 
C141/C142 
pCLA187 Sub C139 + C140 pCLA183 SmR gene on pCLA171 replaced 
by AmpR gene with AgeI + NheI 
C111/ 
C141/C142 
pCLA193 QC C143 + C144 pCLA101 Embedding ORBS while “killing” 
the WT Shine-Dalgarno sequence 
C145 
pCLA194 QC C146 + C147 pCLA193 sfGFP gene exchanged by 
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8.4 Sequence Alignments 
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8.4.4 MjYT_UCCU Promoter Library 
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8.5 In-Cell sfGFP Fluorescence Measurements 
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